
<html lang="en"     class="pb-page"  data-request-id="72f50abe-5d7f-40cd-b6ba-9e51b308f009"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm2016864;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor" /></meta><meta name="dc.Creator" content="Jose María  Cid" /></meta><meta name="dc.Creator" content="Guillaume  Duvey" /></meta><meta name="dc.Creator" content="Gary  Tresadern" /></meta><meta name="dc.Creator" content="Vanthea  Nhem" /></meta><meta name="dc.Creator" content="Rocco  Furnari" /></meta><meta name="dc.Creator" content="Philippe  Cluzeau" /></meta><meta name="dc.Creator" content="Juan Antonio  Vega" /></meta><meta name="dc.Creator" content="Ana Isabel  de Lucas" /></meta><meta name="dc.Creator" content="Encarnación  Matesanz" /></meta><meta name="dc.Creator" content="José Manuel  Alonso" /></meta><meta name="dc.Creator" content="María Lourdes  Linares" /></meta><meta name="dc.Creator" content="José Ignacio  Andrés" /></meta><meta name="dc.Creator" content="Sonia M.  Poli" /></meta><meta name="dc.Creator" content="Robert  Lutjens" /></meta><meta name="dc.Creator" content="Hassan  Himogai" /></meta><meta name="dc.Creator" content="Jean-Philippe  Rocher" /></meta><meta name="dc.Creator" content="Gregor J.  Macdonald" /></meta><meta name="dc.Creator" content="Daniel  Oehlrich" /></meta><meta name="dc.Creator" content="Hilde  Lavreysen" /></meta><meta name="dc.Creator" content="Abdelah  Ahnaou" /></meta><meta name="dc.Creator" content="Wilhelmus  Drinkenburg" /></meta><meta name="dc.Creator" content="Claire  Mackie" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Description" content="The discovery and characterization of compound 48, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational explorat..." /></meta><meta name="Description" content="The discovery and characterization of compound 48, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational explorat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2016864" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2016864" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2016864" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2016864" /></link>
        
    
    

<title>Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2016864" /></meta><meta property="og:title" content="Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0005.jpeg" /></meta><meta property="og:description" content="The discovery and characterization of compound 48, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational exploration of the initial HTS hit 13 guided by an overlay model built with reported mGlu2 receptor PAM chemotypes. The initial weak in vitro activity of the hit 13 was quickly improved, although compounds still had suboptimal druglike properties. Subsequent modulation of the physicochemical properties resulted in compounds having a more balanced profile, combining good potency and in vivo pharmacokinetic properties. Final refinement by addressing cardiovascular safety liabilities led to the discovery of compound 48. Besides good potency, selectivity, and ADME properties, compound 48 displayed robust in vivo activity in a sleep–wake electroencephalogram (sw-EEG) assay consistent with mGlu2 receptor activation, in accordance with previous work from our laboratories." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2016864"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2016864">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2016864&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2016864&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2016864&amp;href=/doi/10.1021/jm2016864" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2388-2405</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201685h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201690h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose+Mar%C3%ADa++Cid">Jose María Cid</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guillaume++Duvey">Guillaume Duvey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Tresadern">Gary Tresadern</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vanthea++Nhem">Vanthea Nhem</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rocco++Furnari">Rocco Furnari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Cluzeau">Philippe Cluzeau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+Antonio++Vega">Juan Antonio Vega</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Isabel++de+Lucas">Ana Isabel de Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Encarnaci%C3%B3n++Matesanz">Encarnación Matesanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Manuel++Alonso">José Manuel Alonso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Lourdes++Linares">María Lourdes Linares</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Ignacio++Andr%C3%A9s">José Ignacio Andrés</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonia+M.++Poli">Sonia M. Poli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Lutjens">Robert Lutjens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hassan++Himogai">Hassan Himogai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Philippe++Rocher">Jean-Philippe Rocher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor+J.++Macdonald">Gregor J. Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Oehlrich">Daniel Oehlrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilde++Lavreysen">Hilde Lavreysen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abdelah++Ahnaou">Abdelah Ahnaou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wilhelmus++Drinkenburg">Wilhelmus Drinkenburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Mackie">Claire Mackie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Neuroscience Medicinal Chemistry, <sup>§</sup>Neuroscience Biology, and <sup>∥</sup>Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +34 925 245767. Fax: +34 925 245771. E-mail: <a href="/cdn-cgi/l/email-protection#cfa5aca6ab8fa6bbbce1a5a1a5e1aca0a2"><span class="__cf_email__" data-cfemail="bfd5dcd6dbffd6cbcc91d5d1d591dcd0d2">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2016864&amp;href=/doi/10.1021%2Fjm2016864" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2388–2405</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 24, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 December 2011</li><li><span class="item_label"><b>Published</b> online</span>24 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2016864" title="DOI URL">https://doi.org/10.1021/jm2016864</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2388%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJose%2BMar%25C3%25ADa%2BCid%252C%2BGuillaume%2BDuvey%252C%2BGary%2BTresadern%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D5%26contentID%3Djm2016864%26title%3DDiscovery%2Bof%2B1%252C4-Disubstituted%2B3-Cyano-2-pyridones%253A%2BA%2BNew%2BClass%2Bof%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B2%2BReceptor%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2405%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2016864"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1786</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2016864" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;María Cid&quot;},{&quot;first_name&quot;:&quot;Guillaume&quot;,&quot;last_name&quot;:&quot;Duvey&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Tresadern&quot;},{&quot;first_name&quot;:&quot;Vanthea&quot;,&quot;last_name&quot;:&quot;Nhem&quot;},{&quot;first_name&quot;:&quot;Rocco&quot;,&quot;last_name&quot;:&quot;Furnari&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Cluzeau&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Antonio Vega&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Isabel de Lucas&quot;},{&quot;first_name&quot;:&quot;Encarnación&quot;,&quot;last_name&quot;:&quot;Matesanz&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Manuel Alonso&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Lourdes Linares&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Ignacio Andrés&quot;},{&quot;first_name&quot;:&quot;Sonia&quot;,&quot;last_name&quot;:&quot;M. Poli&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Lutjens&quot;},{&quot;first_name&quot;:&quot;Hassan&quot;,&quot;last_name&quot;:&quot;Himogai&quot;},{&quot;first_name&quot;:&quot;Jean-Philippe&quot;,&quot;last_name&quot;:&quot;Rocher&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;J. Macdonald&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Oehlrich&quot;},{&quot;first_name&quot;:&quot;Hilde&quot;,&quot;last_name&quot;:&quot;Lavreysen&quot;},{&quot;first_name&quot;:&quot;Abdelah&quot;,&quot;last_name&quot;:&quot;Ahnaou&quot;},{&quot;first_name&quot;:&quot;Wilhelmus&quot;,&quot;last_name&quot;:&quot;Drinkenburg&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Mackie&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;2388-2405&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2016864&quot;},&quot;abstract&quot;:&quot;The discovery and characterization of compound 48, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational exploration of the initial HTS hit 13 guided by an overlay model built with reported mGlu2 receptor PAM chemotypes. The initial weak in vitro activity of the hit 13 was quickly improved, although compounds still had suboptimal druglike properties. Subsequent modulation of the physicochemical properties resulted in compounds having a more balanced profile, combining good potency and in vivo pharmacokinetic properties. Final refinement by addressing cardiovascular safety liabilities led to the discovery of compound 48. Besides good potency, selectivity, and ADME properties, compound 48 displayed robust in vivo activity in a sleep–wake electroencephalogram (sw-EEG) assay consistent with mGlu2 receptor activation, in accordance with previous work from our laboratories.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016864&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016864" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016864&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016864" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2016864&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016864" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2016864&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2016864&amp;href=/doi/10.1021/jm2016864" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2016864" /></input><a href="/doi/pdf/10.1021/jm2016864" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26pmid%3D22364337%26genre%3Darticle%26aulast%3DCid%26date%3D2012%26atitle%3DDiscovery%2Bof%2B1%252C4-Disubstituted%2B3-Cyano-2-pyridones%253A%2BA%2BNew%2BClass%2Bof%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B2%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D2388%26epage%3D2405%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The discovery and characterization of compound <b>48</b>, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational exploration of the initial HTS hit <b>13</b> guided by an overlay model built with reported mGlu2 receptor PAM chemotypes. The initial weak in vitro activity of the hit <b>13</b> was quickly improved, although compounds still had suboptimal druglike properties. Subsequent modulation of the physicochemical properties resulted in compounds having a more balanced profile, combining good potency and in vivo pharmacokinetic properties. Final refinement by addressing cardiovascular safety liabilities led to the discovery of compound <b>48</b>. Besides good potency, selectivity, and ADME properties, compound <b>48</b> displayed robust in vivo activity in a sleep–wake electroencephalogram (sw-EEG) assay consistent with mGlu2 receptor activation, in accordance with previous work from our laboratories.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) of vertebrates and modulates the synaptic response via activation of either ionotropic (iGlu) or metabotropic glutamate (mGlu) receptors.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Eight G-protein-coupled mGlu receptor subtypes are known and have been classified into three groups based on homology, pharmacology, and signaling pathways: group I, mGlu1 and mGlu5 receptors; group II, mGlu2 and mGlu3 receptors; group III, mGlu4, -6, -7, and -8 receptors.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Group I receptors are primarily expressed postsynaptically, whereas both groups II and III are mainly presynaptic where they reduce glutamate release.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> The group II mGlu2 receptor is widely distributed in the brain, and high levels are found in forebrain and limbic areas such as prefrontal cortex, hippocampus, and amygdala where excessive glutamate neurotransmission may be implicated in the pathophysiology of anxiety and schizophrenia.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a> It is therefore expected that activation of mGlu2 receptors may provide anxiolytic and/or antipsychotic effects.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> This was confirmed in a phase II trial with LY2140023, a prodrug of the mixed mGlu2/3 receptor agonist LY404039, which showed improvements in positive and negative symptoms in schizophrenic patients.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, anxiolytic efficacy of the agonist LY354740 was demonstrated in a CO<sub>2</sub> inhalation study by reduction in number and severity of panic symptoms in patients with DMS-IV panic disorder.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Multiple preclinical studies have shown the efficacy of mGlu2 receptor activation in animal models of disorders such as anxiety/stress and depression.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><div class="NLM_p">Constrained glutamate agonists such as LY404039 and LY354740 bind at the orthosteric site, and behavioral studies in knockout mice suggest that their activity is mGlu2 receptor mediated.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> Receptor activation with positive allosteric modulators (PAMs) which act via alternative allosteric site(s) offers several advantages. First, allosteric molecules are likely to be less polar and have improved CNS penetration, as they do not require amino acid functional groups necessary at the orthosteric site. The allosteric site(s) can be less conserved and therefore allow improved mGlu receptor subtype selectivity. They only act in the presence of endogenous glutamate and so may be less prone to cause receptor desensitization,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> and they respond to physiological glutamate fluctuations. Given these potential advantages, the number of reported mGlu2 receptor PAM chemical series has increased over the past years (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Pyridylmethylsulfonamides (2,2,2-TEMPS, <b>1</b>),<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> acetophenones (<b>2</b>),<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28-31)</a> bicyclic ketones (BINA, <b>3</b>),<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> and indoles (<b>4</b>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> were the earliest reported mGlu2 receptor PAMs. Subsequently AstraZeneca and NPS Pharmaceuticals filed patent applications for isoindolones (<b>5</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and pyrazolones (<b>6</b>);<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the former compounds were included in a recent article presenting BINA analogues with improved pharmacokinetic (PK) properties.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Newer series of benzimidazoles (<b>7</b>),<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> oxazolidinones (<b>8</b>),<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> and oxazolobenzimidazoles (<b>9</b>)<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> have been reported, as well as isoquinolones (<b>10</b>),<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> imidazopyridines (<b>11</b>),<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and 1,5-disubstituted-2-pyridones (<b>12</b>)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> from our laboratories (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_p">We have recently reported the discovery and exploration of a series of isoquinolones<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> and 1,5-disubstituted-2-pyridones<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> for which we have shown that combining appropriate potency and metabolic stability was a challenge. As a result, lead compounds from these chemical classes suffered from poor pharmacokinetics (PK) properties that precluded their further development.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Here we report the identification and in vivo evaluation of advanced leads from a novel 1,4-disubstituted-2-pyridone series of mGlu2 receptor PAMs.<a onclick="showRef(event, 'ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51">(49-51)</a></div><div class="NLM_p">2-Pyridone <b>13</b> was identified as a hit from a high throughput screening (HTS) of the Addex Pharmaceuticals compound collection. The molecule displayed low micromolar activity in a mGlu2 receptor PAM fluorometric imaging plate reader (FLIPR) assay which was subsequently confirmed in a follow-up [<sup>35</sup>S]GTPγS functional assay with an EC<sub>50</sub> of 8 μM and <i>E</i><sub>MAX</sub> <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> of 117%. The HTS hit <b>13</b> was considered in terms of its 3D similarity to mGlu2 receptor PAMs <b>2</b>, <b>3</b>, <b>5</b>, and <b>6</b> known at the time. There was good overlap between the pyridone scaffold, matching the carbonyl acceptor (feature F1) and the ring centers present in other mGlu2 receptor PAMs. In addition, there was excellent match of the isopentyl group in hydrophobic region (F2), while the cyano compared well to the methyl, bromo, and chloro species present within a small volume (V1) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). However, the HTS hit was clearly lacking the large substituent in the 4 position on the pyridone ring present in the other reference molecules. A lead optimization strategy is described here to identify in vivo active mGlu2 receptor PAMs via modification at the 4 position of the HTS hit <b>13</b>. In this report we describe our optimization efforts that led to the discovery of the advanced lead <b>48</b>. This molecule showed good mGlu2 receptor PAM in vitro activity and selectivity, acceptable preliminary safety profile, and good brain exposure. We have shown previously that mGlu2 receptor activation with the agonist LY354740 and/or PAM BINA (<b>3</b>) shows common changes of rapid eye movement (REM) sleep variables in a sleep-wake electroencephalogram (sw-EEG) assay, and that combining both compounds produces synergistic effects.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compound <b>48</b> displayed robust in vivo activity in the same model, consistent with mGlu2 receptor activation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported mGlu2 receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Origin of the 1,4-disubstituted 2-pyridone mGlu2 receptor PAM series. Shown are HTS hit <b>13</b> and overlay comparison of <b>13</b> (blue) with other known mGlu2 receptor PAMs: <b>2</b> (yellow), <b>3</b> (magenta), <b>5</b> (green), and <b>6</b> (black). Dotted spheres show similar overlapping features. F1 is a scaffold acceptor. F2 is a hydrophobic group. V1 is a volume containing a small substituent such as Br, Me, or Cl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthesis of target compounds <b>13</b>–<b>50</b> are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. They were prepared via Suzuki coupling of the corresponding 4-bromopyridones <b>51a</b>–<b>d</b> with an array of either boronic acids (<b>52</b>) or esters (<b>53</b>). The chemical structures of compounds <b>13</b>–<b>50</b> are shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Final Compounds <b>13</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O/1,4-dioxane, 150 °C, 10 min, microwave.</p></p></figure><div class="NLM_p">The key bromopyridone intermediates <b>51a</b>–<b>d</b> and noncommercially available boronic acids <b>52</b> and esters <b>53</b> were prepared following the procedures shown in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Intermediate pyridones <b>51a</b>–<b>d</b> were obtained via the three-step sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Thus, treatment of 2-hydroxypyridine derivative <b>54</b> with the required alkyl halides <b>55a</b>–<b>d</b> afforded the N-alkylated 2-pyridones <b>56a</b>–<b>d</b>. Subsequent cleavage of the methyl ether followed by treatment of the resulting hydroxypyridones <b>57a</b>–<b>d</b> with POBr<sub>3</sub> yielded the target intermediates <b>51a</b>–<b>d</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Bromopyridone Building Blocks <b>51a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeCN, 100 °C, 18 h; (b) NaOH, H<sub>2</sub>O, reflux, 18 h; (c) POBr<sub>3</sub>, DMF, 110 °C, 3 h.</p></p></figure><div class="NLM_p">The synthesis of the tetrahydropyranyl substituted boronates <b>53a</b>,<b>b</b> was accomplished in two steps (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The oxygen-linked tetrahydropyranyl derivative <b>53a</b> was prepared via Mitsunobu reaction of 4-hydroxytetrathydropyran <b>58</b> with 4-bromo-2-chlorophenol <b>59</b> followed by palladium catalyzed reaction of the intermediate bromophenyl ether <b>60</b> with bis(pinacolato)diboron. In the case of the nitrogen-linked analogue <b>53b</b>, the required intermediate bromoaniline <b>63</b> was obtained by reductive amination of the pyranone <b>61</b> with 4-bromo-2-chloroaniline <b>62</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tetrahydropyranyl Substituted Boronates <b>53a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) polymer supported PPh<sub>3</sub>, DBAD, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (b) PdCl<sub>2</sub>dppf, AcOK, DMF/1,4-dioxane, 150 °C, 10 min, microwave; (c) NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, rt, 16 h.</p></p></figure><div class="NLM_p">The 3-pyridyloxy substituted boronates <b>53c</b>–<b>g</b> were prepared following the synthesis sequence shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Nucleophilic aromatic substitution of 4-fluoronitrobenzenes <b>65a</b>,<b>b</b> with 3-hydroxypyridines <b>64a</b>–<b>c</b> led to the 3-pyridyl 4-nitrophenyl ethers <b>66a</b>–<b>e</b>. Subsequent reduction of the nitro group followed by Sandmeyer reaction on the intermediate anilines <b>67a</b>–<b>e</b> yielded the bromophenylethers <b>68a</b>–<b>e</b> that were finally transformed into the boronates <b>53c</b>–<b>g</b> by palladium catalyzed reaction with bis(pinacolato)diboron.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 3-Pyridyloxy Substituted Boronates <b>53c</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 170 °C, 30 min, microwave; (b) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 130 °C, 16–24 h; (c) H<sub>2</sub> (1 atm), Pd/C, EtOAc, rt, 16 h; (d) SnCl<sub>2</sub>, EtOH, 90 °C, 1 h; (e) NaNO<sub>2</sub>, HBr, H<sub>2</sub>O, rt, 2 h; (f) CuBr, rt, 2 h, then 140 °C, 2 h; (g) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, DMSO, 120 °C, 5 h; (h) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, 1,4-dioxane, DMF, 150 °C, 10 min, microwave.</p></p></figure><div class="NLM_p">The 4-pyridyloxy substituted boronates <b>53h</b>–<b>k</b> were prepared by reaction of 4-bromophenol <b>70a</b>–<b>c</b> with the corresponding 4-chloropyridines <b>69a</b>–<b>c</b> followed by standard “bromo-to-boron” transformation of the intermediate bromophenyl ethers <b>71a</b>–<b>d</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). In the case of the more electron deficient halogen-substituted 4-bromophenols <b>73a</b>–<b>c</b>, the nucleophilic substitution with 4-chloropyridines <b>69a</b>–<b>c</b> failed and starting materials were recovered. Nevertheless, the use of the more electrophilic 4-nitropyridine <i>N</i>-oxide <b>72</b> solved the problem and the required bromophenyl ethers <b>74a</b>–<b>c</b> could be obtained. Interestingly, the standard “bromo-to-boron” transformation led to simultaneous reduction of the pyridine <i>N</i>-oxide, yielding the final boronates <b>53l</b>–<b>n</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 4-Pyridyloxy Substituted Boronates <b>53h</b>–<b>n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH or K<sub>2</sub>CO<sub>3</sub>, DMF, 170 °C, 30 min, microwave; (b) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, DMSO, 120 °C, 5 h; (c) NaH or K<sub>2</sub>CO<sub>3</sub>, solvent, 150–180 °C, 3 h to 2 days.</p></p></figure><div class="NLM_p last">The required boronic acids or esters required for the preparation of compounds <b>13</b>–<b>19</b>, <b>24</b>, <b>25</b>, <b>28</b>, <b>30</b>, and <b>31</b> are commercially available.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For our initial exploration we kept constant the isopentyl group at position 1 of the cyanopyridone core and explored different substituents and decoration patterns of the C-4 phenyl ring (<b>13</b>–<b>31</b>). In general, most compounds showed excellent potentiation with <i>E</i><sub>MAX</sub> values ranging from 135% to 249% (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Initial SAR showed that substitution at the para-position was preferred for activity, as moving the 4-methoxy group of compound <b>14</b> to meta-position (<b>15</b>) and ortho-position (<b>16</b>) resulted in a decrease in activity. Introduction of a fluorine atom adjacent to the methoxy group <b>17</b> resulted in activity comparable to that of <b>15</b>. Better results were obtained with groups such as chlorine or methoxy, and compounds <b>18</b> and <b>19</b> had EC<sub>50</sub> values of 363 and 260 nM, respectively. In vitro metabolic stability for <b>18</b> was comparable to <b>13</b>. In general, replacement of the methoxy group by larger alkyloxy substituents <b>20</b>–<b>27</b> provided compounds with improved potency, indicating that increased lipophilicity in that area of the molecule is advantageous for potency. Compound <b>20</b>, having a bulkier and more lipophilic ether, was significantly more potent (EC<sub>50</sub> = 290 nM) than <b>13</b>. In addition, <b>20</b> was found to be metabolically more stable in both human liver microsomes (HLM, 17%) and rat liver microsomes (RLM, 16%). As in the case of <b>18</b>, introduction of an adjacent chlorine atom to the cyclopropylmethyloxy group of compound <b>20</b> gave compound <b>21</b>, which had increased potency (EC<sub>50</sub> = 110 nM) but higher metabolic turnover in RLM (72%). The same trend in activity was observed with compound <b>22</b> (EC<sub>50</sub> = 100 nM). The less liphophilic tetrahydropyranyl derivative <b>23</b> was slightly less potent than <b>21</b> and <b>22</b> and showed a reduced metabolism in RLM (54%). Following the trend shown by previous analogues the more liphophilic biaryl ether <b>24</b> showed higher potency than previous ethers (EC<sub>50</sub> = 42 nM) and was metabolically more stable in both HLM and RLM (36% and 32%, respectively). Unfortunately, the aqueous solubility of <b>24</b> was rather poor (<0.001 mg/mL at pH 4–7.4), which could present a challenge in terms of oral bioavailability and would also complicate its formulation for in vivo studies.</div><div class="NLM_p">We therefore focused on the design of compounds bearing hydrophilic/polar groups as substituents of the C-4 phenyl ring, <b>25</b>–<b>31</b>. In an attempt to improve aqueous solubility, the set of pyridyl ethers <b>25</b>–<b>27</b> was prepared. These compounds were found to be at least 10-fold less active than the biaryl ether analogue <b>24</b> with EC<sub>50</sub> values ranging from 479 to 646 nM. Metabolic stability for these pyridine analogues was promising. As anticipated, the basic pyridine nitrogen had a beneficial effect for the aqueous solubility of these analogues, particularly pyridine derivatives <b>26</b> and <b>27</b> (≥4 mg/mL at 20% HP-β-CD buffer, pH 4).</div><div class="NLM_p">To complete the SAR analysis, we examined the effect of replacing the ether linker by <i>N</i>-alkyl substitutients. Relative to the ether <b>14</b>, compound <b>28</b> bearing a methylamino substituent was ∼4-fold more potent (EC<sub>50</sub> = 460 nM). This trend was not confirmed by other N-linked analogues such as <b>29</b>, which showed potency comparable to that of its ether analogue <b>23</b>. Tertiary amines <b>30</b> were overall less potent. Finally, compound <b>31</b> turned out to be 3-fold less potent than its oxygen analogue <b>27</b>. In this case, the increased basicity of the pyridine nitrogen could account for the loss of activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity and Metabolic Stability Data of Representative mGlu2 Receptor PAMs <b>13-31</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0001.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are the mean of three experiments. Only differences in pEC<sub>50</sub> up to 0.6 log units (SD < 0.5) were considered as reproducible and were maintained.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">HLM and RLM data refer to percent of compound metabolized after incubation with microsomes for 15 min at 5 μM.</p></div></div><div></div></div><div class="NLM_p">Analysis of the structure–activity relationship (SAR) generated from the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> showed that both potency and fair metabolic stability could be achieved in this novel 1,4-disubstituted 2-pyridone series. However, the most potent compounds (<b>21</b>, <b>22</b>, and <b>24</b>) suffered from poor solubility. Taking this into account, compounds <b>26</b> and <b>27</b> combining moderate activity, metabolic stability, and good solubility were selected for further evaluation.</div><div class="NLM_p">Further profiling of <b>27</b> and related analogues revealed some potential safety issues associated with these pyridyl derivatives. For instance, compound <b>27</b> showed significant CYP450 inhibition<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> (>50% at1 μM) of the major isozymes, 3A4 (70%), 2C9 (82%), 2D6 (84%), 1A2 (80%), and 2C19 (97%), which could translate into potential drug–drug interactions in the case of coadministration with other drugs. Moreover, <b>27</b> showed a moderate hERG channel interaction (52% inhibition at 3 μM) in a patch clamp assay, which may result in QTc prolongation and lead to serious cardiac arrhythmias. The optimization of the pyridyl derivatives, besides improving potency, also focused on ways to attenuate the possible safety concerns derived from CYP450 and hERG channel interactions. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> shows representatives that best illustrate our SAR understanding and progress.</div><div class="NLM_p">Introduction of a methyl group in the adjacent position of the pyridine nitrogen led to a remarkable improvement of the CYP450 profile, and compound <b>32</b> showed less than 50% inhibition toward the 5 isoforms at 5 μM. <b>32</b> was slightly more potent than <b>27</b>; however, it showed a worse metabolic stability profile in HLM (61% vs 21% for <b>27</b>). Metabolite identification studies after in vitro incubation with RLM and HLM revealed that oxidation of the <i>N</i>-isopentyl chain was the preferred metabolic pathway for <b>32</b>. Looking for compounds with better metabolic stability led us to prepare <b>33</b>–<b>35</b>, where the metabolically unstable isopentyl chain was replaced with a variety of aliphatic groups. A 3-fold increase in activity was found with the <i>N</i>-cyclobutylmethyl analogue <b>33</b> (EC<sub>50</sub> = 126 nM); unfortunately, this increase in potency was accompanied by a strong interaction with the hERG channel (80% inhibition at 3 μM). A better overall profile was identified in <b>34</b> having an <i>N</i>-butyl substituent, which showed good potency and CYP450 profile comparable to those of <b>27</b>. Furthermore its metabolic stability in HLM was enhanced (31% vs 61% for <b>32</b>). Compound <b>35</b>, contained a less lipophilic <i>N</i>-cyclopropylmethyl substituent and showed 2-fold reduction in potency relative to <b>32</b>. The data generated for <b>32</b>–<b>35</b> proved that while increasing lipophilicity around the pyridone nitrogen was beneficial for primary activity, it also increased the liability of oxidative metabolic pathways. A similar trend was found in the 3-pyridyl derivatives <b>36</b>–<b>38</b>. Interestingly, compound <b>36</b> proved to be cleaner in the hERG patch clamp assay compared to its corresponding regioisomer compound <b>34</b>. Although not reported here, all attempts to increase potency and metabolic stability by polar/hydrophilic substituents on the pyridinyl ring were fruitless.</div><div class="NLM_p">An SAR trend on liphophilicity vs potency was observed with analogues having a second methyl on the pyridine ring, <b>39</b>–<b>41</b>. These compounds showed on average a 3-fold increase in potency when compared to their corresponding monomethylated versions <b>36</b> and <b>38</b>. The introduction of an additional methyl group had little effect on metabolism of these compounds. Moreover, we examined the influence of the introduction of a chlorine atom on the phenyl ring in the pyridine series. As previously observed for compounds <b>20</b> and <b>21</b>, chloro-substituted pyridyloxy derivatives <b>44</b>–<b>47</b> showed a 3- to 4-fold increase in potency when compared to their corresponding nonchlorinated analogues. Interestingly, the chloro substituent was preferred in the position adjacent to the ether linker, as moving it to an alternative location, as in <b>43</b>, led to a substantial loss of activity. This might be explained as a result of possible conformational changes in the molecule due to an unfavorable interaction between the cyano and chloro groups. The additional chloro substituent had little or no effect on the microsomal stability of these compounds, which ranged from moderate to good in all cases. The introduction of the liphophilic chlorine atom had an effect not only on primary activity but also on the hERG interaction. Thus, compounds <b>44</b>–<b>47</b> showed inhibition values greater than 55% at 3 μM.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity and Metabolic Stability Data of Representative Pyridyloxyaryl-Substituted mGlu2 Receptor PAMs <b>32</b>–<b>47</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0002.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0003.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are the mean of three experiments. Only differences in pEC<sub>50</sub> up to 0.6 log units (SD < 0.5) were considered as reproducible and were maintained.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">HLM and RLM data refer to percent of compound metabolized after 15 min at 5 μM.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Experiments were performed using HEK293 cells stably transfected with the hERG potassium channel. Whole-cell currents were recorded with an automated patch-clamp system (PatchXpress 7000A). Three concentrations of compound were tested (0.1, 0.3, and 3 μM; <i>n</i> = 3) and compared to vehicle (0.1% DMSO; <i>n</i> = 3). Data are presented as percent inhibition at the highest concentration tested (3 μM).</p></div></div><div></div></div><div class="NLM_p">To better understand the origin of this hERG liability, additional compounds were further profiled in the patch-clamp assay and relevant physicochemical properties (cLogP and p<i>K</i><sub>a</sub>) were calculated. The results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. A careful analysis of data showed that there was a relationship between the basicity of the pyridine nitrogen and the percent of inhibition in the patch-clamp test. Thus, the less basic 2- and 3-pyridyloxy derivatives <b>25</b> and <b>26</b> showed a less pronounced hERG interaction when compared to their regioisomeric 4-pyridyloxy analogue <b>27</b>. This effect was more pronounced for <b>31</b> where the strong hERG affinity (91%) is consistent with a remarkable increase in basicity when compared to <b>27</b>. The same effect was found with the methyl substituted pyridyloxy analogues <b>34</b>, <b>44</b>, and <b>46</b>, where additional methyl groups enhanced the basicity. Thus, the dimethyl derivative <b>46</b> showed higher affinity for the hERG channel than its monomethyl analogue <b>44</b>. These data also suggest that the overall lipophilicity of the compounds contributes to their interaction with the hERG channel, with the more liphophilic analogues having greater inhibition values.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Patch-Clamp Data and Calculated Physicochemical Properties of Analogues <b>25</b>–<b>27</b>, <b>31</b>, <b>34</b>, <b>44</b>, and <b>46</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hERG<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">cLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">5.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Experiments were performed using HEK293 cells stably transfected with the hERG potassium channel. Whole-cell currents were recorded with an automated patch-clamp system (PatchXpress 7000A). Three concentrations of compound were tested (0.1, 0.3, and 3 μM; <i>n</i> = 3) and compared to vehicle (0.1% DMSO; <i>n</i> = 3). Data are presented as percent inhibition at the highest concentration tested (3 μM).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Calculated with ACD/pKa, version 12.0.</p></div></div></div><div class="NLM_p">On the basis of these SAR trends, we focused on analogues having an electron withdrawing and less lipophilic fluorine substituent on the phenyl ring in an attempt to modulate the basicity of the distal pyridine ring (p<i>K</i><sub>a</sub> < 6) while keeping the overall lipophilicity in a more optimal range (cLogP ≈ 4). Three selected examples (<b>48</b>–<b>50</b>) from this exploration are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. In relation to primary activity, compound <b>48</b> was 2-fold less potent than its chloro analogue <b>42</b>. On the contrary, a 3-fold improvement in activity was observed with <b>49</b> over its chloro-substituted equivalent <b>43</b>. In this case the smaller fluorine atom may have less interaction with the cyano group and may therefore not affect the conformation of the molecule. The introduction of a second methyl group as in <b>50</b> did not result in a potency increase. Compounds <b>48</b>–<b>50</b> showed good to moderate metabolic stability across human and rat liver microsomes. More interestingly, our hypothesis for hERG interaction was confirmed with analogue <b>48</b>, which when compared to compound <b>34</b> showed a significant reduction in its hERG inhibition (21% for <b>48</b> vs 53% for <b>34</b> at 3 μM). This reduction was consistent with the lower basicity of the pyridine (<b>48</b> p<i>K</i><sub>a</sub> = 5.9 vs <b>34</b> p<i>K</i><sub>a</sub> = 6.7) and equal cLogP for both molecules. The reduction in basicity of the pyridine nitrogen was less pronounced when the fluorine atom was in a position meta to the ether linker, and consequently <b>49</b> showed hERG inhibition similar to that of <b>34</b> (52% for <b>49</b> vs 53% for <b>34</b> at 3 μM). Despite the fluorine substituent, the introduction of a second methyl group on the pyridine ring was detrimental for hERG interaction, and compound <b>50</b> showed 71% inhibition. In this latter case, the additional methyl increased basicity and lipophilicity, which translated into the stronger hERG inhibition.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional Activity, Metabolic Stability, Patch-Clamp Data, and Calculated Physicochemical Properties of Analogues <b>48</b>–<b>50</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0004.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Values are the mean of three experiments. Only differences in pIC<sub>50</sub> up to 0.6 (SD < 0.5) were considered as reproducible and were maintained.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">HLM and RLM data refer to percent of compound metabolized after 15 min at 5 μM.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Experiments were performed using HEK293 cells stably transfected with the hERG potassium channel. Whole-cell currents were recorded with an automated patch-clamp system (PatchXpress 7000A). Three concentrations of compound were tested (0.1, 0.3, and 3 μM; <i>n</i> = 3) and compared to vehicle (0.1% DMSO; <i>n</i> = 3). Data are presented as percent inhibition at the highest concentration tested (3 μM).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Calculated with ACD/pKa, version 12.0.</p></div></div><div></div></div><div class="NLM_p">A selected group of representative compounds from the pyridyloxy class, <b>34</b>, <b>36</b>, and <b>46</b>–<b>48</b>, were evaluated in brain penetration studies in mice. The results obtained are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Using compound <b>34</b> as a baseline, we observed that after subcutaneous administration at 10 mg/kg dose in mice the compound exhibited moderate exposures even 1.5 h postdose. A subtle modification of compound <b>34</b> to its 3-pyridine version <b>36</b> led to a poorer brain penetration with lower brain concentrations, which rapidly declined. Despite their strong hERG liability, we evaluated the effect of the left-hand side in compounds <b>46</b> and <b>47</b>, which rendered these compounds most potent, on plasma and brain exposures. Thus, compound <b>46</b> showed brain exposures similar to those of compound <b>36</b> but only at 1 h after administration, being much lower after 1.5 h. Compound <b>47</b>, having a different N-substitution pattern, showed a reduction in <i>B</i>/<i>P</i> ratios combined with poor exposures. The best results were obtained with compound <b>48</b>, suggesting that the introduction of a fluorine atom is beneficial in terms of in vivo PK properties. Exposure of this compound in brain was comparable to that of analogue <b>34</b> at the 1 h time point and was 2-fold higher at 1.5 h, likely related to reduced clearance. In summary, despite their excellent in vitro potency, compounds <b>46</b> and <b>47</b> were precluded from further in vivo evaluation because of low brain exposures. Compound <b>48</b> appeared to be the most suitable for further in vivo profiling.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Brain Kinetics after a Single Subcutaneous Dose at 10 mg/kg of Compounds <b>34</b>, <b>36</b>, and <b>46</b>–<b>48</b> in the Swiss Mouse<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">brain level ± SEM <a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>(ng/g)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">0.5 h</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">1.5 h</th><th class="colsep0 rowsep0" align="center"><i>B</i>/<i>P</i>(1 h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">1156 ± 259</td><td class="colsep0 rowsep0" align="left">994 ± 122</td><td class="colsep0 rowsep0" align="left">592 ± 115</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">822<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">294<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">1480 ± 173</td><td class="colsep0 rowsep0" align="left">830 ± 482</td><td class="colsep0 rowsep0" align="left">281 ± 196</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">750 ± 220</td><td class="colsep0 rowsep0" align="left">357 ± 15</td><td class="colsep0 rowsep0" align="left">240 ± 47</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">1280<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1117<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1018<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Study in male Swiss mice dosed at 10 mg/kg formulated in 20% HP-β-CD at pH 4.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Data are expressed as geometric mean values of at least two runs ± the standard error of the mean (SEM).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Only one animal was dosed.</p></div></div></div><div class="NLM_p">The ability of compound <b>48</b> to shift the in vitro concentration response curve (CRC) of glutamate was investigated further. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the CRC of glutamate shifted to the left and upward with increasing concentrations of compound <b>48</b>. An ∼11-fold shift in the glutamate EC<sub>50</sub> was observed in the presence of 3 μM <b>48</b>. This result is in line with a positive allosteric interaction between glutamate and compound <b>48</b> and indicates that <b>48</b> as PAM increases both efficacy and potency of glutamate.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glutamate CRC in presence of varying concentration of compound <b>48</b>, demonstrating an approximate 11-fold decrease in glutamate EC<sub>50</sub> at 3 μM <b>48</b> (experiment performed with CHO cells expressing cloned human mGlu2 receptor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Targeting the allosteric site of mGlu receptors is expected to improve the chance of identifying selective ligands. Thus, compound <b>48</b> was tested for agonist or antagonist activity on mGlu receptors in fluorescent Ca<sup>2+</sup> assays using HEK293 cells expressing human mGlu1, mGlu3, and mGlu5 receptors or in [<sup>35</sup>S]GTPγS assays using L929 cells expressing human mGlu4 or using CHO cells expressing rat mGlu6 receptors. Compound <b>48</b> was found to be selective and did not show activity against the other mGlu receptors. In addition, compound <b>48</b> was profiled against ∼50 targets in a selectivity screen performed at CEREP.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Selectivity overall was good, and the only interaction greater than 50% at 10 μM was with the norepinephrine transporter.</div><div class="NLM_p">Given the high expression of mGlu2 receptor in forebrain regions and the relationship between glutamate neurotransmission and sleep process, we decided to evaluate the acute pharmacological effect of <b>48</b> in sw-EEG in rats. The results that we obtained were in accordance with the findings from earlier animal studies in our laboratories, in which modulation of the mGlu2 receptor elicited common changes in a rodent’s sleep–wake architecture.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Relative to control, acute subcutaneous administration of a dose of 10 mg/kg, <b>48</b> exerted significant effect in suppressing REM sleep during the first 2 h without clear effects on the other sleep–wake stages (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Remarkably, at this dose of 10 mg/kg REM sleep reduction was accompanied by a significant lengthening of REM sleep onset latency (bottom right panel). Analysis of sw-EEG parameters indicated that reduction in REM sleep time resulted from a reduction in both number of periods and their mean duration. No clear disturbances in total time spent in different vigilance states or sleep variables were found either during or after these effects of the compound, apart from the reduction in intermediate sleep transients, which are directly linked to (the reduction in) REM sleep occurrence. Last, no indications of sleep fragmentation were revealed by examination of total number of transitions from sleep states toward waking.</div><div class="NLM_p">The effects on sw-EEG architecture in rats demonstrate that compound <b>48</b> (10 mg/kg) was centrally active in rats. Remarkably, <b>48</b> produced a robust inhibition of REM sleep during the first 2 h associated with an increase in REM sleep onset latency while no subsequent homeostatic changes were observed over the recording session.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of subcutaneous administration of <b>48</b> (10 mg/kg) or vehicle (20% CD + 2H2T) on sleep–wake organization in rats during 20 consecutive hours. Mean percentage of occurrence per 30 min period is indicated for each sleep–wake state. Black bar under the graphs indicates dark period. Small bar charts indicate amounts of vigilance states in min (plus SEM) during the first 2 h postadministration. For REM sleep, the REM sleep onset latency (ROL) is indicated additionally in the small bottom right panel. <i>N</i> = 8 for each group. ∗ indicates <i>p</i> < 0.05: Wilcoxon–Mann–Whitney rank sum tests compared to vehicle values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, the discovery and optimization of a novel series of 1,4-disubstituted 2-pyridones in search of mGlu2 receptor PAMs with in vivo activity are reported. The lead optimization strategy started from the hit compound <b>13</b> and was guided by an overlay model built with different mGlu2 receptor PAMs known to date. That exploration led quickly to compounds with remarkably increased potency but poor druglike properties. Further optimization of physicochemical properties of the compounds and subsequent improvement of CV liabilities led to the discovery of compound <b>48</b>. This molecule showed good mGlu2 receptor PAM in vitro activity and selectivity, acceptable preliminary safety profile, and good brain exposure. Furthermore, compound <b>48</b> displayed robust in vivo activity in a sw-EEG assay consistent with mGlu2 receptor activation, in accordance with previous work from our laboratories.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all reagents and solvents were obtained from commercial suppliers and used without further purification. Thin layer chromatography (TLC) was carried out on silica gel 60 F254 plates (Merck). Flash column chromatography was performed on silica gel, particle size 60 Å, mesh = 230–400 (Merck), under standard techniques. Microwave assisted reactions were performed in a single-mode reactor, Biotage Initiator Sixty microwave reactor (Biotage), or in a multimode reactor, MicroSYNTH Labstation (Milestone, Inc.). Nuclear magnetic resonance (NMR) spectra were recorded with either a Bruker DPX-400 or a Bruker AV-500 spectrometer (broaduker AG) with standard pulse sequences operating at 400 and 500 MHz, respectively, using CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> as solvents. Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane (δ = 0). Coupling constants are reported in hertz. Splitting patterns are defined by s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), quin (quintet), sex (sextet), sep (septet), or m (multiplet). Liquid chromatography combined with mass spectrometry (LC–MS) was performed either on a HP 1100 HPLC system (Agilent Technologies) or Advanced Chromatography Technologies system composed of a quaternary or binary pump with degasser, an autosampler, a column oven, a diode array detector (DAD), and a column as specified in the respective methods. Flow from the column was split to a MS spectrometer. The MS detector was configured with either an electrospray ionization source or an ES-CI dual ionization source (electrospray combined with atmospheric pressure chemical ionization). Nitrogen was used as the nebulizer gas. Data acquisition was performed with MassLynx-Openlynx software or with Chemsation-Agilent Data Browser software. Detailed information about the different LCMS methods employed can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Retention time (<i>t</i><sub>R</sub>) is expressed in min. Gas chromatography combined with mass spectrometry (GC–MS) was performed using a 6890 series gas chromatograph (Agilent Technologies) system comprising a 7683 series injector and autosampler, a column oven, and a J&W HP-5MS coupled to a 5973N MSD mass selective detector (single quadrupole, Agilent Technologies). The MS detector was configured with an electronic impact ionization source/chemical ionization source (EI/CI). EI low-resolution mass spectra were acquired by scanning from 50 to 550 at a rate of 14.29 scans/s. The source temperature was maintained at 230 °C. Helium was used as the nebulizer gas. Data acquisition was performed with Chemstation-Open Action software. Melting point (mp) values are peak values and were obtained with experimental uncertainties that are commonly associated with this analytical method and were determined in open capillary tubes on a Mettler FP62 apparatus with a temperature gradient of 10 °C/min. Maximum temperature was 300 °C.</div><div class="NLM_p last">Purities of all new compounds were determined by analytical reverse phase (RP) HPLC using the area percentage method on the UV trace recorded at a wavelength of 254 nm and were found to have ≥95% purity unless otherwise specified.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1-Isopentyl-2-oxo-4-phenylpyridine-3-carbonitrile (<b>13</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>51a</b> (0.12 g, 0.40 mmol) and phenylboronic acid (0.06 g, 0.50 mmol) in a saturated aqueous solution of NaHCO<sub>3</sub> (3 mL) and 1,4-dioxane (3 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (0.046 g, 0.04 mmol). The mixture was heated at 150 °C for 10 min under microwave irradiation. The mixture was cooled to room temperature and filtered through a Celite pad. The filtrate was diluted with water (20 mL) and extracted with EtOAc (2 × 15 mL). The organic layer was washed with brine (15 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude was purified by flash column chromatography (silica gel, EtOAc in DCM, 0/100 to 20/80) to give the desired product <b>13</b> as a white solid (0.06 g, 51%), mp 140.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.64–1.75 (m, 3H), 3.98–4.07 (m, 2H), 6.34 (d, <i>J</i> = 7.0 Hz, 1H), 7.48–7.53 (m, 3H), 7.53 (d, <i>J</i> = 7.0 Hz, 1H), 7.58–7.65 (m, 2H). LC–MS <i>m</i>/<i>z</i> 267 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.25 min.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-Isopentyl-4-(4-methoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>14</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.06 g, 0.20 mmol) and 4-methoxyphenylboronic acid (0.03 g, 0.22 mmol) and following the procedure described for <b>13</b>, compound <b>14</b> was obtained as a light yellow solid (0.031 g, 43%), mp 99 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.90 (d, <i>J</i> = 6.3 Hz, 6H), 1.50–1.60 (m, 3H), 3.81 (s, 3H), 3.90–4.00 (m, 2H), 6.26 (d, <i>J</i> = 7.1 Hz, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 7.40 (d, <i>J</i> = 7.1 Hz, 1H), 7.55 (d, <i>J</i> = 8.6 Hz, 2H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.07 min.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-Isopentyl-4-(3-methoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>15</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.06 g, 0.20 mmol) and 3-methoxyphenylboronic acid (0.03 g, 0.22 mmol) and following the procedure described for <b>13</b>, compound <b>15</b> was obtained as a white solid (0.025 g, 35%), mp 96 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.91 (d, <i>J</i> = 6.0 Hz, 6H), 1.50–1.60 (m, 3H), 3.80 (s, 3H), 3.90–4.00 (m, 2H), 6.29 (d, <i>J</i> = 7.1 Hz, 1H), 7.00 (dd, <i>J</i> = 8.3, 2.6 Hz, 1H), 7.05–7.15 (m, 2H), 7.35 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H), 7.40 (d, <i>J</i> = 7.1 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.31 min.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1-Isopentyl-4-(2-methoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>16</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.06 g, 0.20 mmol) and 2-methoxyphenylphenylboronic acid (0.03 g, 0.22 mmol) and following the procedure described for <b>13</b>, compound <b>16</b> was obtained as a yellow oil (0.025 g, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.00 (d, <i>J</i> = 6.2 Hz, 6H), 1.64–1.74 (m, 3H), 3.87 (s, 3H), 3.98–4.04 (m, 2H), 6.31 (d, <i>J</i> = 6.8 Hz, 1H), 7.02 (broad d, <i>J</i> = 8.5 Hz, 1H), 7.06 (broad t, <i>J</i> = 7.5 Hz, 1H), 7.31 (dd, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.42–7.47 (m, 1H), 7.46 (d, <i>J</i> = 7.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.11 min.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-Isopentyl-4-(3-fluoro-4-methoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>17</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.1 g, 0.33 mmol) and 3-fluoro-4-methoxyphenylboronic acid (0.06 g, 0.36 mmol) and following the procedure described for <b>13</b>, compound <b>17</b> was obtained as a yellow solid (0.05 g, 70%), mp 133 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.63–1.72 (m, 3H), 3.96 (s, 3H), 3.98–4.04 (m, 2H), 6.29 (d, <i>J</i> = 7.0 Hz, 1H), 7.08 (t, <i>J</i> = 8.5 Hz, 1H), 7.34 (dd, <i>J</i> = 11.8, 2.3 Hz, 1H), 7.46–7.50 (m, 1H), 7.50 (d, <i>J</i> = 7.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 315 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.30 min.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-Isopentyl-4-(3-chloro-4-methoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>18</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.4 g, 1.48 mmol) and 3-chloro-4-methoxyphenylboronic acid (0.28 g, 1.48 mmol) and following the procedure described for <b>13</b>, compound <b>18</b> was obtained as a white solid (0.46 g, 95%), mp 149 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.93 (d, <i>J</i> = 6.2 Hz, 6H), 1.49–1.64 (m, 3H), 3.95 (s, 3H), 3.96–4.02 (m, 2H), 6.56 (d, <i>J</i> = 7.0 Hz, 1H), 7.34 (d, <i>J</i> = 8.7 Hz, 1H), 7.67 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.77 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (d, <i>J</i> = 7.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.33 min.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-Isopentyl-4-(3,4-dimethoxyphenyl)-2-oxopyridine-3-carbonitrile (<b>19</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.3 g, 1.11 mmol) and 3,4-dimethoxyphenylboronic acid (0.22 g, 1.22 mmol) and following the procedure described for <b>13</b>, compound <b>19</b> was obtained as a yellow solid (0.32 g, 65%), mp 52 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.62–1.74 (m, 3H), 3.95 (s, 3H), 3.95 (s, 3H), 3.98–4.04 (m, 2H), 6.35 (d, <i>J</i> = 7.0 Hz, 1H), 7.19–7.26 (m, 3H), 7.48 (d, <i>J</i> = 7.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.03 min.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Isopentyl-4-[4-(cyclopropylmethoxy)phenyl]-2-oxopyridine-3-carbonitrile (<b>20</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.11 g, 0.4 mmol) and 2-(4-cyclopropylmethoxyphenyl)-4,4,5,5-tetramethyl[1,3,2]dioxaborolane (0.31 g,1.62 mmol) and following the procedure described for <b>13</b>, compound <b>20</b> was obtained as a white solid (0.22 g, 64%), mp 114.1 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.32–0.43 (m, 2H), 0.61–0.73 (m, 2H), 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.24–1.34 (m, 1H), 1.63–1.71 (m, 3H), 3.86 (d, <i>J</i> = 6.9 Hz, 2H), 3.97–4.03 (m, 2H), 6.32 (d, <i>J</i> = 6.9 Hz, 1H), 6.98–7.03 (m, 2H), 7.47 (d, <i>J</i> = 7.2 Hz, 1H), 7.57–7.63 (m, 2H). LC–MS <i>m</i>/<i>z</i> 337 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.72 min.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-Isopentyl-4-[3-chloro-4-(cyclopropylmethoxy)phenyl]-2-oxopyridine-3-carbonitrile (<b>21</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.11 g, 0.4 mmol) and 3-chloro-4-cyclopropyloxyphenyl-4,4,5,5-tetramethyl[1,3,2]dioxaborolane (0.11 g, 0.44 mmol) and following the procedure described for <b>13</b>, compound <b>21</b> was obtained as a white solid (0.88 g, 64%), mp 294 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.36–0.48 (m, 2H), 0.63–0.75 (m, 2H), 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.29–1.40 (m, 1H), 1.62–1.72 (m, 3H), 3.96 (d, <i>J</i> = 6.6 Hz, 2H), 3.98–4.04 (m, 2H), 6.30 (d, <i>J</i> = 7.0 Hz, 1H), 7.01 (d, <i>J</i> = 9.3 Hz, 1H), 7.49 (d, <i>J</i> = 7.0 Hz, 1H), 7.57–7.61 (m, 2H). LC–MS <i>m</i>/<i>z</i> 371 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.40 min.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-Isopentyl-4-[3-chloro-4-(cyclopentoxy)phenyl]-2-oxopyridine-3-carbonitrile (<b>22</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.11 g, 0.4 mmol) and 3-chloro-4-cyclopenyloxy)phenyl)-4,4,5,5-tetramethyl[1,3,2]dioxaborolane (0.24 g, 0.7 mmol) and following the procedure described for <b>13</b>, compound <b>22</b> was obtained as a pale yellow solid (0.53 g, 37%), mp 155.6 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.1 Hz, 6H), 1.61–1.72 (m, 5H), 1.81–1.90 (m, 2H), 1.90–1.99 (m, 4H), 3.96–4.04 (m, 2H), 4.88 (quin, <i>J</i> = 4.1 Hz, 1H), 6.30 (d, <i>J</i> = 7.2 Hz, 1H), 7.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (d, <i>J</i> = 6.9 Hz, 1H), 7.55–7.63 (m, 2H). LC–MS <i>m</i>/<i>z</i> 285 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.88 min.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-Isopentyl-4-(3-chloro-4-tetrahydropyran-4-yloxyphenyl)-2-oxopyridine-3-carbonitrile (<b>23</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.65 g, 2.42 mmol) and 2-(3-chloro-4-tetrahydropyran-4-yloxyphenyl)-4,4,5,5-tetramethyl[1,3,2]dioxaborolane <b>53a</b> (0.9 g, 2.66 mmol) and following the procedure described for <b>13</b>, compound <b>23</b> was obtained as a white solid (0.175 g, 18%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.01 (d, <i>J</i> = 6.4 Hz, 6H), 1.63–1.75 (m, 3H), 1.86–1.97 (m, 2H), 2.03–2.13 (m, 2H), 3.66 (ddd, <i>J</i> = 11.4, 7.4, 3.6 Hz, 2H), 3.97–4.10 (m, 4H), 4.64–4.72 (m, 1H), 6.32 (d, <i>J</i> = 7.0 Hz, 1H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (d, <i>J</i> = 7.0 Hz, 1H), 7.59–7.64 (m, 2H). LC–MS <i>m</i>/<i>z</i> 401 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.58 min.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-Isopentyl 4-(4-phenyloxyphenyl)-2-oxopyridine-3-carbonitrile (<b>24</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.15 g, 0.57 mmol) and 4-phenoxyphenylboronic acid (0.12 g, 0.57 mmol) and following the procedure described for <b>13</b>, compound <b>24</b> was obtained as a white solid (0.1 g, 50%), mp 151.3 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.94 (d, <i>J</i> = 6.2 Hz, 6H), 1.50–1.65 (m, 3H), 3.91–4.06 (m, 2H), 6.53 (d, <i>J</i> = 7.0 Hz, 1H), 7.09–7.17 (m, 4H), 7.22–7.27 (m, 1H), 7.43–7.51 (m, 2H), 7.66–7.73 (m, 2H), 8.15 (d, <i>J</i> = 7.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 5.13 min.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-Isopentyl-4-[4-(pyridin-2-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>25</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.11 g, 0.4 mmol) and commercially available 2-[-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenoxy]pyridine (0.25 g, 0.8 mmol) and following the procedure described for <b>13</b>, compound <b>25</b> was obtained as a white solid (0.084 g, 56%), mp 155.9 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.94 (d, <i>J</i> = 6.2 Hz, 6H), 1.53–1.65 (m, 3H), 3.97–4.04 (m, 2H), 6.58 (d, <i>J</i> = 7.0 Hz, 1H), 7.15 (broad d, <i>J</i> = 8.1 Hz, 1H), 7.20 (ddd, <i>J</i> = 7.3, 5.0, 0.8 Hz, 1H), 7.28–7.33 (m, 2H), 7.70–7.75 (m, 2H), 7.92 (ddd, <i>J</i> = 8.3, 7.0, 2.1 Hz, 1H), 8.17 (d, <i>J</i> = 7.0 Hz, 1H), 8.20 (ddd, <i>J</i> = 4.8, 2.1, 0.7 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.23 min.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Isopentyl-4-[4-(pyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>26</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.48 g, 1.79 mmol) and <b>53c</b> (0.8 g, 2.69 mmol) and following the procedure described for <b>13</b>, compound <b>26</b> was obtained as a cream solid (0.42 g, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.93 (d, <i>J</i> = 6.2 Hz, 6H), 1.55–1.68 (m, 3H), 3.92–3.98 (m, 2H), 6.26 (d, <i>J</i> = 7.0 Hz, 1H), 7.05 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.28–7.35 (m, 1H), 7.35–7.41 (m, 1H), 7.46 (d, <i>J</i> = 7.0 Hz, 1H), 7.58 (broad d, <i>J</i> = 8.7 Hz, 2H), 8.32–8.48 (m, 2H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.07 min.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-Isopentyl-4-(4-pyrid-4-yloxyphenyl)-2-oxopyridine-3-carbonitrile (<b>27</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.72 g, 2.7 mmol) and <b>53h</b> (0.95 g, 3.2 mmol) and following the procedure described for <b>13</b>, compound <b>27</b> was obtained as a white solid (0.40 g, 41%), mp 139 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.95 (d, <i>J</i> = 6.4 Hz, 6H), 1.53–1.65 (m, 3H), 3.97–4.05 (m, 2H), 6.58 (d, <i>J</i> = 6.9 Hz, 1H), 7.01–7.07 (m, 2H), 7.34–7.39 (m, 2H), 7.76–7.82 (m, 2H), 8.19 (d, <i>J</i> = 6.9 Hz, 1H), 8.49–8.58 (m, 2H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.09 min.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-Isopentyl-4-(4-methylaminophenyl)-2-oxopyridine-3-carbonitrile (<b>28</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.116 g, 0.4 mmol) and 4-methylaminophenyl-4,4,5,5-tetramethyl[1,3,2]dioxaborolane (0.16 g, 0.5 mmol) and following the procedure described for <b>13</b>, compound <b>27</b> was obtained as a bright yellow solid (0.04 g, 31%), mp 189 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.93 (d, <i>J</i> = 6.2 Hz, 6H), 1.49–1.63 (m, 3H), 2.75 (d, <i>J</i> = 5.0 Hz, 3H), 3.89–3.98 (m, 2H), 6.43–6.50 (m, 1H), 6.48 (d, <i>J</i> = 7.0 Hz, 1H), 6.65 (broad d, <i>J</i> = 8.9 Hz, 2H), 7.52 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.99 (d, <i>J</i> = 7.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 296 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.97 min.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-Isopentyl-4-[3-chloro-4-(tetrahydropyran-4-ylamino)phenyl]-2-oxopyridine-3-carbonitrile (<b>29</b>)</h3><div class="NLM_p last">Starting from <b>51a</b>(1.3 g, 4.94 mmol) and <b>53b</b> (2 g, 5.93 mmol) and following the procedure described for <b>13</b>, compound <b>29</b> was obtained as a pale yellow solid (0.196 g, 10%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.51–1.72 (m, 5H), 2.02–2.11 (m, 2H), 3.55 (td, <i>J</i> = 11.5, 2.3 Hz, 2H), 3.58–3.68 (m, 1H), 3.95–4.07 (m, 4H), 4.63 (broad d, <i>J</i> = 7.7 Hz, 1H), 6.29 (d, <i>J</i> = 7.0 Hz, 1H), 6.76 (broad d, <i>J</i> = 9.1 Hz, 1H), 7.44 (d, <i>J</i> = 7.0 Hz, 1H), 7.53–7.61 (m, 2H). LC–MS <i>m</i>/<i>z</i> 400 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.48 min.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-Isopentyl-4-(4-morpholinophenyl)-2-oxopyridine-3-carbonitrile (<b>30</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.56 g, 2.70 mmol) and 4-(morpholin-1-yl)phenylboronic acid (0.72 g, 2.7 mmol) and following the procedure described for <b>13</b>, compound <b>30</b> was obtained as a yellow solid (0.62 g, 65%), mp 171 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.62–1.73 (m, 3H), 3.24–3.31 (m, 4H), 3.84–3.90 (m, 4H), 3.95–4.03 (m, 2H), 6.33 (d, <i>J</i> = 6.9 Hz, 1H), 6.96 (d, <i>J</i> = 9.0 Hz, 2H), 7.44 (d, <i>J</i> = 7.2 Hz, 1H), 7.62 (d, <i>J</i> = 9.0 Hz, 2H). LC–MS <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.09 min.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-Isopentyl-4-[4-(2-methylpyridin-4-ylamino)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>31</b>)</h3><div class="NLM_p last">Starting from <b>51a</b>(0.54 g, 1.99 mmol) and 4-(4-pyridylamino)phenylboronic acid (0.51 g, 2.36 mmol) and following the procedure described for <b>13</b>, compound <b>29</b> was obtained as a pale yellow solid (0.25 g, 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.94 (d, <i>J</i> = 6.2 Hz, 6H), 1.51–1.64 (m, 3H), 3.93–4.03 (m, 2H), 6.54 (d, <i>J</i> = 7.0 Hz, 1H), 7.03–7.07 (m, 2H), 7.32–7.37 (m, 2H), 7.65–7.70 (m, 2H), 8.12 (d, <i>J</i> = 7.0 Hz, 1H), 8.26–8.31 (m, 2H), 9.21 (s, 1H). LC–MS <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.35 min.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Isopentyl-4-[4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>32</b>)</h3><div class="NLM_p last">Starting from <b>51a</b>(0.74 g, 2.84 mmol) and <b>53i</b> (0.88 g, 2.84 mmol) and following the procedure described for <b>13</b>, compound <b>32</b> was obtained as a white solid (0.35 g, 36%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.93 (d, <i>J</i> = 6.1 Hz, 6H), 1.57–1.68 (m, 3H), 2.51 (s, 3H), 3.93–4.00 (m, 2H), 6.27 (d, <i>J</i> = 6.9 Hz, 1H), 6.70–6.76 (m, 2H), 7.14 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.47 (d, <i>J</i> = 6.9 Hz, 1H), 7.63 (broad d, <i>J</i> = 8.7 Hz, 2H), 8.35 (d, <i>J</i> = 5.8 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.27 min.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-Cyclobutylmethyl-4-[4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>33</b>)</h3><div class="NLM_p last">Starting from <b>51d</b> (0.56 g, 2.1 mmol) and <b>53i</b> (0.65 g, 2.1 mmol) and following the procedure described for <b>13</b>, compound <b>33</b> was obtained as a white solid (0.48 g, 62%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.71–1.81 (m, 2H), 1.81–1.95 (m, 2H), 2.00–2.09 (m, 2H), 2.55 (s, 3H), 2.78 (sep, <i>J</i> = 7.8 Hz, 1H), 3.98 (d, <i>J</i> = 7.5 Hz, 2H), 6.25 (d, <i>J</i> = 6.9 Hz, 1H), 6.75–6.79 (m, 2H), 7.15 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.45 (d, <i>J</i> = 6.9 Hz, 1H), 7.64 (broad d, <i>J</i> = 8.7 Hz, 2H), 8.34–8.38 (m, 1H). LC–MS <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.07 min.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-Butyl-4-[4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>34</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (1.44 g, 5.68 mmol) and <b>53i</b> (1.76 g, 5.68 mmol) and following the procedure described for <b>13</b>, compound <b>34</b> was obtained as a white solid (0.7 g, 36%), mp 121 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.92 (t, <i>J</i> = 7.4 Hz, 3H), 1.31–1.39 (m, 2H), 1.69–1.77 (m, 2H), 2.52 (s, 3H), 3.95 (t, <i>J</i> = 7.5 Hz, 2H), 6.27 (d, <i>J</i> = 6.9 Hz, 1H), 6.71–6.77 (m, 2H), 7.15 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.47 (d, <i>J</i> = 6.9 Hz, 1H), 7.63 (broad d, <i>J</i> = 8.7 Hz, 2H), 8.35 (d, <i>J</i> = 5.8 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.97 min.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-Cyclopropylmethyl-4-[4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>35</b>)</h3><div class="NLM_p last">Starting from <b>51c</b> (0.48 g, 1.91 mmol) and <b>53i</b> (1.05 g, 3.39 mmol) and following the procedure described for <b>13</b>, compound <b>35</b> was obtained as a white solid (0.33 g, 48%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.40–0.47 (m, 2H), 0.49–0.58 (m, 2H), 1.21–1.34 (m, 1H), 2.45 (s, 3H), 3.86 (d, <i>J</i> = 7.2 Hz, 2H), 6.59 (d, <i>J</i> = 6.9 Hz, 1H), 6.84 (dd, <i>J</i> = 5.8, 2.6 Hz, 1H), 6.93 (d, <i>J</i> = 1.7 Hz, 1H), 7.34 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.79 (broad d, <i>J</i> = 8.7 Hz, 2H), 8.22 (d, <i>J</i> = 7.2 Hz, 1H), 8.39 (d, <i>J</i> = 5.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 358 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.7 min.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-Butyl-4-[4-(2-methylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>36</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.61 g, 2.41 mmol) and <b>53d</b> (0.9 g, 2.89 mmol) and following the procedure described for <b>13</b>, compound <b>36</b> was obtained as a white solid (0.51 g, 60%), mp 136.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.98 (t, <i>J</i> = 7.4 Hz, 3H), 1.36–1.46 (m, 2H), 1.75–1.83 (m, 2H), 2.50 (s, 3H), 4.00 (t, <i>J</i> = 7.5 Hz, 2H), 6.31 (d, <i>J</i> = 7.2 Hz, 1H), 6.98–7.03 (m, 2H), 7.18 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.30 (dd, <i>J</i> = 8.1, 0.9 Hz, 1H), 7.49 (d, <i>J</i> = 7.2 Hz, 1H), 7.59–7.64 (m, 2H), 8.39 (dd, <i>J</i> = 4.6, 1.2 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.96 min.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-Isopentyl-4-[4-(2-methylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>37</b>)</h3><div class="NLM_p last">Starting from <b>51a</b>(0.64 g, 2.41 mmol) and <b>53d</b> (0.9 g, 2.89 mmol) and following the procedure described for <b>13</b>, compound <b>37</b> was obtained as a white solid (0.69 g, 76%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.63–1.73 (m, 3H), 2.50 (s, 3H), 3.98–4.05 (m, 2H), 6.31 (d, <i>J</i> = 7.2 Hz, 1H), 6.98–7.03 (m, 2H), 7.19 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 7.31 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 7.50 (d, <i>J</i> = 6.9 Hz, 1H), 7.59–7.64 (m, 2H), 8.39 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.12 min.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-Cyclopropylmehtyl-4-[4-(2-methylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>38</b>)</h3><div class="NLM_p last">Starting from <b>51c</b> (0.39 g, 1.53 mmol) and <b>57d</b> (0.57 g, 1.83 mmol) and following the procedure described for <b>13</b>, compound <b>38</b> was obtained as a yellow solid (0.39 g, 72%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.38–0.46 (m, 2H), 0.48–0.56 (m, 2H), 1.20–1.32 (m, 1H), 2.39 (s, 3H), 3.83 (d, <i>J</i> = 7.2 Hz, 2H), 6.54 (d, <i>J</i> = 6.9 Hz, 1H), 7.08 (broad d, <i>J</i> = 9.0 Hz, 2H), 7.34 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 7.71 (broad d, <i>J</i> = 9.0 Hz, 2H), 8.18 (d, <i>J</i> = 7.2 Hz, 1H), 8.37 (dd, <i>J</i> = 4.6, 1.1 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 358 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.67 min.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-Butyl-4-[4-(2,6-dimethylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>39</b>)</h3><div class="NLM_p last">Starting from <b>51b</b>(0.59 g, 2.33 mmol) and <b>53e</b> (0.91 g, 2.80 mmol) and following the procedure described for <b>13</b>, compound <b>39</b> was obtained as a pale yellow solid (0.57 g, 65%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.98 (t, <i>J</i> = 7.4 Hz, 3H), 1.35–1.46 (m, 2H), 1.74–1.83 (m, 2H), 2.46 (s, 3H), 2.57 (s, 3H), 4.00 (t, <i>J</i> = 7.4 Hz, 2H), 6.32 (d, <i>J</i> = 6.9 Hz, 1H), 6.95–7.01 (m, 2H), 7.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.50 (d, <i>J</i> = 6.9 Hz, 1H), 7.57–7.63 (m, 2H). LC–MS <i>m</i>/<i>z</i> 374 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.24 min.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-Isopentyl-4-[4-(2,6-dimethylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>40</b>)</h3><div class="NLM_p last">Starting from <b>51a</b> (0.63 g, 2.33 mmol) and <b>53e</b> (0.91 g, 2.80 mmol) and following the procedure described for <b>13</b>, compound <b>40</b> was obtained as a pale yellow solid(0.57 g, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.99 (d, <i>J</i> = 6.4 Hz, 6H), 1.61–1.74 (m, 3H), 2.45 (s, 3H), 2.56 (s, 3H), 3.96–4.06 (m, 2H), 6.32 (d, <i>J</i> = 7.0 Hz, 1H), 6.94–7.01 (m, 2H), 7.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.51 (d, <i>J</i> = 7.0 Hz, 1H), 7.57–7.63 (m, 2H). LC–MS <i>m</i>/<i>z</i> 388 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.54 min.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-Cyclopropylmethyl-4-[4-(2,6-dimethylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>41</b>)</h3><div class="NLM_p last">Starting from <b>51c</b> (0.39 g, 1.53 mmol) and <b>53e</b> (0.6 g, 1.84 mmol) and following the procedure described for <b>13</b>, compound <b>41</b> was obtained as a white solid (0.18 g, 31%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.38–0.50 (m, 2H), 0.61–0.76 (m, 2H), 1.28 (m, 1H), 2.45 (s, 3H), 2.56 (s, 3H), 3.87 (d, <i>J</i> = 7.3 Hz, 2H), 6.29–6.37 (m, 1H), 6.95–7.01 (m, 2H), 7.04 (d, <i>J</i> = 8.3 Hz, 1H), 7.22 (d, <i>J</i> = 8.3 Hz, 1H), 7.58–7.66 (m, 3H). LC–MS <i>m</i>/<i>z</i> 372 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.0 min.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-Butyl-4-[3-chloro-4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>42</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.39 g, 1.53 mmol) and <b>53l</b> (0.57 g, 1.83 mmol) and following the procedure described for <b>13</b>, compound <b>42</b> was obtained as a white solid (0.38 g, 63%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.37–1.46 (m, 2H), 1.76–1.84 (m, 2H), 2.54 (s, 3H), 4.03 (t, <i>J</i> = 7.4 Hz, 2H), 6.33 (d, <i>J</i> = 6.9 Hz, 1H), 6.69 (dd, <i>J</i> = 5.8, 2.6 Hz, 1H), 6.73 (d, <i>J</i> = 2.6 Hz, 1H), 7.25 (d, <i>J</i> = 8.7 Hz, 1H), 7.57 (d, <i>J</i> = 6.9 Hz, 1H), 7.62 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.73 (d, <i>J</i> = 2.3 Hz, 1H), 8.41 (d, <i>J</i> = 5.8 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.25 min.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-Butyl-4-[2-chloro-4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>43</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.3 g, 1.17 mmol) and <b>53j</b> (0.41 g, 1.2 mmol) and following the procedure described for <b>13</b>, compound <b>43</b> was obtained as a white solid (0.15 g, 33%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.00 (t, <i>J</i> = 7.4 Hz, 3H), 1.43 (broad sex, <i>J</i> = 7.5 Hz, 2H), 1.82 (broad quin, <i>J</i> = 7.6 Hz, 2H), 2.56 (s, 3H), 4.04 (t, <i>J</i> = 7.5 Hz, 2H), 6.30 (d, <i>J</i> = 6.9 Hz, 1H), 6.76 (dd, <i>J</i> = 5.8, 2.6 Hz, 1H), 6.81 (d, <i>J</i> = 2.6 Hz, 1H), 7.10 (dd, <i>J</i> = 8.4, 2.6 Hz, 1H), 7.24 (d, <i>J</i> = 2.6 Hz, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 6.9 Hz, 1H), 8.44 (d, <i>J</i> = 5.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.25 min.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-Butyl-4-[3-chloro-4-(2-methylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>44</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.51 g, 2 mmol) and <b>53f</b> (0.90 g, 2.6 mmol) and following the procedure described for <b>13</b>, compound <b>44</b> was obtained as a pale yellow solid (0.54 g, 69%), mp 137.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.01 (t, <i>J</i> = 7.4 Hz, 3H), 1.39–1.47 (m, 2H), 1.77–1.85 (m, 2H), 2.57 (s, 3H), 4.04 (t, <i>J</i> = 7.4 Hz, 2H), 6.33 (d, <i>J</i> = 6.9 Hz, 1H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 7.19–7.26 (m, 2H), 7.52–7.58 (m, 2H), 7.74 (d, <i>J</i> = 2.3 Hz, 1H), 8.41 (dd, <i>J</i> = 4.5, 1.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.27 min.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-Cyclopropylmethyl-4-[3-chloro-4-(2-methylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>45</b>)</h3><div class="NLM_p last">Starting from <b>51c</b> (0.6 g, 2.37 mmol) and <b>53f</b> (0.69 g, 2 mol) and following the procedure described for <b>13</b>, compound <b>45</b> (0.4 g, 52%) was obtained as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.38–0.47 (m, 2H), 0.48–0.56 (m, 2H), 1.21–1.32 (m, 1H), 2.43 (s, 3H), 3.84 (d, <i>J</i> = 7.2 Hz, 2H), 6.59 (d, <i>J</i> = 7.2 Hz, 1H), 7.03 (d, <i>J</i> = 8.7 Hz, 1H), 7.33 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.41 (broad d, <i>J</i> = 8.4 Hz, 1H), 7.63 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.97 (d, <i>J</i> = 2.3 Hz, 1H), 8.21 (d, <i>J</i> = 6.9 Hz, 1H), 8.35–8.38 (m, 1H). LC–MS <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.06 min.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-Butyl-4-[3-chloro-4-(2,6-dimethylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>46</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.51 g, 2 mmol) and <b>53g</b> (0.79 g, 2.2 mmol) and following the procedure described for <b>13</b>, compound <b>46</b> was obtained as a white solid (0.36 g, 44%), mp 268.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.00 (t, <i>J</i> = 7.4 Hz, 3H), 1.37–1.48 (m, 2H), 1.76–1.85 (m, 2H), 2.50 (s, 3H), 2.59 (s, 3H), 4.03 (t, <i>J</i> = 7.4 Hz, 2H), 6.32 (d, <i>J</i> = 7.0 Hz, 1H), 6.80 (d, <i>J</i> = 8.5 Hz, 1H), 7.06 (d, <i>J</i> = 8.3 Hz, 1H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 7.51 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 7.55 (d, <i>J</i> = 7.0 Hz, 1H), 7.72 (d, <i>J</i> = 2.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.58 min.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-Cyclopropylmehtyl-4-[3-chloro-4-(2,6-dimethylpyridin-3-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>47</b>)</h3><div class="NLM_p last">Starting from <b>51c</b> (0.51 g, 2 mmol) and <b>53g</b> (0.79 g, 2.2 mmol) and following the procedure described for <b>13</b>, compound <b>47</b> was obtained as a white solid (0.49 g, 60%), mp 201 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.41–0.52 (m, 2H), 0.66–0.77 (m, 2H), 1.25–1.36 (m, 1H), 2.50 (s, 3H), 2.59 (s, 3H), 3.90 (d, <i>J</i> = 7.2 Hz, 2H), 6.34 (d, <i>J</i> = 6.9 Hz, 1H), 6.81 (d, <i>J</i> = 8.7 Hz, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.19 (d, <i>J</i> = 8.1 Hz, 1H), 7.52 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.70 (d, <i>J</i> = 7.2 Hz, 1H), 7.73 (d, <i>J</i> = 2.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.34 min.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-Butyl-4-[3-fluoro-4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>48</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.45 g, 1.77 mmol) and <b>53m</b> (0.58 g, 1.77 mmol) and following the procedure described for <b>13</b>, compound <b>48</b> was obtained as a white solid (0.45 g, 68%), mp 125.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.42 (broad sex, <i>J</i> = 7.5 Hz, 2H), 1.77–1.85 (m, 2H), 2.54 (s, 3H), 4.03 (t, <i>J</i> = 7.4 Hz, 2H), 6.32 (d, <i>J</i> = 6.9 Hz, 1H), 6.72 (dd, <i>J</i> = 5.8, 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 2.6 Hz, 1H), 7.29 (t, <i>J</i> = 8.2 Hz, 1H), 7.46–7.52 (m, 2H), 7.56 (d, <i>J</i> = 6.9 Hz, 1H), 8.41 (d, <i>J</i> = 5.8 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.94 min.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-Butyl-4-[2-fluoro-4-(2-methylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>49</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.45 g, 1.77 mmol) and <b>53n</b> (0.58 g, 1.77 mmol) and following the procedure described for <b>13</b>, compound <b>49</b> was obtained as a white solid (0.45 g, 68%), mp 177.1 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.42 (sex, <i>J</i> = 7.5 Hz, 2H), 1.77–1.84 (m, 2H), 2.56 (s, 3H), 4.03 (t, <i>J</i> = 7.4 Hz, 2H), 6.34 (dd, <i>J</i> = 6.9, 1.7 Hz, 1H), 6.79 (dd, <i>J</i> = 5.6, 2.2 Hz, 1H), 6.83 (d, <i>J</i> = 2.0 Hz, 1H), 6.94 (dd, <i>J</i> = 10.8, 2.2 Hz, 1H), 6.99 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 7.51–7.58 (m, 2H), 8.45 (d, <i>J</i> = 5.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 378 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.02 min.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Butyl-4-[3-fluoro-4-(2,6-dimethylpyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>50</b>)</h3><div class="NLM_p last">Starting from <b>51b</b> (0.25 g, 0.98 mmol) and <b>53k</b> (0.37 g, 1.08 mmol) and following the procedure described for <b>13</b>, compound <b>50</b> was obtained as a white solid (0.22 g, 59%), mp 204 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.99 (t, <i>J</i> = 7.4 Hz, 3H), 1.42 (dq, <i>J</i> = 15.2, 7.4 Hz, 2H), 1.76–1.84 (m, 2H), 2.50 (s, 6H), 4.03 (t, <i>J</i> = 7.4 Hz, 2H), 6.32 (d, <i>J</i> = 6.9 Hz, 1H), 6.58 (s, 2H), 7.27 (t, <i>J</i> = 8.4 Hz, 1H), 7.45–7.51 (m, 2H), 7.56 (d, <i>J</i> = 6.9 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.23 min.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-Bromo-1-butyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>51b</b>)</h3><div class="NLM_p">POBr<sub>3</sub> (13.69 g, 47.7 mmol) was added portionwise to a solution of <b>57b</b> (4.59 g, 23.87 mmol) in DMF (96 mL). The mixture was stirred at 110 °C for 3 h. The mixture was cooled to 0 °C, carefully treated with water, and extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered, and the solvents were evaporated in vacuo. The crude product was purified by flash column chromatography (silica gel, DCM). The desired fractions were collected and concentrated in vacuo. The solid residue was washed with diethyl ether to yield <b>51b</b> as a white solid (3.96 g, 65%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.96 (t, <i>J</i> = 7.37 Hz, 3H), 1.32–1.42 (m, 2H), 1.69–1.78 (m, 2H), 3.95 (t, <i>J</i> = 7.37 Hz, 2H), 6.50 (d, <i>J</i> = 7.22 Hz, 1H), 7.37 (d, <i>J</i> = 7.22 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 257 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>51a</b>,<b>c</b>,<b>d</b> were prepared following the same synthesis procedure as <b>51b</b>.</div></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-Bromo-1-isopentyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>51a</b>)</h3><div class="NLM_p last">Starting from <b>57a</b> (3 g, 14.5 mmol) and following the procedure described for <b>51b</b>, compound <b>51a</b> was obtained as a white solid (3.55 g, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.97 (d, <i>J</i> = 6.2 Hz, 6H), 1.56–1.68 (m, 3H), 3.92–4.00 (m, 2H), 6.51 (d, <i>J</i> = 7.2 Hz, 1H), 7.39 (d, <i>J</i> = 7.4 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 269 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-Bromo-1-cyclopropylmethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>51c</b>)</h3><div class="NLM_p last">Starting from <b>57c</b> (4.68 g, 24.6 mmol) and following the procedure described for <b>51b</b>, compound <b>51c</b> was obtained as a white solid (4.09 g, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.36–0.42 (m, 2H), 0.45–0.55 (m, 2H), 1.15–1.28 (m, 1H), 3.78 (d, <i>J</i> = 7.26 Hz, 2H), 6.82 (d, <i>J</i> = 7.26 Hz, 1H), 8.12 (d, <i>J</i> = 7.26 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 252 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-Bromo-1-cyclobutylmethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>51d</b>)</h3><div class="NLM_p last">Starting from <b>57d</b> (6.17 g, 30.2 mmol) and following the procedure described for <b>51b</b>, compound <b>51d</b> was obtained as a white solid (5.41 g, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.72–1.84 (m, 2H), 1.85–2.01 (m, 2H), 2.02–2.13 (m, 2H), 2.77 (sep, <i>J</i> = 7.7 Hz, 1H), 3.97 (d, <i>J</i> = 7.4 Hz, 2H), 6.49 (d, <i>J</i> = 7.4 Hz, 1H), 7.36 (d, <i>J</i> = 7.2 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 267 [M + H]<sup>+</sup>.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-(3-Chloro-4-tetrahydropyran-4-yloxyphenyl)-4,4,5,5-tetramethyl[1,3,2]dioxaborolane (<b>53a</b>)</h3><div class="NLM_p last">To a suspension of <b>60</b> (1.8 g, 6.17 mmol), bis(pinacolato)diboron (1.88 g, 7.4 mmol), and AcOK (1.81 g, 18.5 mmol) in a mixture of previously degassed 1,4-dioxane (8 mL) and DMF (1 mL) was added PdCl<sub>2</sub>dppf (0.15 g, 0.18 mmol). The mixture was heated at 150 °C for 10 min under microwave irradiation. The mixture was cooled to room temperature and then filtered through a Celite pad. The filtrate was diluted with water (50 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extracts were washed with brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by flash column chromatography (silica gel, DCM in heptane, 0/100 to 100/0) to yield <b>53a</b> as a pale yellow oil (2 g, 66%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 1.33 (s, 12H), 1.81–1.90 (m, 2H), 1.97–2.06 (m, 2H), 3.61 (ddd, <i>J</i> = 11.34, 7.44, 3.47 Hz, 2H), 4.00 (td, <i>J</i> = 7.59, 3.61 Hz, 2H), 4.58–4.65 (m, 1H), 6.92 (d, <i>J</i> = 8.38 Hz, 1H), 7.63 (dd, <i>J</i> = 8.09, 1.44 Hz, 1H), 7.82 (d, <i>J</i> = 1.45 Hz, 1H). GC–MS (EI): <i>m</i>/<i>z</i> 339 [M]<sup>+</sup>.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> [2-Chloro-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl](tetrahydropyran-4-yl)amine (<b>53b</b>)</h3><div class="NLM_p last">To a suspension of <b>62</b> (3.66 g, 12.6 mmol) in previously degassed 1,4-dioxane (10 mL) were added bis(pinacolato)diboron (3.84 g, 15.1 mmol), AcOK (3.71 g, 37.8 mmol), and PdCl<sub>2</sub>dppf (0.55 g, 0.75 mmol). The mixture was heated at 95 °C for 12 h. The mixture was cooled to room temperature and then filtered through a Celite pad. The filtrate was diluted with water (50 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extracts were washed with brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by flash column chromatography (silica gel, EtOAc/heptane, 1/9) to yield <b>53a</b> as colorless oil (2.87 g, 67%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.32 (s, 12H), 1.49–1.62 (m, 2H), 1.99–2.09 (m, 2H), 3.49–3.65 (m, 3H), 4.01 (dt, <i>J</i> = 11.8, 3.7 Hz, 2H), 4.48 (broad d, <i>J</i> = 7.9 Hz, 1H), 6.64 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 7.70 (d, <i>J</i> = 0.7 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 338 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxy]-2-methylpyridine (<b>53d</b>)</h3><div class="NLM_p last">Starting from <b>68b</b> (0.66 g, 2.5 mmol) and following the procedure described for <b>53a</b>, compound <b>53d</b> was obtained as a dark brown oil (0.65 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.34 (s, 12H), 2.48 (s, 3H), 6.89 (broad d, <i>J</i> = 8.7 Hz, 2H), 7.13 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.21 (d, <i>J</i> = 8.1 Hz, 1H), 7.78 (broad d, <i>J</i> = 8.4 Hz, 2H), 8.33 (broad d, <i>J</i> = 4.6 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 312 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxy]-2,6-dimethylpyridine (<b>53e</b>)</h3><div class="NLM_p last">To a degassed suspension of <b>68c</b>(0.90 g, 3.23 mmol), bis(pinacolato)diboron (0.81 g, 3.23 mmol), and AcOK (0.95 g, 9.69 mmol) in DMSO (20 mL) was added PdCl<sub>2</sub>dppf (0.08 g, 0.1 mmol). The mixture was heated at 117 °C for 5 h. The mixture was cooled to room temperature and filtered through a Celite pad. The filtrate was diluted with water (10 mL) and extracted with EtOAc (2 × 10 mL). The organic layer was concentrated in vacuo to yield <b>53e</b> as dark brown oil (0.85 g, 84%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.34 (s, 12H), 2.42 (s, 3H), 2.54 (s, 3H), 6.85 (broad d, <i>J</i> = 8.7 Hz, 2H), 6.99 (d, <i>J</i> = 8.1 Hz, 1H), 7.15 (d, <i>J</i> = 8.1 Hz, 1H), 7.76 (broad d, <i>J</i> = 8.4 Hz, 2H). LC–MS <i>m</i>/<i>z</i> 326 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-[2-Chloro-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxy]-2-methylpyridine (<b>53f</b>)</h3><div class="NLM_p last">Starting from <b>68d</b> (2.4 g, 8.03 mmol) and following the procedure described for <b>53e</b>, compound <b>53f</b> was obtained as a dark brown oil (2.32 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.34 (s, 12H), 2.53 (s, 3H), 6.77 (d, <i>J</i> = 8.1 Hz, 1H), 7.06–7.14 (m, 2H), 7.62 (d, <i>J</i> = 8.1 Hz, 1H), 7.92 (s, 1H), 8.32 (broad d, <i>J</i> = 3.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-[2-Chloro-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxy]-2,6-dimethylpyridine (<b>53g</b>)</h3><div class="NLM_p last">Starting from <b>68e</b> (2.4 g, 8.03 mmol) and following the procedure described for <b>53e</b>, compound <b>53g</b> was obtained as a dark brown oil (1.98 g, 71%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.32–1.36 (m, 12H), 2.45 (s, 3H), 2.54 (s, 3H), 6.67 (d, <i>J</i> = 8.09 Hz, 1H), 6.98 (d, <i>J</i> = 8.38 Hz, 1H), 7.06 (d, <i>J</i> = 8.67 Hz, 1H), 7.58 (dd, <i>J</i> = 8.09, 1.44 Hz, 1H), 7.90 (d, <i>J</i> = 1.45 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)phenoxy]-2-methylpyridine (<b>53i</b>)</h3><div class="NLM_p last">To a degassed solution of <b>71b</b> (2.22 g, 8.33 mmol) in 1,4-dioxane (8 mL) and DMF (3 mL) were added bis(pinacolato)diboron (6.35 g, 24.98 mmol), AcOK (2.45 g, 24.98 mmol), and PdCl<sub>2</sub>dppf (0.27 g, 0.33 mmol). The resulting mixture was heated at 150 °C for 10 min under microwave irradiation. The reaction mixture was then cooled to room temperature, diluted with water, and extracted with EtOAc. The organic layer was washed with brine and then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to yield a crude residue that was purified using column chromatography, eluting with 0–10 7 N NH<sub>3</sub>·MeOH in DCM to yield of <b>53i</b> (2.31 g, 89%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (s, 12H), 2.49 (s, 3H), 6.65–6.72 (m, 2H), 7.07 (broad d, <i>J</i> = 8.3 Hz, 2H), 7.87 (broad d, <i>J</i> = 8.3 Hz, 2H), 8.32–8.38 (m, 1H). LC–MS <i>m</i>/<i>z</i> 312 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-3-chlorophenoxy]-2-methylpyridine (<b>53j</b>)</h3><div class="NLM_p last">To a degassed solution of <b>71c</b> (2.4 g, 2.0 mmol) in DMSO (10 mL) were added bis(pinacolato)diboron (0.58 g, 2.30 mmol), AcOK (0.59 g, 6.00 mmol), and PdCl<sub>2</sub>dppf (0.049 g, 0.06 mmol). The resulting mixture was heated at 150 °C for 10 min under microwave irradiation. The reaction mixture was then cooled to room temperature, diluted with water, and extracted with EtOAc. The organic fraction was separated, washed with brine, and then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to yield <b>53j</b> (3.00 g, 100%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.38 (s, 12H), 2.50 (s, 3H), 6.66–6.72 (m, 2H), 6.96 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 7.09 (d, <i>J</i> = 2.0 Hz, 1H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 8.37 (d, <i>J</i> = 6.1 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-2-fluorophenoxy]-2,6-dimethylpyridine (<b>53k</b>)</h3><div class="NLM_p last">Starting from <b>71d</b> (0.50 g, 1.67 mmol) and following the procedure described for <b>53i</b>, compound <b>53k</b> was obtained as an oil (0.30 g, 96%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.36 (s, 12H), 2.46 (s, 6H), 6.50 (s, 2H), 7.14 (t, <i>J</i> = 7.7 Hz, 1H), 7.58–7.67 (m, 2H). LC–MS <i>m</i>/<i>z</i> 344 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-2-chlorophenoxy]-2-methylpyridine (<b>53l</b>)</h3><div class="NLM_p last">To a degassed solution of <b>74a</b> (2.43 g, 7.73 mmol) and following the procedure described for <b>53i</b>, compound <b>53l</b> was obtained as an oil (2.97 g, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (s, 12H), 2.49 (s, 3H), 6.61–6.65 (m, 2H), 7.13 (d, <i>J</i> = 8.1 Hz, 1H), 7.74 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.94 (d, <i>J</i> = 1.4 Hz, 1H), 8.33 (d, <i>J</i> = 6.2 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-2-fluorophenoxy]-2-methylpyridine (<b>53m</b>)</h3><div class="NLM_p last">Starting from <b>74b</b> (0.50 g, 1.67 mmol) and following the procedure described for <b>53i</b>, compound <b>53m</b> was obtained as an oil (0.30 g, 96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (s, 12H), 2.49 (s, 3H), 6.63–6.68 (m, 2H), 7.15 (t, <i>J</i> = 7.9 Hz, 1H), 7.59–7.68 (m, 2H), 8.35 (d, <i>J</i> = 6.7 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-[-4-(4,4,5,5-Tetramethyl[1,3,2]dioxaborolan-2-yl)-3-fluorophenoxy]-2-methylpyridine (<b>53n</b>)</h3><div class="NLM_p last">Starting from <b>74c</b> (0.50 g, 1.77 mmol) and following the procedure described for <b>53i</b>, compound <b>53n</b> was obtained as an oil (0.58 g, 100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.37 (s, 12H), 2.51 (s, 3H), 6.69–6.74 (m, 2H), 6.76 (dd, <i>J</i> = 9.8, 2.2 Hz, 1H), 6.86 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.78 (dd, <i>J</i> = 8.3, 6.9 Hz, 1H), 8.38 (d, <i>J</i> = 5.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 330 [M + H]<sup>+</sup>.</div></div><div id="secy" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1-Isopentyl-4-methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>56a</b>)</h3><div class="NLM_p last">Isopentyl bromide <b>55a</b> (24.1 mL, 160 mmol) was added to a stirred suspension of 2-hydroxy-4-methoxynicotinonitrile <b>54</b> (20 g, 133 mmol) and K<sub>2</sub>CO<sub>3</sub> (55.2 g, 400 mmol) in CH<sub>3</sub>CN (600 mL). The mixture was stirred at reflux for 20 h. The cooled mixture was filtered through a Celite pad and concentrated in vacuo. The residue thus obtained was precipitated by treatment with diisopropyl ether. The resulting solid was filtered off and dried in the vacuum oven (50 °C) to yield <b>56a</b> (24 g, 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.90 (d, <i>J</i> = 6.22 Hz, 6H), 1.42–1.58 (m, 3H), 3.86–3.92 (m, 2H), 3.98 (s, 3H), 6.44 (d, <i>J</i> = 7.88 Hz, 1H), 8.12 (d, <i>J</i> = 7.88 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-Butyl-4-methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>56b</b>)</h3><div class="NLM_p last">Starting from butyl bromide <b>55b</b> (11.21 mL, 103 mmol) and <b>54</b> (8 g, 53.3 mmol) and following the procedure described for <b>56a</b>, compound <b>56b</b> was obtained as a white solid (11.15 g, quantitative), mp 78.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.95 (t, <i>J</i> = 7.4 Hz, 3H), 1.36 (sex, <i>J</i> = 7.5 Hz, 2H), 1.71 (quin, <i>J</i> = 7.5 Hz, 2H), 3.93 (t, <i>J</i> = 7.4 Hz, 2H), 3.99 (s, 3H), 6.07 (d, = 7.8 Hz, 1H), 7.50 (d, <i>J</i> = 7.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 207 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-Cyclopropylmethyl-4-methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>56c</b>)</h3><div class="NLM_p last">Starting from bromomethylcyclopropane <b>55c</b> (11.95 g, 103 mmol) and <b>54</b> (8 g, 53.3 mmol) and following the procedure described for <b>56a</b>, compound <b>56c</b> was obtained as a white solid (10.9 g, quantitative), mp 139.1 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.34–0.45 (m, 2H), 0.58–0.70 (m, 2H), 1.17–1.27 (m, 1H), 3.80 (d, <i>J</i> = 7.2 Hz, 2H), 4.01 (s, 3H), 6.13 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (d, <i>J</i> = 7.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-Cyclobutylmethyl-4-methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>56d</b>)</h3><div class="NLM_p last">Starting from bromomethylcyclobutane <b>55d</b> (11.36 g, 76.2 mmol) and <b>54</b> (10 g, 66.6 mmol) and following the procedure described for <b>56a</b>, compound <b>56d</b> was obtained as a white solid (14.4 g, quantitative), mp 117.5 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.70–1.83 (m, 2H), 1.83–1.99 (m, 2H), 2.00–2.10 (m, 2H), 2.76 (sep, <i>J</i> = 7.8 Hz, 1H), 3.95 (d, <i>J</i> = 7.5 Hz, 2H), 3.99 (s, 3H), 6.05 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.8 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 219 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1-Isopentyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>57a</b>)</h3><div class="NLM_p last">A mixture of <b>56a</b> (24 g, 110 mmol) in 1 N aqueous NaOH (40 mL) was stirred at 100 °C for 20 h. The mixture was cooled to 0 °C and acidified with 2 N aqueous HCl to pH 2–3. The product precipitated in the mixture, and it was filtered, washed with cold diisopropyl ether, and dried at 50 °C in a vacuum oven to yield <b>57a</b> as a white solid (21.5 g, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.89 (d, <i>J</i> = 6.22 Hz, 6H), 1.34–1.60 (m, 3H), 3.73–3.91 (m, 2H), 6.04 (d, <i>J</i> = 7.67 Hz, 1H), 7.84 (d, <i>J</i> = 7.67 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 207 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-Butyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>57b</b>)</h3><div class="NLM_p last">Starting from <b>56b</b> (11 g, 53.3 mmol) and following the procedure described for <b>57a</b>, compound <b>57b</b> was obtained as a white solid (7.58 g, 74%), mp 192.6 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.88 (t, <i>J</i> = 7.4 Hz, 3H), 1.25 (dq, <i>J</i> = 15.1, 7.4 Hz, 2H), 1.50–1.62 (m, 2H), 3.82 (t, <i>J</i> = 7.2 Hz, 2H), 6.04 (d, <i>J</i> = 7.4 Hz, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 12.64 (broad s, 1H). LC–MS <i>m</i>/<i>z</i> 193 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-Cyclopropylmethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>57c</b>)</h3><div class="NLM_p last">Starting from <b>56c</b> (10.88 g, 53.3 mmol) and following the procedure described for <b>57a</b>, compound <b>57c</b> was obtained as a white solid (8.2 g, 81%), mp 231.1 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.30–0.37 (m, 2H), 0.39–0.55 (m, 2H), 1.06–1.22 (m, 1H), 3.67 (d, <i>J</i> = 7.26 Hz, 2H), 6.04 (d, <i>J</i> = 7.46 Hz, 1H), 7.87 (d, <i>J</i> = 7.46 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 191 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-Cyclobutylmethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carbonitrile (<b>57d</b>)</h3><div class="NLM_p last">Starting from <b>56d</b> (14.53 g, 66.6 mmol) and following the procedure described for <b>57a</b>, compound <b>57d</b> was obtained as a white solid (6.17 g, 45%), mp 296.7. °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.64–2.00 (m, 6H), 2.62 (sep, <i>J</i> = 7.7 Hz, 1H), 3.85 (d, <i>J</i> = 7.4 Hz, 2H), 6.04 (d, <i>J</i> = 7.6 Hz, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 12.66 (broad s, 1H). LC–MS <i>m</i>/<i>z</i> 205 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-(4-Bromo-2-chlorophenoxy)tetrahydropyran (<b>60</b>)</h3><div class="NLM_p last">To a cooled suspension (0 °C) of 4-hydroxytetrahydropyrane <b>58</b> (2.2 mL, 23.1 mmol), 3-chloro-4-hydroxybromobenzene <b>59</b> (4 g, 19.3 mmol), and polymer supported PPh<sub>3</sub> (17.29 g, 39.6 mmol) in dry DCM (250 mL) was added di-<i>tert</i>-butyl azodicarboxylate (6.65 g, 28.9 mmol) portionwise. The mixture was stirred at 0 °C for 5 min and at room temperature for 2 h. The resin was filtered off and washed with DCM (2 × 100 mL). The filtrates were concentrated under reduced pressure. The residue thus obtained was purified by flash column chromatography (silica gel, 7 N solution of ammonia in MeOH in DCM, 0/100 to 2/98) to give <b>60</b> as a colorless oil (5.38 g, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.79–1.89 (m, 2H), 1.96–2.05 (m, 2H), 3.59 (ddd, <i>J</i> = 11.4, 7.5, 3.7 Hz, 2H), 4.00 (ddd, <i>J</i> = 11.4, 7.2, 3.6 Hz, 2H), 4.51 (tt, <i>J</i> = 7.3, 3.7 Hz, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 1H), 7.30 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 2.5 Hz, 1H). GC–MS (EI): <i>m</i>/<i>z</i> 290 [M]<sup>+</sup>.</div></div><div id="sec5_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (4-Bromo-2-chorophenyl)tetrahydropyranylamine (<b>63</b>)</h3><div class="NLM_p last">4-Bromo-2-choroaniline <b>62</b> (4.0 g, 19.37 mmol) was added to stirred suspension of tetrahydropyranone <b>61</b> (2.69 mL, 29.05 mmol), sodium triacetoxyborohydride (6.12 g, 29.05 mmol), and 4 Å molecular sieves in dry DCM (100 mL). The mixture was stirred at room temperature for 72 h and then filtered over a Celite pad. The filtrate was concentrated in vacuo. The resulting crude product was purified by column chromatography (silica gel, 7 M solution of ammonia in MeOH/DCM, 0/100 to 5/95) to yield <b>16</b> as a white solid (4.83 g, 86%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.49–1.59 (m, 2H), 1.98–2.06 (m, 2H), 3.45–3.56 (m, 3H), 4.01 (dt, <i>J</i> = 11.9, 3.9 Hz, 2H), 4.21 (broad d, <i>J</i> = 8.1 Hz, 1H), 6.55 (d, <i>J</i> = 8.7 Hz, 1H), 7.21 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.39 (d, <i>J</i> = 2.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 291 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 3-(4-Nitrophenoxy)-2-methylpyridine (<b>66b</b>)</h3><div class="NLM_p last">4-Fluoronitrobenzene <b>65a</b> (2.58 g, 18.3 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (8.9 g, 27.5 mmol) were added to a mixture of 3-hydroxy-2-methylpyridine <b>64b</b> (2 g, 18.3 mmol) in dry DMF (5 mL). The mixture was heated at 170 °C for 30 min under microwave irradiation. After the mixture was cooled to room temperature, the solids were filtered off and the filtrate was concentrated in vacuo. The resulting residue was treated with water (10 mL) and extracted with DCM (2 × 10 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated in vacuo. The resulting crude product was purified by column chromatography (silica gel, MeOH in DCM, 0/100 to 5/95) to yield <b>66b</b> as a bright yellow solid (4.01 g, 95%), mp 76.4 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.45 (s, 3H), 6.95 (broad d, <i>J</i> = 9.0 Hz, 2H), 7.23 (dd, <i>J</i> = 7.9, 4.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.1 Hz, 1H), 8.23 (broad d, <i>J</i> = 9.0 Hz, 2H), 8.45 (d, <i>J</i> = 4.6 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 231 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 3-(4-Nitrophenoxy)-2,6-dimethylpyridine (<b>66c</b>)</h3><div class="NLM_p last">Starting from 4-fluoronitrobenzene <b>65a</b> (3.41 g, 24.3 mmol) and 2,6-dimethyl-3-hydroxypyridine <b>64c</b> (3 g, 24.3 mmol) and following the procedure described for <b>66b</b>, compound <b>66c</b> was obtained as a yellow solid (5.2 g, 89%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.40 (s, 3H), 2.58 (s, 3H), 6.90–6.95 (m, 2H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 8.19–8.24 (m, 2H). LC–MS <i>m</i>/<i>z</i> 244 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 3-(2-Chloro-4-nitrophenoxy)-2-methylpyridine (<b>66d</b>)</h3><div class="NLM_p last">A mixture of 3-hydroxy-2-methylpyridine <b>64b</b> (1.4 g, 17.2 mmol), 3-chloro-4-fluoronitrobenzene <b>65b</b> (3 g, 17.2 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (8.43 g, 26.1 mmol) in DMF (25 mL) was stirred at 130 °C for 16 h in a sealed tube. After cooling to room temperature the solvent was evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH/DCM, 2/98) to yield <b>66d</b> as a bright yellow solid (3.69 g, 81%), mp 96.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.48 (s, 3H), 6.73 (d, <i>J</i> = 9.2 Hz, 1H), 7.24 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 7.30 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 8.07 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 2.8 Hz, 1H), 8.47 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 264 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 3-(2-Chloro-4-nitrophenoxy)-2,6-dimethylpyridine (<b>66e</b>)</h3><div class="NLM_p last">Starting from 2,6-dimethyl-3-hydroxypyridine <b>64c</b> (4.24 g, 34.5 mmol) and 3-chloro-4-fluoronitrobenzene <b>65b</b> (6 g, 34.2 mmol) and following the procedure described for <b>66d</b>, compound <b>66e</b> was obtained as a yellow solid (3.30 g, 34%), mp 77.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.41 (s, 3H), 2.58 (s, 3H), 6.68 (d, <i>J</i> = 9.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.3 Hz, 1H), 7.22 (d, <i>J</i> = 8.1 Hz, 1H), 8.05 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 8.40 (d, <i>J</i> = 2.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 279 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 4-(2-Methylpyridin-3-yloxy)phenylamine (<b>67b</b>)</h3><div class="NLM_p last">Palladium (10% on carbon, 0.2 g) was added to a mixture of <b>66b</b> (4 g, 17.4 mmol) in EtOAc (150 mL). The mixture was hydrogenated at room temperature for 24 h. The mixture was filtered through a Celite pad and the filtrate evaporated in vacuo to yield <b>67b</b> as a pale pink solid (3.2 g, 92%), mp 85.3 °C. (3.2 g, 92%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.56 (s, 3H), 3.61 (broad s, 2H), 6.65–6.72 (m, 2H), 6.78–6.84 (m, 2H), 6.98–7.06 (m, 2H), 8.19 (dd, <i>J</i> = 3.9, 2.1 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 201 [M + H]<sup>+</sup></div></div><div id="sec5_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 3-(4-Aminophenoxy)-2,6-dimethylpyridine (<b>67c</b>)</h3><div class="NLM_p last">Starting from <b>66d</b> (4 g, 16.38 mmol) and following the procedure described for <b>67b</b>, compound <b>67c</b> was obtained as a white solid (3.2 g, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (s, 3H), 2.50 (s, 3H), 6.62–6.69 (m, 2H), 6.73–6.79 (m, 2H), 6.86–6.92 (m, 1H), 6.94–7.00 (m, 1H). LC–MS <i>m</i>/<i>z</i> 215 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 4-(2-Methylpyridin-3-yloxy)-3-chlorophenylamine (<b>67d</b>)</h3><div class="NLM_p last">SnCl<sub>2</sub> (11.54 g, 51.2 mmol) was added at once to a stirred solution of <b>66d</b> (2.73 g, 10.23 mmol) in EtOH (100 mL). The mixture was stirred at 90 °C for 1 h in a sealed tube, and then it was cooled to room temperature and the volatiles were evaporated in vacuo. The residue thus obtained was taken up in EtOAc and washed twice with an aqueous K<sub>2</sub>CO<sub>3</sub> saturated solution. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent evaporated in vacuo to yield <b>67d</b> as a pale cream solid (2.36 g, 98%), mp 75.9 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.61 (s, 3H), 3.70 (broad s, 2H), 6.57 (dd, <i>J</i> = 8.4, 2.6 Hz, 1H), 6.80 (d, <i>J</i> = 2.3 Hz, 1H), 6.81–6.87 (m, 2H), 7.01 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 8.18 (d, <i>J</i> = 4.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 235 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 4-(2,6-Dimethylpyridin-3-yloxy)-3-chlorophenylamine (<b>67e</b>)</h3><div class="NLM_p last">Starting from <b>66e</b> (3.3 g, 11.7 mmol) and following the procedure described for <b>67d</b>, compound <b>67e</b> was obtained as a pale cream solid (2.78 g, 95%), mp 126.5 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.48 (s, 3H), 2.56 (s, 3H), 3.66 (broad s, 2H), 6.55 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 6.75–6.82 (m, 2H), 6.84–6.89 (m, 1H), 7.26 (s, 1H). LC–MS <i>m</i>/<i>z</i> 249 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 3-(4-Bromophenoxy)-2-methylpyridine (<b>68b</b>)</h3><div class="NLM_p last">A solution of NaNO<sub>2</sub> (2.85 g, 40.9 mmol) in water (20 mL) was added dropwise over 45 min to a mixture of <b>67b</b> (4 g, 19.9 mmol) in 48% aqueous HBr (25 mL) at 0 °C. The reaction mixture was stirred at room temperature for 2 h, and then CuBr (4.28 g, 29.8 mmol) was added slowly at 0 °C. The reaction mixture was stirred at room temperature for 2 h and then at 140 °C for 20 h. After the mixture was cooled to room temperature, the crude product was carefully treated with an aqueous NaHCO<sub>3</sub> saturated solution and extracted with EtOAc (3 × 10 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtOAc in heptane, 1/4) to yield <b>68b</b> as a brown oil (3.5 g, 66%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (s, 3H), 6.78–6.83 (m, 2H), 7.13 (dd, <i>J</i> = 8.3, 4.6 Hz, 1H), 7.18 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.41–7.47 (m, 2H), 8.32 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 265 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 3-(4-Bromophenoxy)-2,6-dimethylpyridine (<b>68c</b>)</h3><div class="NLM_p last">Starting from <b>67c</b> (4 g, 18.58 mmol) and following the procedure described for <b>68b</b>, compound <b>68c</b> was obtained as a brown oil (4.1 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.43 (s, 3H), 2.53 (s, 3H), 6.71–6.80 (m, 2H), 6.97 (d, <i>J</i> = 8.1 Hz, 1H), 7.10 (d, <i>J</i> = 8.3 Hz, 1H), 7.34–7.43 (m, 2H). LC–MS <i>m</i>/<i>z</i> 278 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 3-(4-Bromo-2-chlorophenoxy)-2-methylpyridine (<b>68d</b>)</h3><div class="NLM_p last">Starting from <b>67d</b> (2.36 g, 10.1 mmol) and following the procedure described for <b>68b</b>, compound <b>68d</b> was obtained as a brown oil (2.4 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.54 (s, 3H), 6.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 7.11 (ddd, <i>J</i> = 8.1, 4.4, 0.5 Hz, 1H), 7.34 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 7.63 (d, <i>J</i> = 2.3 Hz, 1H), 8.31 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 3-(2-Chloro-4-bromophenoxy)-2,6-dimethylpyridine (<b>68e</b>)</h3><div class="NLM_p last">Starting from <b>67e</b> (2.78 g, 11.2 mmol) and following the procedure described for <b>68b</b>, compound <b>68e</b> was obtained as a brown oil (3.13 g, 96%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.47 (s, 3H), 2.53 (s, 3H), 6.63 (d, <i>J</i> = 8.7 Hz, 1H), 6.97 (d, <i>J</i> = 8.1 Hz, 1H), 7.01 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.61 (d, <i>J</i> = 2.3 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 314 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 4-(4-Bromophenoxy)-2-methylpyridine (<b>71b</b>)</h3><div class="NLM_p last">To a suspension of NaH (0.055 g, 13.8 mmol) in DMF (14 mL) at 0 °C was added portionwise 4-bromophenol <b>70a</b> (2.00 g, 11.6 mmol). The reaction mixture was stirred at 0 °C for 10 min, and then 4-chloro-2-picoline <b>69b</b> (1.47 g, 11.6 mmol) was added. The resulting mixture was heated at 180 °C for 45 min under microwave irradiation. After cooling to room temperature the reaction mixture was filtered through a Celite pad and the filtrate was concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, 0–3% MeOH in DCM) to yield <b>71b</b> as a yellow oil (2.22 g, 69%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (s, 3H), 6.65 (dd, <i>J</i> = 5.5, 2.3 Hz, 1H), 6.68 (d, <i>J</i> = 2.3 Hz, 1H), 6.94–6.99 (m, 2H), 7.49–7.54 (m, 2H), 8.35 (d, <i>J</i> = 5.8 Hz, 1H). GC–MS <i>m</i>/<i>z</i> 264 [M]<sup>+</sup>.</div></div><div id="sec5_3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-(4-Bromo-3-chlorophenoxy)-2-methylpyridine (<b>71c</b>)</h3><div class="NLM_p last">To a solution of 4-bromo-3-chlorophenol <b>70b</b> (4.80 g, 23.5 mmol) in xylenes (50 mL) were added 4-chloropicoline <b>69b</b> (3.00 g, 23.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (3.90 g, 28.5 mmol). The resulting solution was then heated at 150 °C for 5 days. The reaction mixture was then filtered through a Celite pad. The filtrate was concentrated in vacuo to yield a residue that was purified by column chromatography (silica gel, 0–3% MeOH in DCM) to yield <b>71c</b> as a pale brown solid (4.95 g, 70%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.52 (s, 3H), 6.66–6.73 (m, 2H), 6.88 (dd, <i>J</i> = 8.8, 2.7 Hz, 1H), 7.21 (d, <i>J</i> = 2.9 Hz, 1H), 7.64 (d, <i>J</i> = 8.7 Hz, 1H), 8.39 (d, <i>J</i> = 5.5 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 4-(4-Bromo-2-fluorophenoxy)-2,6-dimethylpyridine (<b>71d</b>)</h3><div class="NLM_p last">Starting from 4-bromo-2-fluorophenol <b>70c</b> (3.10 g, 16.2 mmol) and 4-chloro-2,6-dimethylpyridine <b>69c</b> (3.00 g, 16.2 mmol) and following the procedure described for <b>71c</b>, compound <b>71d</b> was obtained as a pale brown solid (3.20 g, 66%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.47 (s, 6H), 6.49 (s, 2H), 7.05 (t, <i>J</i> = 8.4 Hz, 1H), 7.33 (broad d, <i>J</i> = 8.7 Hz, 1H), 7.40 (dd, <i>J</i> = 9.5, 2.0 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 4-(4-Bromo-2-chlorophenoxy)-2-methylpyridine 1-Oxide (<b>74a</b>)</h3><div class="NLM_p last">To a solution of 4-bromo-2-chlorophenol <b>73a</b> (5.37 g, 26.0 mmol) in DMF (10 mL) at 0 °C was added NaH (0.93 g, 38.9 mmol) portionwise. The mixture was stirred for 10 min at 0 °C, and then 4-nitro-2-picoline <i>N</i>-oxide <b>72</b> (4 g, 25.9 mmol) was added. Stirring was continued for 1 h at room temperature, and then the mixture was heated at 180 °C for 40 min under microwave irradiation. The reaction mixture was cooled to room temperature, filtered through a Celite pad, and the filtrate was diluted with water and extracted with EtOAc (4 × 10 mL). The combined organic extracts were dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtOAc/heptane, 50/50) to yield <b>74a</b> (4.03 g, 49%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.50 (s, 3H), 6.69 (dd, <i>J</i> = 7.2, 3.5 Hz, 1H), 6.76 (d, <i>J</i> = 3.5 Hz, 1H), 7.04 (d, <i>J</i> = 8.7 Hz, 1H), 7.47 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.67 (d, <i>J</i> = 2.3 Hz, 1H), 8.19 (d, <i>J</i> = 6.9 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 315 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 4-(4-Bromo-2-fluorophenoxy)-2-methylpyridine 1-Oxide (<b>74b</b>)</h3><div class="NLM_p last">To a solution of 4-bromo-3-fluorophenol <b>73b</b> (2.00 g, 10.4 mmol) in <i>N</i>-methylpyrrolidone (14 mL) at 0 °C was added NaH (0.054 g, 13.6 mmol) portionwise. The mixture was stirred for 10 min at 0 °C, and then <b>72</b> (1.77 g, 11.5 mmol) was added. The reaction mixture was heated at 240 °C for 60 min under microwave irradiation. The reaction mixture was cooled to room temperature, filtered through a Celite pad, and the filtrate was diluted with Et<sub>2</sub>O and washed with water (4 × 20 mL). The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give a residue that was purified by column chromatography (silica gel, 0–3% MeOH·NH<sub>3</sub> (7 N) in DCM) to yield <b>74b</b> (2.35 g, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.50 (s, 3H), 6.73 (dd, <i>J</i> = 6.9, 3.0 Hz, 1H), 6.80 (broad s, 1H), 7.08 (t, <i>J</i> = 8.4 Hz, 1H), 7.36 (d, <i>J</i> = 8.6 Hz, 1H), 7.42 (dd, <i>J</i> = 9.7, 1.6 Hz, 1H), 8.19 (d, <i>J</i> = 7.2 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 4-(4-Bromo-3-fluorophenoxy)-2-methylpyridine 1-Oxide (<b>74c</b>)</h3><div class="NLM_p last">Starting from 4-bromo-3-fluorophenol <b>73c</b> (6 g, 31.4 mmol) and following the procedure described for <b>74a</b>, compound <b>74c</b> was obtained as an oil (3.61 g, 40%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.53 (s, 3H), 6.78–6.84 (m, 2H), 6.87–6.92 (m, 2H), 7.61 (dd, <i>J</i> = 8.8, 7.6 Hz, 1H), 8.25 (d, <i>J</i> = 7.2 Hz, 1H). LC–MS <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Biology. Membrane Preparation</h3><div class="NLM_p last">CHO cells were cultured to preconfluence and stimulated with 5 mM butyrate for 24 h, prior to washing in PBS, and then collection was by scraping in homogenization buffer (50 mM Tris-HCl buffer, pH 7.4, 4 °C). Cell lysates were homogenized briefly (15 s) using an ULTRA-TURRAX homogenizer. The homogenate was centrifuged at 23500<i>g</i> for 10 min and the supernatant discarded. The pellet was resuspended in 5 mM Tris-HCl, pH 7.4, and centrifuged again (30000<i>g</i>, 20 min, 4 °C). The final pellet was resuspended in 50 mM HEPES, pH 7.4, and stored at −80 °C in appropriate aliquots before use. Protein concentration was determined by the Bradford method (Bio- Rad, U.S.) with bovine serum albumin as standard.</div></div><div id="sec5_4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> [<sup>35</sup>S]GTPγS Binding Assay</h3><div class="NLM_p last">Measurement of mGluR2 positive allosteric modulatory activity of test compounds in membranes containing human mGluR2 was performed using frozen membranes that were thawed and briefly homogenized prior to preincubation in 96-well microplates (15 mg/assay well, 30 min, 30 °C) in assay buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 3 mM MgCl<sub>2</sub>, 50 μM GDP, 10 mg mL<sup>–1</sup> saponin) with increasing concentrations of positive allosteric modulator (from 0.3 nM to 50 μM) and either a minimal predetermined concentration of glutamate (PAM assay) or no added glutamate. For the PAM assay, membranes were preincubated with glutamate at EC<sub>25</sub> concentration, i.e., a concentration that gives 25% of the maximal response glutamate. After addition of [<sup>35</sup>S]GTPγS (0.1 nM, fc) to achieve a total reaction volume of 200 μL, microplates were shaken briefly and further incubated to allow [<sup>35</sup>S]GTPγS incorporation on activation (30 min, 30 °C). The reaction was stopped by rapid vacuum filtration over glass-fiber filter plates (Unifilter 96-well GF/B filter plates, Perkin-Elmer, Downers Grove, IL, U.S.), using a 96-well plate cell harvester (Filtermate, Perkin-Elmer, U.S.), and then by washing three times with 300 μL of ice-cold wash buffer (Na<sub>2</sub>PO<sub>4</sub>·2H<sub>2</sub>O, 10 mM, NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 10 mM, pH 7.4). Filters were then air-dried, and 40 mL of liquid scintillation cocktail (Microscint-O) was added to each well. Membrane-bound [<sup>35</sup>S]GTPγS was measured in a 96-well scintillation plate reader (Top-Count, Perkin-Elmer, U.S.). Nonspecific [<sup>35</sup>S]GTPγS binding is determined in the presence of cold 10 mM GTP. Each curve was performed at least three times using duplicate sample per data point and at 11 concentrations.</div></div><div id="sec5_4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Data Analysis</h3><div class="NLM_p last">The concentration–response curves in the presence of added EC<sub>25</sub> of mGluR2 agonist glutamate to determine positive allosteric modulation (PAM), were generated using the Prism GraphPad software (Graph Pad Inc., San Diego, USA). The curves were fitted to a four-parameter logistic equation (<i>Y</i> = bottom + (top – bottom)/(1 + 10<sup>((log EC<sub>50</sub>–<i>X</i>)(Hill slope)</sup>) allowing determination of EC<sub>50</sub> values. The EC<sub>50</sub> is the concentration of a compound that causes a half-maximal potentiation of the glutamate response. This is calculated by subtracting the maximal responses of glutamate in the presence of a fully saturating concentration of a positive allosteric modulator from the response of glutamate in the absence of a positive allosteric modulator. The concentration producing the half-maximal effect is then calculated as EC<sub>50</sub>. The pEC<sub>50</sub> values are calculated as the −log EC<sub>50</sub> (wherein EC<sub>50</sub> is expressed in mol L<sup>–1</sup>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Patch Clamp Assay</h3><div class="NLM_p last">Experiments were performed using HEK293 cells stably expressing the HERG potassium channel. Cells were grown at 37 °C and 5% CO<sub>2</sub> in culture flasks in MEM medium supplemented with 10% heat-inactivated fetal bovine serum, 1% <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin solution, 1% nonessential amino acids (100×), 1% sodium pyruvate (100 mM), and 0.8% Geneticin (50 mg/mL). Before use, the cells were subcultured in MEM medium in the absence of 5 mL of <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin. For use in the automated patch-clamp system PatchXpress 7000A (Axon Instruments) cells were harvested to obtain cell suspension of single cells. Extracellular solution contained the following (mM): 150 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 10 HEPES, 5 glucose (pH 7.4 with NaOH). Pipette solution contained the following (mM): 120 KCl, 10 HEPES, 5 EGTA, 4 ATP-Mg<sub>2</sub>, 2 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub> (pH 7.2 with KOH). Patch-clamp experiments were performed in the voltage-clamp mode, and whole-cell currents were recorded with an automated patch-clamp assay utilizing the PatchXpress 7000A system (Axon Instruments). Current signals were amplified and digitized by a Multiclamp amplifier and stored and analyzed by using the PatchXpress, DataXpress software, and Igor 5.0 (Wavemetrics). The holding potential was −80 mV. The HERG current (K<sup>+</sup>-selective outward current) was determined as the maximal tail current at −40 mV after a 2 s depolarization to +60 mV. Pulse cycling rate was 15 s. Before each test pulse a short pulse (0.5 s) from the holding potential to −60 mV was given to determine (linear) leak current. After whole-cell configuration and a stability period were established, the vehicle was applied for 5 min followed by the test substance with increasing concentrations of 10<sup>–7</sup>, 3 × 10<sup>–7</sup>, and 3 × 10<sup>–6</sup> M. Each concentration of the test substance was applied twice. The effect of each concentration was determined after 5 min as an average current of three sequential voltage pulses. To determine the extent of block, the residual current was compared with vehicle pretreatment.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Method for Identification of Main Metabolites</h3><div class="NLM_p last">The test compounds were incubated with human and rat liver microsomes, at 0.4% final solvent concentration (0.16% DMSO and 0.24% MeCN). The study was conducted to identify the main metabolites formed after 0 min (control) and 60 min of incubation time in the presence of NADPH generating system at 37 °C. Test concentration of the compound was 5 μM. Samples were compared to the control incubations in which compound was added at termination. Data were acquired on a Waters UPLC/QToF Premier mass spectrometer using a 10 min generic UPLC method and a generic MSe method. Complementary MS/MS experiments were performed when necessary. An Acquity UPLC C18 (2.1 mm × 100 mm, 1.8 μm) column was used. Interpretation of data was performed with Waters Metabolynx software.</div></div><div id="sec5_6_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Sleep–Wake EEG. Animals, Drug Treatment, and Experimental Procedure</h3><div class="NLM_p">All in vivo experimental procedures were performed according the applicable European Communities Council Directive of November 24, 1986 (86/609/EEC), and approved by the Animal Care and Use Committee of Janssen Pharmaceutical Companies of Johnson & Johnson and by the local ethical committee.</div><div class="NLM_p">Male Sprague–Dawley rats (Charles River, France) weighing 250–300 g were used. Animals were chronically implanted with electrodes for recording the cortical electroencephalogram (EEG), electrical neck muscle activity (EMG), and ocular movements (EOG). All animals were housed in individually ventilated cages under environmentally controlled conditions (ambient temperature, 22 °C; humidity, 60%) on a 12 h light/dark cycle (lights on from 12:00 a.m. to 12:00 p.m., illumination intensity of ∼100 lx). The animals had free access to food and tap water.</div><div class="NLM_p">The effects of the tested molecule and vehicle on sleep–wake distribution during the lights-on period were investigated in 16 rats (<i>n</i> = 8 each group). Two EEG recording sessions were performed: the first recording session started at 13:30 h and lasted 20 h following oral administration of saline. The second recording session was performed during the same consecutive circadian time and for the same duration following administration of either vehicle (20% CD + 2H2T) or tested compound.</div><div class="NLM_p last">Sleep polysomnographic variables were determined offline using a sleep stages analyzer, scoring each 2 s epoch before averaging stages over 30 min periods. Sleep–wake state classifications were assigned based on a combination of dynamics of five EEG frequency domains, integrated EMG, EOG, and body activity level: active wake (AW); passive wake (PW); intermediate stage (pre-REM transients); rapid eye movement sleep (REM); light non-REM sleep (lSWS); deep non-REM sleep (dSWS). Different sleep–wake parameters were investigated over 20 h postadministration: amount of time spent in each vigilance state, sleep parameters, latencies for first REM sleep period, and the number of transitions between states.</div></div><div id="sec5_6_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Statistical Analysis</h3><div class="NLM_p last">Time spent in each vigilance state (AW, PW, lSWS, dSWS, IS, and REMS) was expressed as a percentage of the recording period. A statistical analysis of the obtained data was carried out by a nonparametric analysis of variance of each 30 min period, followed by a Wilcoxon–Mann–Whitney rank sum test of comparisons with the control group.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106"><a href="/doi/suppl/10.1021/jm2016864">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of LC–MS methods. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016864/suppl_file/jm2016864_si_001.pdf">jm2016864_si_001.pdf (135.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2016864" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose María Cid</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1cbc2c8c5e1c8d5d28fcbcfcb8fc2cecc"><span class="__cf_email__" data-cfemail="69030a000d29001d1a47030703470a0604">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillaume Duvey</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Tresadern</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanthea Nhem</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rocco Furnari</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Cluzeau</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Antonio Vega</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Isabel de Lucas</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Encarnación Matesanz</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Manuel Alonso</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Lourdes Linares</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Ignacio Andrés</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonia M. Poli</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Lutjens</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hassan Himogai</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Philippe Rocher</span> - <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor J. Macdonald</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Oehlrich</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilde Lavreysen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdelah Ahnaou</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wilhelmus Drinkenburg</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Mackie</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span>; 
    <span class="hlFld-Affiliation affiliation">‡Neuroscience Medicinal Chemistry, §Neuroscience Biology, and ∥Discovery ADME/Tox, Janssen Research & Development, Janssen Pharmaceutica
NV, Turnhoutseweg 30, B-2340, Beerse, Belgium</span>; 
    <span class="hlFld-Affiliation affiliation">Addex Pharmaceuticals, 12 Chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S.A., Jarama 75, 45007-Toledo,
Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1436e6672-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the members of the purification and analysis group.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i108" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i108"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i109" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i109"> Abbreviations Used</h2><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DMS-IV</td><td class="NLM_def"><p class="first last">diagnostic statistical manual of mental disorders volume IV</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">mGlu2</td><td class="NLM_def"><p class="first last">metabotropic glutamate 2</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">nm</td><td class="NLM_def"><p class="first last">not measurable</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">REM</td><td class="NLM_def"><p class="first last">rapid eye movement</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">ROL</td><td class="NLM_def"><p class="first last">rapid eye movement sleep onset latency</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">sw-EEG</td><td class="NLM_def"><p class="first last">sleep–wake electroencephalogram</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Watkins, J. C.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Glutamate as a central neurotransmitter: looking back</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1042%2F0300-5127%3A0280297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=10961913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=297-310&author=J.+C.+Watkins&title=l-Glutamate+as+a+central+neurotransmitter%3A+looking+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">L-Glutamate as a central neurotransmitter: looking back</span></div><div class="casAuthors">Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-310</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 114 refs.  The high concn. in brain of unbound L-glutamic acid (in its anionic form, L-glutamate) fueled considerable speculation as to its role in central nervous function more than 50 yr ago.  Claims in the 1940s that it could improve cognitive acuity in patients with mental impairment were particularly intriguing, though later refuted.  In the early 1950s Hayashi found that L-glutamate could cause convulsions and proposed that it might be a central synaptic transmitter.  Soon thereafter, Curtis and colleagues showed that L-glutamate depolarized and excited central neurons, as expected for an excitatory transmitter; however, various aspects of the action of L-glutamate seemed to argue strongly against a transmitter function.  This neg. view prevailed for some 20 yr, before compelling evidence for such a role was adduced.  Over the last two decades, extensive research has revealed a host of glutamate receptor subtypes, subserving several different functions in excitatory synaptic transmission.  This paper gives a very brief and personal over-view of the development of the field over the last 50 yr from a mainly pharmacol. stand-point.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ2Xbf1GO6rVg90H21EOLACvtfcHk0li8D3JneFupuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D&md5=feb7517645ed59e3eaa0179c4ac6bd60</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2F0300-5127%3A0280297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0300-5127%253A0280297%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DJ.%2BC.%26atitle%3Dl-Glutamate%2520as%2520a%2520central%2520neurotransmitter%253A%2520looking%2520back%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2000%26volume%3D28%26spage%3D297%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J. P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.+P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0li8D3JneFupuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psyhopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+C.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0li8D3JneFupuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsyhopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2FS0163-7258%2803%2900038-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=12782243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2003&pages=325-354&author=J.+P.+Pinauthor=T.+Galvezauthor=L.+Prezeau&title=Evolution%2C+structure%2C+and+activation+mechanism+of+family+3%2FC+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span></div><div class="casAuthors">Pin, Jean-Philippe; Galvez, Thierry; Prezeau, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-354</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) represent one of the largest gene families in the animal genome.  These receptors can be classified into several groups based on the sequence similarity of their common heptahelical domain.  The family 3 (or C) GPCRs are receptors for the main neurotransmitters glutamate and γ-aminobutyric acid, for Ca2+, for sweet and amino acid taste compds., and for some pheromone mols., as well as for odorants in fish.  Although none of these family 3 receptors have been found in plants, members have been identified in ancient organisms, such as slime molds (Dictyostelium) and sponges.  Like any other GPCRs, family 3 receptors possess a transmembrane heptahelical domain responsible for G-protein activation.  However, most of these identified receptors also possess a large extracellular domain that is responsible for ligand recognition, is structurally similar to bacterial periplasmic proteins involved in the transport of small mols., and is called a Venus Flytrap module.  The recent resoln. of the structure of this binding domain in one of these receptors, the metabotropic glutamate 1 receptor, together with the recent demonstration that these receptors are dimers, revealed a unique mechanism of activation for these GPCRs.  Such data open new possibilities in the development of drugs aimed at modulating these receptors, and raise a no. of interesting questions on the activation mechanism of the other GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNRDDmZSLFrVg90H21EOLACvtfcHk0li8D3JneFupuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D&md5=33ed658debc421c5dbd63a8b6dbf56b1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900038-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900038-X%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DGalvez%26aufirst%3DT.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DEvolution%252C%2520structure%252C%2520and%2520activation%2520mechanism%2520of%2520family%25203%252FC%2520G-protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D98%26spage%3D325%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F138945007779315614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=17266540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=169-184&author=H.+Brauner-Osborneauthor=P.+Wellendorphauthor=A.+A.+Jensen&title=Structure%2C+pharmacology+and+therapeutic+prospects+of+family+C+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span></div><div class="casAuthors">Brauner-Osborne Hans; Wellendorph Petrine; Jensen Anders A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five orphan receptors.  Aside from the orphan receptors, the family C GPCRs are characterised by a large amino-terminal domain, which bind the endogenous orthosteric agonists.  Recently, a number of allosteric modulators binding to the seven transmembrane domains of the receptors have also been reported.  Family C GPCRs regulate a number of important physiological functions and are thus intensively pursued as drug targets.  So far, two drugs acting at family C receptors (the GABA(B) agonist baclofen and the positive allosteric CaR modulator cinacalcet) have been marketed.  Cinacalcet is the first allosteric GPCR modulator to enter the market, which demonstrates that the therapeutic principle of allosteric modulation can also be extended to this important drug target class.  In this review we outline the structure and function of family C GPCRs with particular focus on the ligand binding sites, and we present the most important pharmacological agents and the therapeutic prospects of the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMO1HRaArq6WxpATR2EQURfW6udTcc2eabstoSiXCyJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D&md5=242ec346ee4fd59c033b5574983fd164</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138945007779315614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945007779315614%26sid%3Dliteratum%253Aachs%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DStructure%252C%2520pharmacology%2520and%2520therapeutic%2520prospects%2520of%2520family%2520C%2520G-protein%2520coupled%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=9295396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADyaK2sXmtl2lt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=7503-7522&author=R.+Shigemotoauthor=A.+Kinoshitaauthor=E.+Wadaauthor=S.+Nomuraauthor=H.+Ohishiauthor=M.+Takadaauthor=P.+J.+Florauthor=A.+Nekiauthor=T.+Abeauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+presynaptic+localization+of+metabotropic+glutamate+receptor+subtypes+in+the+rat+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus</span></div><div class="casAuthors">Shigemoto, Ryuichi; Kinoshita, Ayae; Wada, Eiki; Nomura, Sakashi; Ohishi, Hitoshi; Takada, Masahiko; Flor, Peter J.; Neki, Akio; Abe, Takaaki; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7503-7522</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurotransmission in the hippocampus is modulated variously through presynaptic metabotropic glutamate receptors (mGluRs).  To establish the precise localization of presynaptic mGluRs in the rat hippocampus, the authors used subtype-specific antibodies for eight mGluRs (mGluR1-mGluR8) for immunohistochem. combined with lesioning of the three major hippocampal pathways: the perforant path, mossy fiber, and Schaffer collateral.  Immunoreactivity for group II (mGluR2) and group III (mGluR4a, mGluR7a, mGluR7b, and mGluR8) mGluRs was predominantly localized to presynaptic elements, whereas that for group I mGluRs (mGluR1 and mGluR5) was localized to postsynaptic elements.  The medial perforant path was strongly immunoreactive for mGluR2 and mGluR7a throughout the hippocampus, and the lateral perforant path was prominently immunoreactive for mGluR8 in the dentate gyrus and CA3 area.  The mossy fiber was labeled for mGluR2, mGluR7a, and mGluR7b, whereas the Schaffer collateral was labeled only for mGluR7a.  Electron microscopy further revealed the spatial segregation of group II and group III mGluRs within presynaptic elements.  Immunolabeling for the group III receptors was predominantly obsd. in presynaptic active zones of asym. and sym. synapses, whereas that for the group II receptor (mGluR2) was found in preterminal rather than terminal portions of axons.  Target cell-specific segregation of receptors, first reported for mGluR7a, was also apparent for the other group III mGluRs, suggesting that transmitter release is differentially regulated by 2-amino-4-phosphonobutyrate-sensitive mGluRs in individual synapses on single axons according to the identity of postsynaptic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXc5O2pAWWw7Vg90H21EOLACvtfcHk0ljT4MR9zMUnjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtl2lt7s%253D&md5=80decb8f071ae684aeb5378de4df9281</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DKinoshita%26aufirst%3DA.%26aulast%3DWada%26aufirst%3DE.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DTakada%26aufirst%3DM.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DNeki%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520presynaptic%2520localization%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtypes%2520in%2520the%2520rat%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D7503%26epage%3D7522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lgEL0XuSLfM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of the messenger RNA for metabotropic glutamate receptor, mGlu2, in the central nervous system of the rat</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=1009-1018&author=H.+Ohishiauthor=R.+Shigemotoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Distribution+of+the+messenger+RNA+for+metabotropic+glutamate+receptor%2C+mGlu2%2C+in+the+central+nervous+system+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520the%2520messenger%2520RNA%2520for%2520metabotropic%2520glutamate%2520receptor%252C%2520mGlu2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D53%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPγS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+J.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTP%CE%B3S+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0lgEL0XuSLfM6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTP%25CE%25B3S%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span> </span><span class="NLM_article-title">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1197</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.brainres.2007.12.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=18242587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1197&publication_year=2008&pages=47-62&author=G.+Guauthor=D.+S.+Lorrainauthor=H.+Weiauthor=R.+L.+Coleauthor=X.+Zhangauthor=L.+P.+Daggettauthor=H.+J.+Schaffhauserauthor=L.+J.+Bristowauthor=S.+M.+Lechner&title=Distribution+of+metabotropic+glutamate+2+and+3+receptors+in+the+rat+forebrain%3A+implication+in+emotional+responses+and+central+disinhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition</span></div><div class="casAuthors">Gu, Guibao; Lorrain, Daniel S.; Wei, Hongbing; Cole, Rebecca L.; Zhang, Xin; Daggett, Lorrie P.; Schaffhauser, Herve J.; Bristow, Linda J.; Lechner, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-62</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The receptor localization of metabotropic glutamate receptors (mGlu) 2 and 3 was examd. by using in situ hybridization and a well-characterized mGlu2-selective antibody in the rat forebrain.  The mGlu2 was highly and discretely expressed in cell bodies in almost all of the key regions of the limbic system in the forebrain, including the midline and intralaminar structures of the thalamus, the assocn. cortices, the dentate gyrus of the hippocampus, the medial mammillary nucleus, and the lateral and basolateral nuclei of the amygdala.  Moreover, presynaptic mGlu2 terminals were found in most of the forebrain structures, esp. in the lateral part of the central nucleus of the amygdala, and the CA1 region of the hippocampus.  Although some overlaps exist, such as in the hippocampus and the amygdala, the expression of mGlu3 mRNA, however, appeared to be more disperse, compared with that of mGlu2 mRNA.  These distribution results support previous behavioral studies that the mGlu2 and 3 receptors may play important roles in emotional responses.  In addn. to its expression in glia, mGlu3 was distinctively expressed in cells in the GABAergic reticular nucleus of the thalamus.  Local infusion of a non-selective mGlu2/3 agonist, LY 379268, in the reticular nucleus of the thalamus, significantly reduced GABA release, suggesting that mGlu3 may also play a role in central disinhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fnpYDrcWc7Vg90H21EOLACvtfcHk0ljeG7cOPo_S4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D&md5=48befca37fcd63a7a5b86562a5672826</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DG.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DR.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26atitle%3DDistribution%2520of%2520metabotropic%2520glutamate%25202%2520and%25203%2520receptors%2520in%2520the%2520rat%2520forebrain%253A%2520implication%2520in%2520emotional%2520responses%2520and%2520central%2520disinhibition%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1197%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ghose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Amezcua, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1176%2Fappi.ajp.2009.08091445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19487395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=812-820&author=S.+Ghoseauthor=K.+A.+Gleasonauthor=B.+W.+Pottsauthor=K.+Lewis-Amezcuaauthor=C.+A.+Tamminga&title=Differential+expression+of+metabotropic+glutamate+receptors+2+and+3+in+schizophrenia%3A+a+mechanism+for+antipsychotic+drug+action%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span></div><div class="casAuthors">Ghose Subroto; Gleason Kelly A; Potts Bryan W; Lewis-Amezcua Kelly; Tamminga Carol A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Preclinical and clinical data implicate the group II metabotropic glutamate receptors mGluR2 and mGluR3 in the pathophysiology of schizophrenia.  Moreover, a recent phase II clinical trial demonstrated the antipsychotic efficacy of a mGluR2/mGluR3 agonist.  The purpose of the present study was to distinguish the expression of mGluR2 and mGluR3 receptor proteins in schizophrenia and to quantify glutamate carboxypeptidase II (GCP II) in order to explore a role for the metabotropic receptors in schizophrenia therapeutics.  GCP II is an enzyme that metabolizes N-acetyl-aspartyl-glutamate (NAAG), which is the only known specific endogenous agonist of mGluR3 in the mammalian brain.  METHOD:  The normal expression levels of mGluR2, mGluR3, and GCP II were determined for 10 regions of the postmortem human brain using specific antibodies.  Differences in expression levels of each protein were examined in the dorsolateral prefrontal cortex, temporal cortex, and motor cortex in 15 postmortem schizophrenia subjects and 15 postmortem matched normal comparison subjects.  Chronic antipsychotic treatment in rodents was conducted to examine the potential effect of antipsychotic drugs on expression of the three proteins.  RESULTS:  Findings revealed a significant increase in GCP II protein and a reduction in mGluR3 protein in the dorsolateral prefrontal cortex in schizophrenia subjects, with mGluR2 protein levels unchanged.  Chronic antipsychotic treatment in rodents did not influence GCP II or mGluR3 levels.  CONCLUSIONS:  Increased GCP II expression and low mGluR3 expression in the dorsolateral prefrontal cortex suggest that NAAG-mediated signaling is impaired in this brain region in schizophrenia.  Further, these data implicate the mGluR3 receptor in the antipsychotic action of mGluR2/mGluR3 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH7FPLGZ5fKrHHuJhbyicZfW6udTcc2eakQz8TmjKbVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D&md5=b2f45d5fc6ff54baa76c335b0fa08c4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.08091445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.08091445%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DS.%26aulast%3DGleason%26aufirst%3DK.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BW.%26aulast%3DLewis-Amezcua%26aufirst%3DK.%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DDifferential%2520expression%2520of%2520metabotropic%2520glutamate%2520receptors%25202%2520and%25203%2520in%2520schizophrenia%253A%2520a%2520mechanism%2520for%2520antipsychotic%2520drug%2520action%253F%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D812%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Swanson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Glutamate receptors as novel targets for anxiety and stress disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=131-144&author=C.+J.+Swansonauthor=M.+Buresauthor=M.+P.+Johnsonauthor=A.+M.+Lindenauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Glutamate+receptors+as+novel+targets+for+anxiety+and+stress+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DC.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DGlutamate%2520receptors%2520as%2520novel%2520targets%2520for%2520anxiety%2520and%2520stress%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D131%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacology of mGluR2/3 receptor agonists: novel agents for schizophrenia?</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F1568007024606177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=215-225&author=D.+D.+Schoeppauthor=G.+J.+Marek&title=Preclinical+pharmacology+of+mGluR2%2F3+receptor+agonists%3A+novel+agents+for+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?</span></div><div class="casAuthors">Schoepp, Darryle D.; Marek, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Agonists for mGlu2/3 receptors decrease the evoked release of glutamate at certain (ie. forebrain / limbic) glutamatergic synapses, indicating that the functional role of mGlu2 and/or mGlu3 receptors is to suppress glutamate excitations.  This offers a mechanism for dampening glutamate excitation under pathol. states resulting from excessive glutamate release.  Based, in part, on the psychotomimetic actions of phencyclidine (PCP)-like drugs, excessive or pathol. glutamate release has been implicated in a no. of clin. conditions including psychosis.  With this in mind, the pharmacol. of multiple mGlu2/3 receptor agonists have been investigated in PCP treated rats.  Agonists for mGlu2/3 receptors such as LY354740 and LY379268 have been shown to block certain behavioral responses to PCP in rats.  The effects of mGlu2/3 agonists on PCP-induced behaviors are blocked by a low doses of a selective mGlu2/3 receptor antagonist, indicating that these actions are mediated via mGlu2/3 receptors.  In addn., mGlu2/3 agonists potently suppress glutamate release in rat prefrontal cortex, as reflected by excitatory post-synaptic potentials (EPSPs) induced by serotonin (5-HT) acting on 5HT2A receptors.  These actions of LY354740 and LY379268 are also blocked by a selective mGlu2/3 antagonist.  Atypical antipsychotic drugs such as clozapine also suppress 5-HT-induced EPSPs in this brain region, thus suggesting a common pathway for the actions of atypical antipsychotic drugs and mGlu2/3 receptor agonists.  As glutamatergic dysfunction has been implicated in psychotic states and possibly in the etiol. of schizophrenia, clin. studies with mGlu2/3 agonists may be warranted to further explore the validity of the glutamatergic hypothesis of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEl6C2-lj4rVg90H21EOLACvtfcHk0lhGwuvf-Jdu1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2nu7o%253D&md5=7b0d86049ef459f8bc419e63cfd6b653</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1568007024606177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007024606177%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DPreclinical%2520pharmacology%2520of%2520mGluR2%252F3%2520receptor%2520agonists%253A%2520novel%2520agents%2520for%2520schizophrenia%253F%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2002%26volume%3D1%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.tips.2008.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19058862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=25-30&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+metabotropic+glutamate+receptors+as+a+novel+approach+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span></div><div class="casAuthors">Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, the metabotropic glutamate (mGlu) receptors have emerged as potential new drug targets for treatment of a range of CNS disorders.  Some of the most compelling advances have been made in targeting specific mGlu receptor subtypes as a fundamentally new approach to the treatment of schizophrenia.  Recent animal and clin. studies provide strong evidence that agonists of group II mGlu receptors (mGluR2 and mGluR3) are effective in the treatment of the pos. symptoms of schizophrenia, and animal studies suggest that mGluR5 agonists could provide a novel approach for the treatment of all major symptom domains (pos., neg., and cognitive) of this disorder.  Although the discovery of selective agonists of these receptors is a challenge, there have been recent advances in the discovery of highly selective pos. allosteric modulators (PAMs) of mGluR2 and mGluR5.  These mGlu receptor-selective PAMs have properties needed for optimization as clin. candidates and have robust effects in animal models that predict efficacy in treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_CxX6LmkZObVg90H21EOLACvtfcHk0lg0YuoAwOoVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D&md5=06ee21863b9528fb70211f87827b98ce</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptors%2520as%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Shigeyuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohiko, H.</span><span> </span><span class="NLM_article-title">Targeting of metabotropic glutamate receptors for the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F138161211795049570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=21355835" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=94-102&author=C.+Shigeyukiauthor=H.+Hirohiko&title=Targeting+of+metabotropic+glutamate+receptors+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F138161211795049570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049570%26sid%3Dliteratum%253Aachs%26aulast%3DShigeyuki%26aufirst%3DC.%26aulast%3DHirohiko%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520metabotropic%2520glutamate%2520receptors%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0lg0YuoAwOoVVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Levine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by a CO<sub>2</sub> challenge in patients diagnosed with panic disorder</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=294&author=L.+Levineauthor=B.+Gaydosauthor=D.+Sheehanauthor=A.+Goddardauthor=J.+Feighnerauthor=W.+Potterauthor=D.+D.+Schoepp&title=The+mGlu2%2F3+receptor+agonist%2C+LY354740%2C+reduces+panic+anxiety+induced+by+a+CO2+challenge+in+patients+diagnosed+with+panic+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DL.%26aulast%3DGaydos%26aufirst%3DB.%26aulast%3DSheehan%26aufirst%3DD.%26aulast%3DGoddard%26aufirst%3DA.%26aulast%3DFeighner%26aufirst%3DJ.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mGlu2%252F3%2520receptor%2520agonist%252C%2520LY354740%252C%2520reduces%2520panic%2520anxiety%2520induced%2520by%2520a%2520CO2%2520challenge%2520in%2520patients%2520diagnosed%2520with%2520panic%2520disorder%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. N.</span><span> </span><span class="NLM_article-title">Recent developments in metabotropic glutamate receptors as novel drug targets</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1358%2Fdof.2010.035.04.1487693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=307-324&author=M.+J.+O%E2%80%99Neillauthor=M.+J.+Fellauthor=K.+A.+Svenssonauthor=J.+M.+Witkinauthor=S.+N.+Mitchell&title=Recent+developments+in+metabotropic+glutamate+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in metabotropic glutamate receptors as novel drug targets</span></div><div class="casAuthors">O'Neill, M. J.; Fell, M. J.; Svensson, K. A.; Witkin, J. M.; Mitchell, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, activating ionotropic (iGlu) and metabotropic (mGlu) glutamate receptors.  Targeting iGlu receptors has proven difficult, as these receptors play such a crit. role in fast synaptic transmission.  In recent years, there has been a switch in the focus of the pharmaceutical industry to target mGlu receptors, as these receptors have a more modulatory role in the brain.  Eight subtypes of the C protein-coupled mGlu receptors have been cloned and classified into three groups according to their second messenger assocn., sequence homol. and agonist selectivity.  Group I (mGlu1 and mGlu5) receptors are pos. coupled to phosphatidylinositol (PI) hydrolysis, while group II (mGlu2 and mGlu3) and group III (mGlu4, mGlu6, mGlu7 and mGlu8) receptors are neg. coupled to adenylate cyclase and thought to act as presynaptic autoreceptors, regulating glutamate transmission.  There has been rapid progress in understanding the biol. of mGlu receptors and their function in the central nervous system (CNS), and the field now has highly potent and selective ligands for many of the mGlu receptor subtypes.  Pharmacol. tools include both orthosteric and allosteric agonists and antagonists.  These mols. have been explored across a range of CNS conditions, the findings of which will be discussed briefly in this review.  Recently, some of the most promising mols. have progressed into clin. trials (mGlu2/3 receptor agonists for the treatment of anxiety and schizophrenia and mGlu5 receptor antagonists for acute migraine and L-DOPA-induced dyskinesia) and achieved proof of concept.  These encouraging results suggest mGlu receptors as novel drug targets with application in a range of psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9EtQj2lZSbVg90H21EOLACvtfcHk0li_UxIfPlKPtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D&md5=1b51466a1778a814d0988eab288c623e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.04.1487693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.04.1487693%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DMitchell%26aufirst%3DS.%2BN.%26atitle%3DRecent%2520developments%2520in%2520metabotropic%2520glutamate%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=342-353&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wooley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pemberton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span> </span><span class="NLM_article-title">The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=431-440&author=M.+L.+Wooleyauthor=D.+J.+Pembertonauthor=S.+Bateauthor=C.+Cortiauthor=D.+M.+Jones&title=The+mGlu2+but+not+the+mGlu3+receptor+mediates+the+actions+of+the+mGluR2%2F3+agonist%2C+LY379268%2C+in+mouse+models+predictive+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWooley%26aufirst%3DM.%2BL.%26aulast%3DPemberton%26aufirst%3DD.%2BJ.%26aulast%3DBate%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mGlu2%2520but%2520not%2520the%2520mGlu3%2520receptor%2520mediates%2520the%2520actions%2520of%2520the%2520mGluR2%252F3%2520agonist%252C%2520LY379268%252C%2520in%2520mouse%2520models%2520predictive%2520of%2520antipsychotic%2520activity%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0lin9doXL1hSxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.+P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0liiwwEO1hRn7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span> </span><span class="NLM_article-title">Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1622</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1038%2Fsj.npp.1300238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=12825094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFeisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1622-1632&author=D.+S.+Lorrainauthor=H.+Schaffhauserauthor=U.+C.+Campbellauthor=C.+S.+Bacceiauthor=L.+D.+Correaauthor=B.+Roweauthor=D.+E.+Rodriguezauthor=J.+J.+Andersonauthor=M.+A.+Varneyauthor=A.+B.+Pinkertonauthor=J.-M.+Vernierauthor=L.+J.+Bristow&title=Group+II+mGlu+receptor+activation+suppresses+norepinephrine+release+in+the+ventral+hippocampus+and+locomotor+responses+to+acute+ketamine+challenge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge</span></div><div class="casAuthors">Lorrain, Daniel S.; Schaffhauser, Herve; Campbell, Una C.; Baccei, Christopher S.; Correa, Lucia D.; Rowe, Blake; Rodriguez, Dana E.; Anderson, Jeffery J.; Varney, Mark A.; Pinkerton, Anthony B.; Vernier, Jean-Michel; Bristow, Linda J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1622-1632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Group II mGlu receptor agonists (eg LY379268 and LY354740) have been shown to reverse many of the behavioral responses to PCP as well as glutamate release elicited by PCP and ketamine.  In the present set of expts., the authors used in vivo microdialysis to show that, in addn. to reversing PCP- and ketamine-evoked glutamate release, group II mGlu receptor stimulation also prevents ketamine-evoked norepinephrine (NE) release.  Pretreating animals with the mixed 2/3 metabotropic glutamate (mGlu2/3) receptor agonist LY379268 (0.3-10 mg/kg) dose-dependently inhibited ketamine (25 mg/kg)-evoked NE release in the ventral hippocampus (VHipp).  Ketamine hyperactivity was also reduced in a similar dose range.  Following the authors' initial observation on NE release, they conducted a series of microinjection expts. to reveal that the inhibitory effects of LY379268 on VHipp NE release may be linked to glutamate transmission within the medial prefrontal cortex.  Finally, the authors were able to mimic the inhibitory effects of LY379268 on ketamine-evoked NE release by using a novel mGlu2 receptor selective pos. modulator.  (+/-) 2,2,2-Trifluoroethyl [3-(1-methyl-butoxy)-phenyl]-pyridin-3-ylmethyl-sulfonamide (2,2,2-TEMPS, characterized through in vitro GTPγS binding) at a dose of 100 mg/kg significantly reduced the NE response.  Together, these results demonstrate a novel means to suppress noradrenergic neurotransmission (i.e. by activating mGlu2 receptors) and may, therefore, have important implications for neuropsychiatric disorders in which aberrant activation of the noradrenergic system is thought to be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1EmzIVF7NI7Vg90H21EOLACvtfcHk0liApIULuilQlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFeisLY%253D&md5=b17d585f28f71d8ef7d52cdcac2697f5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300238%26sid%3Dliteratum%253Aachs%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DRowe%26aufirst%3DB.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DAnderson%26aufirst%3DJ.%2BJ.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26atitle%3DGroup%2520II%2520mGlu%2520receptor%2520activation%2520suppresses%2520norepinephrine%2520release%2520in%2520the%2520ventral%2520hippocampus%2520and%2520locomotor%2520responses%2520to%2520acute%2520ketamine%2520challenge%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1622%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callagaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of <i>N</i>-(4-(2-methoxyphenoxy)phenyl)-<i>N</i>-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3192</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034015u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3189-3192&author=M.+P.+Johnsonauthor=M.+Baezauthor=G.+E.+Jagdmannauthor=T.+C.+Brittonauthor=T.+H.+Largeauthor=D.+O.+Callagaroauthor=J.+P.+Tizzanoauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Discovery+of+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor%3A+synthesis+and+subtype+selectivity+of+N-%284-%282-methoxyphenoxy%29phenyl%29-N-%282%2C2%2C2-trifluoroethylsulfonyl%29pyrid-3-ylmethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm034015u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034015u%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DLarge%26aufirst%3DT.%2BH.%26aulast%3DCallagaro%26aufirst%3DD.%2BO.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%253A%2520synthesis%2520and%2520subtype%2520selectivity%2520of%2520N-%25284-%25282-methoxyphenoxy%2529phenyl%2529-N-%25282%252C2%252C2-trifluoroethylsulfonyl%2529pyrid-3-ylmethylamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3189%26epage%3D3192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Barda, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, <i>N</i>-(4-phenoxyphenyl)-<i>N</i>-(3-pyridylmethyl)ethanesulfonamide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3099-3102&author=D.+A.+Bardaauthor=Z.-Q.+Wangauthor=T.+C.+Brittonauthor=S.+S.+Henryauthor=G.+E.+Jagdmannauthor=D.+S.+Colemanauthor=M.+P.+Johnsonauthor=S.+L.+Andisauthor=D.+D.+Schoepp&title=SAR+study+of+a+subtype+selective+allosteric+potentiator+of+metabotropic+glutamate+2+receptor%2C+N-%284-phenoxyphenyl%29-N-%283-pyridylmethyl%29ethanesulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarda%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DZ.-Q.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DHenry%26aufirst%3DS.%2BS.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DColeman%26aufirst%3DD.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DSAR%2520study%2520of%2520a%2520subtype%2520selective%2520allosteric%2520potentiator%2520of%2520metabotropic%2520glutamate%25202%2520receptor%252C%2520N-%25284-phenoxyphenyl%2529-N-%25283-pyridylmethyl%2529ethanesulfonamide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3099%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span> </span><span class="NLM_article-title">Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiators for the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4595</span><span class="NLM_x">–</span> <span class="NLM_lpage">4599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040088h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4595-4599&author=A.+B.+Pinkertonauthor=J.-M.+Vernierauthor=H.+Schaffhauserauthor=B.+A.+Roweauthor=U.+C.+Campbellauthor=D.+E.+Rodriguezauthor=D.+S.+Lorrainauthor=C.+S.+Bacceiauthor=L.+P.+Daggettauthor=L.+J.+Bristow&title=Phenyl-tetrazolyl+acetophenones%3A+discovery+of+positive+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm040088h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040088h%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26atitle%3DPhenyl-tetrazolyl%2520acetophenones%253A%2520discovery%2520of%2520positive%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4595%26epage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: identification and synthesis of phenyl-tetrazolyl acetophenones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5329</span><span class="NLM_x">–</span> <span class="NLM_lpage">5332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5329-5332&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=X.+Zhaoauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+1%3A+identification+and+synthesis+of+phenyl-tetrazolyl+acetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25201%253A%2520identification%2520and%2520synthesis%2520of%2520phenyl-tetrazolyl%2520acetophenones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5329%26epage%3D5332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5867</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5867-5872&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=J.+K.+Jamesauthor=M.+F.+Gardnerauthor=H.+Schaffhauserauthor=B.+A.+Roweauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+2%3A+4-thiopyridyl+acetophenones+as+non-tetrazole+containing+mGlu2+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25202%253A%25204-thiopyridyl%2520acetophenones%2520as%2520non-tetrazole%2520containing%2520mGlu2%2520receptor%2520potentiators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5867%26epage%3D5872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span> </span><span class="NLM_article-title">3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)-phenoxy]butoxy}phenylpropanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2389</span><span class="NLM_x">–</span> <span class="NLM_lpage">2393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2389-2393&author=R.+V.+Cubeauthor=J.-M.+Vernierauthor=J.+H.+Hutchinsonauthor=M.+F.+Gardnerauthor=J.+K.+Jamesauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=L.+Daggettauthor=A.+B.+Pinkerton&title=3-%282-Ethoxy-4-%7B4-%5B3-hydroxy-2-methyl-4-%283-methylbutanoyl%29-phenoxy%5Dbutoxy%7Dphenylpropanoic+acid%3A+a+brain+penetrant+allosteric+potentiator+at+the+metabotropic+glutamate+receptor+2+%28mGluR2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DDaggett%26aufirst%3DL.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3D3-%25282-Ethoxy-4-%257B4-%255B3-hydroxy-2-methyl-4-%25283-methylbutanoyl%2529-phenoxy%255Dbutoxy%257Dphenylpropanoic%2520acid%253A%2520a%2520brain%2520penetrant%2520allosteric%2520potentiator%2520at%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2389%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T. M.</span><span> </span><span class="NLM_article-title">Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4354-4358&author=C.+Bonnefousauthor=J.-M.+Vernierauthor=J.+H.+Hutchinsonauthor=M.+F.+Gardnerauthor=M.+Cramerauthor=J.+K.+Jamesauthor=B.+A.+Roweauthor=L.+P.+Daggettauthor=H.+Schaffhauserauthor=T.+M.+Kamenecka&title=Biphenyl-indanones%3A+allosteric+potentiators+of+the+metabotropic+glutamate+subtype+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DCramer%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DBiphenyl-indanones%253A%2520allosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520subtype%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: identification and biological activity of indanone containing mGlu2 receptor potentiators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1565-1571&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=J.+K.+Jamesauthor=M.+F.+Gardnerauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=D.+E.+Rodriguezauthor=L.+P.+Campbellauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+3%3A+identification+and+biological+activity+of+indanone+containing+mGlu2+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25203%253A%2520identification%2520and%2520biological%2520activity%2520of%2520indanone%2520containing%2520mGlu2%2520receptor%2520potentiators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1565%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Govek, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuiston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pracitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4068</span><span class="NLM_x">–</span> <span class="NLM_lpage">4072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4068-4072&author=S.+P.+Govekauthor=C.+Bonnefousauthor=J.+H.+Hutchinsonauthor=T.+Kameneckaauthor=J.+McQuistonauthor=R.+Pracittoauthor=L.+X.+Zhaoauthor=M.+F.+Gardnerauthor=J.+K.+Jamesauthor=L.+P.+Daggettauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=L.+J.+Bristowauthor=U.+C.+Campbellauthor=D.+E.+Rodriguesauthor=J.-M.+Vernier&title=Benzazoles+as+allosteric+potentiators+of+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+efficacy+in+an+animal+model+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGovek%26aufirst%3DS.%2BP.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DMcQuiston%26aufirst%3DJ.%26aulast%3DPracitto%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DRodrigues%26aufirst%3DD.%2BE.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DBenzazoles%2520as%2520allosteric%2520potentiators%2520of%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520efficacy%2520in%2520an%2520animal%2520model%2520for%2520schizophrenia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4068%26epage%3D4072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Clayton, J.; Ma, F.; Van Wagenen, B.; Ukkiramapandian, R.; Egle, I.; Empfield, J.; Isaac, M.; Slassi, A.; Steelman, G.; Urbanek, R.; Walsh, S.</span> Patent WO2006/020879 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clayton%2C+J.%3B+Ma%2C+F.%3B+Van+Wagenen%2C+B.%3B+Ukkiramapandian%2C+R.%3B+Egle%2C+I.%3B+Empfield%2C+J.%3B+Isaac%2C+M.%3B+Slassi%2C+A.%3B+Steelman%2C+G.%3B+Urbanek%2C+R.%3B+Walsh%2C+S.+Patent+WO2006%2F020879+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DJ.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Balestra, M.; Bunting, H.; Chen, D.; Egle, I.; Forst, J.; Frey, J.; Isaac, M.; Ma, F.; Nugiel, D.; Slassi, A.; Steelman, G.; Sun, G.; Sundar, B.; Ukkiramapandian, R.; Urbanek, R.; Walsh, S.</span> Patent WO2006/071730 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balestra%2C+M.%3B+Bunting%2C+H.%3B+Chen%2C+D.%3B+Egle%2C+I.%3B+Forst%2C+J.%3B+Frey%2C+J.%3B+Isaac%2C+M.%3B+Ma%2C+F.%3B+Nugiel%2C+D.%3B+Slassi%2C+A.%3B+Steelman%2C+G.%3B+Sun%2C+G.%3B+Sundar%2C+B.%3B+Ukkiramapandian%2C+R.%3B+Urbanek%2C+R.%3B+Walsh%2C+S.+Patent+WO2006%2F071730+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBalestra%26aufirst%3DM.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Dhanya, R. -P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highfield Nickols, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=342-353&author=R.+-P.+Dhanyaauthor=S.+Sidiqueauthor=D.+S.+Shefflerauthor=H.+Highfield+Nickolsauthor=A.+Herathauthor=L.+Yangauthor=R.+Dahlauthor=R.+Ardeckyauthor=S.+Semenovaauthor=A.+Markouauthor=P.+J.+Connauthor=N.+D.+P.+Cosford&title=Design+and+synthesis+of+an+orally+active+metabotropic+glutamate+receptor+subtype-2+%28mGluR2%29+positive+allosteric+modulator+%28PAM%29+that+decreases+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span></div><div class="casAuthors">Dhanya, Raveendra-Panickar; Sidique, Shyama; Sheffler, Douglas J.; Nickols, Hilary Highfield; Herath, Ananda; Yang, Li; Dahl, Russell; Ardecky, Robert; Semenova, Svetlana; Markou, Athina; Conn, P. Jeffrey; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modification of 3'-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid (BINA, I) by incorporating heteroatoms into the structure and replacing the cyclopentyl moiety led to the development of new mGluR2 pos. allosteric modulators (PAMs) with optimized potency and superior druglike properties.  These analogs are more potent than I in vitro and are highly selective for mGluR2 vs other mGluR subtypes.  They have significantly improved pharmacokinetic (PK) properties, with excellent oral bioavailability and brain penetration.  The benzisothiazol-3-one deriv. II decreased cocaine self-administration in rats, providing proof-of-concept for the use of mGluR2 PAMs for the treatment of cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmO8DAzKVg7Vg90H21EOLACvtfcHk0lilw6Y9IiEYpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO&md5=402c4f95aa11618fe07c8d146ffc2a8e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1012165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012165%26sid%3Dliteratum%253Aachs%26aulast%3DDhanya%26aufirst%3DR.%2B-P.%26aulast%3DSidique%26aufirst%3DS.%26aulast%3DSheffler%26aufirst%3DD.%2BS.%26aulast%3DHighfield%2BNickols%26aufirst%3DH.%26aulast%3DHerath%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520active%2520metabotropic%2520glutamate%2520receptor%2520subtype-2%2520%2528mGluR2%2529%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520that%2520decreases%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span> </span><span class="NLM_article-title">3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5493-5496&author=L.+Zhangauthor=B.+N.+Rogersauthor=A.+J.+Duplantierauthor=S.+F.+McHardyauthor=I.+Efremovauthor=H.+Berkeauthor=W.+Qianauthor=A.+Q.+Zhangauthor=N.+Makladauthor=J.+Candlerauthor=A.+C.+Doranauthor=J.+T.+Lazarroauthor=A.+H.+Ganong&title=3-%28Imidazolyl+methyl%29-3-aza-bicyclo%5B3.1.0%5Dhexan-6-yl%29methyl+ethers%3A+a+novel+series+of+mGluR2+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DBerke%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DLazarro%26aufirst%3DJ.%2BT.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26atitle%3D3-%2528Imidazolyl%2520methyl%2529-3-aza-bicyclo%255B3.1.0%255Dhexan-6-yl%2529methyl%2520ethers%253A%2520a%2520novel%2520series%2520of%2520mGluR2%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5493%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">D’Alessandro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppe, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Fuente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=759-762&author=P.+L.+D%E2%80%99Alessandroauthor=C.+Cortiauthor=A.+Rothauthor=A.+Ugoliniauthor=A.+Savaauthor=D.+Montanariauthor=F.+Bianchiauthor=S.+L.+Garlandauthor=B.+Powneyauthor=E.+L.+Koppeauthor=M.+Rochevilleauthor=G.+Osborneauthor=P.+Perezauthor=J.+de+la+Fuenteauthor=M.+De+Los+Frailesauthor=P.+W.+Smithauthor=C.+Branchauthor=D.+Nashauthor=S.+P.+Watson&title=The+identification+of+structurally+novel%2C+selective%2C+orally+bioavailable+positive+modulators+of+mGluR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DP.%2BL.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DF.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DKoppe%26aufirst%3DE.%2BL.%26aulast%3DRocheville%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3Dde%2Bla%2BFuente%26aufirst%3DJ.%26aulast%3DDe%2BLos%2BFrailes%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DBranch%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520structurally%2520novel%252C%2520selective%252C%2520orally%2520bioavailable%2520positive%2520modulators%2520of%2520mGluR2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span> </span><span class="NLM_article-title">1-[(1-Methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101414h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1724-1739&author=L.+Zhangauthor=M.+A.+Brodneyauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+J.+Duplantierauthor=I.+V.+Efremovauthor=E.+Evrardauthor=K.+Krausauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Jenzaauthor=J.+T.+Lazzaroauthor=N.+Makladauthor=S.+A.+McCarthyauthor=W.+Qianauthor=B.+N.+Rogersauthor=M.+D.+Rottasauthor=C.+J.+Schmidtauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=A.+Q.+Zhang&title=1-%5B%281-Methyl-1H-imidazol-2-yl%29methyl%5D-4-phenylpiperidines+as+mGluR2+positive+allosteric+modulators+for+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm101414h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101414h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DJenza%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DRottas%26aufirst%3DM.%2BD.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26atitle%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1724%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.-</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: hit to lead and lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2524-2529&author=A.+J.+Duplantierauthor=I.+Efremovauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+H.-+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Krausauthor=J.+T.+Lazzaroauthor=J.+Luauthor=N.+Makladauthor=S.+A.+McCarthyauthor=T.+J.+O%E2%80%99Sullivanauthor=B.+N.+Rogersauthor=J.+A.+Siuciakauthor=D.+K.+Spracklinauthor=L.+Zhang&title=3-Benzyl-1%2C3-oxazolidin-2-ones+as+mGluR2+positive+allosteric+modulators%3A+hit+to+lead+and+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DGanong%26aufirst%3DA.%2BH.-%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D3-Benzyl-1%252C3-oxazolidin-2-ones%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%253A%2520hit%2520to%2520lead%2520and%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: hit-to-lead efforts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3129-3133&author=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=M.+E.+Laytonauthor=J.+M.+Sandersauthor=C.+Culbersonauthor=M.+A.+Jacobsonauthor=B.+C.+Magliaroauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=S.+L.+Huszarauthor=J.+M.+Uslanerauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=S.+M.+Surauthor=G.+D.+Hartman&title=3-Aryl-5-phenoxymethyl-1%2C3-oxazolidin-2-ones+as+positive+allosteric+modulators+of+mGluR2+for+the+treatment+of+schizophrenia%3A+hit-to-lead+efforts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3D3-Aryl-5-phenoxymethyl-1%252C3-oxazolidin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520hit-to-lead%2520efforts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3129%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as positive allosteric modulators for the mGluR2 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+positive+allosteric+modulators+for+the+mGluR2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520positive%2520allosteric%2520modulators%2520for%2520the%2520mGluR2%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-8-chloro-6-substituted isoquinolones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=971-976&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=H.+Lavreysenauthor=S.+Poliauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-8-chloro-6-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-8-chloro-6-substituted%2520isoquinolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D971%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-5-substituted isoquinolones</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1039%2Fc0md00200c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=132-139&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=S.+Poliauthor=H.+Lavreysenauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-5-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones</span></div><div class="casAuthors">Trabanco, Andres A.; Duvey, Guillaume; Cid, Jose Maria; Macdonald, Gregor J.; Cluzeau, Philippe; Nhem, Vanthea; Furnari, Rocco; Behaj, Nadia; Poulain, Geraldine; Finn, Terry; Poli, Sonia; Lavreysen, Hilde; Raux, Alexandre; Thollon, Yves; Poirier, Nicolas; D'Addona, David; Andres, Jose Ignacio; Lutjens, Robert; Le Poul, Emmanuel; Imogai, Hassan; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of N-propyl-5-substituted isoquinolones was identified as pos. allosteric modulators (PAM) of metabotropic glutamate receptor 2 (mGluR2) via high-throughput screening (HTS).  The subsequent synthesis and preliminary SAR exploration that led to the identification of compd. 20 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w5fK6sXL07Vg90H21EOLACvtfcHk0liWM3wF3N5IcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D&md5=f729cbf8bcdeb592859e3e921c089be1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0md00200c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00200c%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-5-substituted%2520isoquinolones%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garc%C3%ADaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-disubstituted pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C.+Boleaauthor=T.+Finnauthor=S.+Poliauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Metesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=J.+Oyarzabalauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andresauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C5-disubstituted+pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0ljLlWcxvl96Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMetesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C5-disubstituted%2520pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Imogai, H. I.; Cid-Nuñez, J. M.; Andrés-Gil, J. I.; Trabanco-Suárez, A. A.; Oyarzábal-Santamarina, J.; Dautzenberg, F. M.; Macdonald, G. J.; Pullan, S. E.; Lutjens, R. J.; Duvey, G. A. J.; Nhem, V.; Finn, T. P.; Melikyan, G.</span> Patent WO2007/104783 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Imogai%2C+H.+I.%3B+Cid-Nu%C3%B1ez%2C+J.+M.%3B+Andr%C3%A9s-Gil%2C+J.+I.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Oyarz%C3%A1bal-Santamarina%2C+J.%3B+Dautzenberg%2C+F.+M.%3B+Macdonald%2C+G.+J.%3B+Pullan%2C+S.+E.%3B+Lutjens%2C+R.+J.%3B+Duvey%2C+G.+A.+J.%3B+Nhem%2C+V.%3B+Finn%2C+T.+P.%3B+Melikyan%2C+G.+Patent+WO2007%2F104783+A2%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BI.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.</span> Patent WO2008/107480 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid-Nu%C3%B1ez%2C+J.+M.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Macdonald%2C+G.+J.%3B+Duvey%2C+G.+A.+J.+Patent+WO2008%2F107480+A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.</span> Patent WO2008/107481 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid-Nu%C3%B1ez%2C+J.+M.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Macdonald%2C+G.+J.%3B+Duvey%2C+G.+A.+J.+Patent+WO2008%2F107481+A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="note"><p class="first last">The in vitro [<sup>35</sup>S]GTPγS assay provides two measures of compound activity: pEC<sub>50</sub>, which is defined as the negative logarithm of the concentration at which half-maximal potentiation of glutamate is reached; % <i>E</i><sub>MAX</sub>, which is the maximal increase in observed glutamate response.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibelin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H. I. M.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">603</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.ejphar.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19046965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=603&publication_year=2009&pages=62-72&author=A.+Ahnaouauthor=F.+M.+Dautzenbergauthor=H.+Geysauthor=H.+Imogaiauthor=A.+Gibelinauthor=D.+Moecharsauthor=T.+Stecklerauthor=W.+H.+I.+M.+Drinkenburg&title=Modulation+of+group+II+metabotropic+glutamate+receptor+%28mGlu2%29+elicits+common+changes+in+rat+and+mice+sleep-wake+architecture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span></div><div class="casAuthors">Ahnaou, Abdellah; Dautzenberg, Frank M.; Geys, Helena; Imogai, Hassan; Gibelin, Antoine; Moechars, Dieder; Steckler, Thomas; Drinkenburg, Wilhelmus H. I. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">603</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">62-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compiling pharmacol. evidence implicates metabotropic glutamate mGlu2 receptors in the regulation of emotional states and suggests pos. modulators as a novel therapeutic approach of Anxiety/Depression and Schizophrenia.  Here, we investigated s.c. effects of the metabotropic glutamate mGlu2/3 agonist (LY354740) on sleep-wake architecture in rat.  To confirm the specific effects on rapid eye movement (REM) sleep were mediated via metabotropic glutamate mGlu2 receptors, we characterized the sleep-wake cycles in metabotropic glutamate mGlu2 receptor deficient mice (mGlu2R-/-) and their arousal response to LY354740.  We furthermore examd. effects on sleep behavior in rats of the pos. allosteric modulator, biphenyl-indanone A (BINA) alone and in combination with LY354740 at sub-EDs.  LY354740 (1, 3 and 10 mg/kg) dose-dependently suppressed REM sleep and prolonged its onset latency.  Metabotropic glutamate mGlu2R-/- and their wild type (WT) littermates exhibited similar spontaneous sleep-wake phenotype, while LY354740 (10 mg/kg) significantly affected REM sleep variables in WT but not in the mutant.  In rats, BINA (1, 3, 10, 20, 40 mg/kg) dose-dependently suppressed REM sleep, lengthened its onset latency and slightly enhanced passive waking.  Addnl., combined treatment elicited a synergistic action on REM sleep variables.  Our findings show common changes of REM sleep variables following modulation of metabotropic glutamate mGlu2 receptor and support an active role of this receptor in the regulation of REM sleep.  The synergistic action of BINA on LY354740's effects on sleep pattern implies that pos. modulators would tune the endogenous glutamate tone suggesting potential benefit in the treatment of psychiatric disorders, in which REM sleep overdrive is manifested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUXqoXCoqp7Vg90H21EOLACvtfcHk0ljLlWcxvl96Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D&md5=eb1e676deebb6b39aad64cf14a281bf2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DGeys%26aufirst%3DH.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DGibelin%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%2BI.%2BM.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520%2528mGlu2%2529%2520elicits%2520common%2520changes%2520in%2520rat%2520and%2520mice%2520sleep-wake%2520architecture%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D603%26spage%3D62%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penman, B. W.</span><span> </span><span class="NLM_article-title">Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespiauthor=V.+P.+Millerauthor=B.+W.+Penman&title=Microtiter+plate+assays+for+inhibition+of+human%2C+drug-metabolizing+cytochromes+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DPenman%26aufirst%3DB.%2BW.%26atitle%3DMicrotiter%2520plate%2520assays%2520for%2520inhibition%2520of%2520human%252C%2520drug-metabolizing%2520cytochromes%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Miller, V. P.; Ackermann, J.; Stresser, D. M.; Crespi, C. L.</span><span> </span><span class="NLM_article-title">Novel High Throughput Fluorescent P450 Assays</span>. <span class="NLM_publisher-name">GENTEST Corp.</span>: <span class="NLM_publisher-loc">Woburn, MA</span>; <a href="http://www.bdj.co.jp/gentest/articles/hkdqj2000001c7w6-att/Poster2-6_Novel_HTS_CYP_I.pdf" class="extLink">http://www.bdj.co.jp/gentest/articles/hkdqj2000001c7w6-att/Poster2-6_Novel_HTS_CYP_I.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Miller%2C+V.+P.%3B+Ackermann%2C+J.%3B+Stresser%2C+D.+M.%3B+Crespi%2C+C.+L.+Novel+High+Throughput+Fluorescent+P450+Assays.+GENTEST+Corp.%3A+Woburn%2C+MA%3B+http%3A%2F%2Fwww.bdj.co.jp%2Fgentest%2Farticles%2Fhkdqj2000001c7w6-att%2FPoster2-6_Novel_HTS_CYP_I.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DV.%2BP.%26atitle%3DNovel%2520High%2520Throughput%2520Fluorescent%2520P450%2520Assays%26pub%3DGENTEST%2520Corp" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, Beta<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':[],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tao Chen, Hao Xiong, Jing-Fang Yang, Xiao-Lei Zhu, Ren-Yu Qu, <span class="NLM_string-name hlFld-ContribAuthor">Guang-Fu Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Diaryl Ether: A Privileged Scaffold for Drug and Agrochemical Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (37)
                                     , 9839-9877. <a href="https://doi.org/10.1021/acs.jafc.0c03369" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c03369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c03369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c03369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiaryl%252BEther%25253A%252BA%252BPrivileged%252BScaffold%252Bfor%252BDrug%252Band%252BAgrochemical%252BDiscovery%26aulast%3DChen%26aufirst%3DTao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D11082020%26date%3D11082020%26date%3D29082020%26date%3D11082020%26volume%3D68%26issue%3D37%26spage%3D9839%26epage%3D9877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ana Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, María Lourdes Linares, Aránzazu García Molina, Gary Tresadern, Hilde Lavreysen, Andrés A. Trabanco, <span class="NLM_string-name hlFld-ContribAuthor">José María Cid</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1H-benzimidazol-2-ones as mGlu2 Receptor PAMs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 303-308. <a href="https://doi.org/10.1021/acsmedchemlett.9b00350" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00350%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiro-oxindole%252BPiperidines%252Band%252B3-%252528Azetidin-3-yl%252529-1H-benzimidazol-2-ones%252Bas%252BmGlu2%252BReceptor%252BPAMs%26aulast%3Dde%2BLucas%26aufirst%3DAna%2BIsabel%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31072019%26date%3D10102019%26date%3D16102019%26date%3D10102019%26volume%3D11%26issue%3D3%26spage%3D303%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maarten
L. J. Doornbos, Xuesong Wang, Sophie C. Vermond, Luc Peeters, Laura Pérez-Benito, Andrés A. Trabanco, Hilde Lavreysen, José María Cid, Laura H. Heitman, Gary Tresadern, <span class="NLM_string-name hlFld-ContribAuthor">Adriaan P. IJzerman</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 223-233. <a href="https://doi.org/10.1021/acs.jmedchem.8b00051" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00051%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BAllosteric%252BProbe%252Bfor%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%2525C2%2525A02%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%26aulast%3DDoornbos%26aufirst%3DMaarten%2BL.%2BJ.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12012018%26date%3D07032018%26date%3D01032018%26volume%3D62%26issue%3D1%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Andres A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">John P.  Overington</span>, <span class="hlFld-ContribAuthor ">Herman W. T.  van Vlijmen</span>, and <span class="hlFld-ContribAuthor ">Gerard J. P.  van Westen</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (12)
                                     , 2976-2985. <a href="https://doi.org/10.1021/acs.jcim.7b00338" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00338%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BAllosteric%252BModulators%252Bof%252BMetabotropic%252BGlutamate%252B7%252BReceptor%252BUsing%252BProteochemometric%252BModeling%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06062017%26date%3D12122017%26date%3D26122017%26date%3D26112017%26volume%3D57%26issue%3D12%26spage%3D2976%26epage%3D2985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten L. J.  Doornbos</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>, <span class="hlFld-ContribAuthor ">Jordi  Haubrich</span>, <span class="hlFld-ContribAuthor ">Alexandro  Nunes</span>, <span class="hlFld-ContribAuthor ">Jasper W.  van de Sande</span>, <span class="hlFld-ContribAuthor ">Sophie C.  Vermond</span>, <span class="hlFld-ContribAuthor ">Thea  Mulder-Krieger</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus H.  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6704-6720. <a href="https://doi.org/10.1021/acs.jmedchem.7b00669" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00669%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BKinetic%252BProfiling%252Bof%252B7-Aryl-1%25252C2%25252C4-triazolo%25255B4%25252C3-a%25255Dpyridines%25253A%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DDoornbos%26aufirst%3DMaarten%2BL.%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10052017%26date%3D01082017%26date%3D10082017%26date%3D13072017%26volume%3D60%26issue%3D15%26spage%3D6704%26epage%3D6720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, and <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>  . </span><span class="cited-content_cbyCitation_article-title">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6707-6741. <a href="https://doi.org/10.1021/acs.chemrev.5b00656" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPractical%252BStrategies%252Band%252BConcepts%252Bin%252BGPCR%252BAllosteric%252BModulator%252BDiscovery%25253A%252BRecent%252BAdvances%252Bwith%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLindsley%26aufirst%3DCraig%2BW.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06112015%26date%3D16022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6707%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph E.  Pero</span>, <span class="hlFld-ContribAuthor ">Michael A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Kelly, III</span>, <span class="hlFld-ContribAuthor ">Hannah D. G. F.  Lehman</span>, <span class="hlFld-ContribAuthor ">Mark E.  Layton</span>, <span class="hlFld-ContribAuthor ">Robert M.  Garbaccio</span>, <span class="hlFld-ContribAuthor ">Julie A.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Brian C.  Magliaro</span>, <span class="hlFld-ContribAuthor ">Jason M.  Uslaner</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Huszar</span>, <span class="hlFld-ContribAuthor ">Kerry L.  Fillgrove</span>, <span class="hlFld-ContribAuthor ">Cuyue  Tang</span>, <span class="hlFld-ContribAuthor ">Yuhsin  Kuo</span>, <span class="hlFld-ContribAuthor ">Leo A.  Joyce</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, and <span class="hlFld-ContribAuthor ">Marlene A.  Jacobson</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 312-317. <a href="https://doi.org/10.1021/acsmedchemlett.5b00459" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00459%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252BNovel%252BAza-benzimidazolone%252BmGluR2%252BPAMs%252Bwith%252BRespect%252Bto%252BLLE%252Band%252BPK%252BProperties%252Band%252BMitigation%252Bof%252BCYP%252BTDI%26aulast%3DPero%26aufirst%3DJoseph%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01122015%26date%3D09012016%26date%3D13012016%26date%3D10032016%26date%3D10012016%26volume%3D7%26issue%3D3%26spage%3D312%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José María  Cid</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Robert  Lütjens</span>, <span class="hlFld-ContribAuthor ">Terry  Finn</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>, <span class="hlFld-ContribAuthor ">Sonia  Poli</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  de Lucas</span>, <span class="hlFld-ContribAuthor ">Encarnación  Matesanz</span>, <span class="hlFld-ContribAuthor ">María Lourdes  Linares</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcazar</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Abdelah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Stefan  Pype</span>, <span class="hlFld-ContribAuthor ">David  Gallacher</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6495-6512. <a href="https://doi.org/10.1021/jm500496m" title="DOI URL">https://doi.org/10.1021/jm500496m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500496m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500496m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-Butyl-3-chloro-4-%2525284-phenyl-1-piperidinyl%252529-%2525281H%252529-pyridone%252B%252528JNJ-40411813%252529%25253A%252BA%252BNovel%252BPositive%252BAllosteric%252BModulator%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252B2%252BReceptor%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BMar%25C3%25ADa%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28032014%26date%3D28072014%26date%3D14082014%26date%3D17072014%26volume%3D57%26issue%3D15%26spage%3D6495%26epage%3D6512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magnus S.  Alphey</span>, <span class="hlFld-ContribAuthor ">Lisa  Pirrie</span>, <span class="hlFld-ContribAuthor ">Leah S.  Torrie</span>, <span class="hlFld-ContribAuthor ">Wassila Abdelli  Boulkeroua</span>, <span class="hlFld-ContribAuthor ">Mary  Gardiner</span>, <span class="hlFld-ContribAuthor ">Aurijit  Sarkar</span>, <span class="hlFld-ContribAuthor ">Marko  Maringer</span>, <span class="hlFld-ContribAuthor ">Wulf  Oehlmann</span>, <span class="hlFld-ContribAuthor ">Ruth  Brenk</span>, <span class="hlFld-ContribAuthor ">Michael S.  Scherman</span>, <span class="hlFld-ContribAuthor ">Michael  McNeil</span>, <span class="hlFld-ContribAuthor ">Martin  Rejzek</span>, <span class="hlFld-ContribAuthor ">Robert A.  Field</span>, <span class="hlFld-ContribAuthor ">Mahavir  Singh</span>, <span class="hlFld-ContribAuthor ">David  Gray</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Westwood</span>, and <span class="hlFld-ContribAuthor ">James H.  Naismith</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Competitive Inhibitors of the Glucose-1-phosphate Thymidylyltransferase (RmlA) from Pseudomonas aeruginosa. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (2)
                                     , 387-396. <a href="https://doi.org/10.1021/cb300426u" title="DOI URL">https://doi.org/10.1021/cb300426u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb300426u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb300426u%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAllosteric%252BCompetitive%252BInhibitors%252Bof%252Bthe%252BGlucose-1-phosphate%252BThymidylyltransferase%252B%252528RmlA%252529%252Bfrom%252BPseudomonas%252Baeruginosa%26aulast%3DAlphey%26aufirst%3DMagnus%2BS.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15082012%26date%3D08112012%26date%3D28112012%26date%3D15022013%26date%3D08112012%26volume%3D8%26issue%3D2%26spage%3D387%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyama  Sidique</span>, <span class="hlFld-ContribAuthor ">Raveendra-Panickar  Dhanya</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Hilary Highfield  Nickols</span>, <span class="hlFld-ContribAuthor ">Li  Yang</span>, <span class="hlFld-ContribAuthor ">Russell  Dahl</span>, <span class="hlFld-ContribAuthor ">Arianna  Mangravita-Novo</span>, <span class="hlFld-ContribAuthor ">Layton H.  Smith</span>, <span class="hlFld-ContribAuthor ">Manoranjan S.  D’Souza</span>, <span class="hlFld-ContribAuthor ">Svetlana  Semenova</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Athina  Markou</span>, and <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>  . </span><span class="cited-content_cbyCitation_article-title">Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9434-9445. <a href="https://doi.org/10.1021/jm3005306" title="DOI URL">https://doi.org/10.1021/jm3005306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3005306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3005306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOrally%252BActive%252BMetabotropic%252BGlutamate%252BSubtype%252B2%252BReceptor%252BPositive%252BAllosteric%252BModulators%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BAssessment%252Bin%252Ba%252BRat%252BModel%252Bof%252BNicotine%252BDependence%26aulast%3DSidique%26aufirst%3DShyama%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D14042012%26date%3D23102012%26date%3D26112012%26date%3D25092012%26volume%3D55%26issue%3D22%26spage%3D9434%26epage%3D9445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José-Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>, <span class="hlFld-ContribAuthor ">Meri  De Angelis</span>, <span class="hlFld-ContribAuthor ">Laura  Iturrino</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, and <span class="hlFld-ContribAuthor ">Guy  Bormans</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Evaluation, and Radiolabeling of New Potent Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2 as Potential Tracers for Positron Emission Tomography Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (20)
                                     , 8685-8699. <a href="https://doi.org/10.1021/jm300912k" title="DOI URL">https://doi.org/10.1021/jm300912k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300912k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300912k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BEvaluation%25252C%252Band%252BRadiolabeling%252Bof%252BNew%252BPotent%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252B2%252Bas%252BPotential%252BTracers%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9-Ignacio%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D28062012%26date%3D11102012%26date%3D25102012%26date%3D20092012%26volume%3D55%26issue%3D20%26spage%3D8685%26epage%3D8699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose María  Cid</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  de Lucas</span>, <span class="hlFld-ContribAuthor ">Encarnación  Matesanz</span>, <span class="hlFld-ContribAuthor ">Laura  Iturrino</span>, <span class="hlFld-ContribAuthor ">María Lourdes  Linares</span>, <span class="hlFld-ContribAuthor ">Aránzazu  Garcia</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Anton  Megens</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Stefan  Pype</span>, <span class="hlFld-ContribAuthor ">David  Gallacher</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (20)
                                     , 8770-8789. <a href="https://doi.org/10.1021/jm3010724" title="DOI URL">https://doi.org/10.1021/jm3010724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3010724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3010724%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Cyclopropylmethyl-7-%2525284-phenylpiperidin-1-yl%252529-8-trifluoromethyl%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridine%252B%252528JNJ-42153605%252529%25253A%252BA%252BPositive%252BAllosteric%252BModulator%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252B2%252BReceptor%26aulast%3DCid%26aufirst%3DJose%2BMar%25C3%25ADa%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D23072012%26date%3D16102012%26date%3D25102012%26volume%3D55%26issue%3D20%26spage%3D8770%26epage%3D8789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Yaping  Xue</span>, <span class="hlFld-ContribAuthor ">Jielian  Lu</span>, <span class="hlFld-ContribAuthor ">Chuanfei  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113644. <a href="https://doi.org/10.1016/j.ejmech.2021.113644" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113644%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1-%2525284-%252528piperazin-1-yl%252529phenyl%252529pyridin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bpotential%252BSSRIs%26aulast%3DXu%26aufirst%3DTengfei%26date%3D2021%26volume%3D223%26spage%3D113644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Hong‐Ru  Tan</span>, <span class="hlFld-ContribAuthor ">Yu‐Long  An</span>, <span class="hlFld-ContribAuthor ">Zhi‐Yu  Shao</span>, <span class="hlFld-ContribAuthor ">Sheng‐Yin  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and DABCO‐induced demethylation of 3‐cyano‐4‐methoxy‐2‐pyridone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (1)
                                     , 486-496. <a href="https://doi.org/10.1002/jhet.3783" title="DOI URL">https://doi.org/10.1002/jhet.3783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3783%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252BDABCO%2525E2%252580%252590induced%252Bdemethylation%252Bof%252B3%2525E2%252580%252590cyano%2525E2%252580%2525904%2525E2%252580%252590methoxy%2525E2%252580%2525902%2525E2%252580%252590pyridone%252Bderivatives%26aulast%3DLi%26aufirst%3DJing%26date%3D2020%26date%3D2019%26volume%3D57%26issue%3D1%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Claudia  Llinas del Torrent</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">The computational modeling of allosteric modulation of metabotropic glutamate receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-33. <a href="https://doi.org/10.1016/bs.apha.2020.02.004" title="DOI URL">https://doi.org/10.1016/bs.apha.2020.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2020.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2020.02.004%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bcomputational%252Bmodeling%252Bof%252Ballosteric%252Bmodulation%252Bof%252Bmetabotropic%252Bglutamate%252Breceptors%26aulast%3DP%25C3%25A9rez-Benito%26aufirst%3DLaura%26date%3D2020%26spage%3D1%26epage%3D33%26pub%3DElsevier%26atitle%3DFrom%252BStructure%252Bto%252BClinical%252BDevelopment%25253A%252BAllosteric%252BModulation%252Bof%252BG%252BProtein-Coupled%252BReceptors%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoltán  Orgován</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1768-1781. <a href="https://doi.org/10.2174/1568026619666190808150039" title="DOI URL">https://doi.org/10.2174/1568026619666190808150039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190808150039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190808150039%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BApproaches%252Bfor%252BAllosteric%252BMetabotropic%252BGlutamate%252BReceptor%252B%252528mGluR%252529%252BModulators%26aulast%3DOrgov%25C3%25A1n%26aufirst%3DZolt%25C3%25A1n%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1768%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Llinas del Torrent</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (6)
                                     , 1098. <a href="https://doi.org/10.3390/molecules24061098" title="DOI URL">https://doi.org/10.3390/molecules24061098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24061098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24061098%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComputational%252BDrug%252BDesign%252BApplied%252Bto%252Bthe%252BStudy%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLlinas%2Bdel%2BTorrent%26aufirst%3DClaudia%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D6%26spage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santhosh  Govindaraju</span>, <span class="hlFld-ContribAuthor ">Sumaiya  Tabassum</span>, <span class="hlFld-ContribAuthor ">Mohamed Afzal  Pasha</span>. </span><span class="cited-content_cbyCitation_article-title">Silica iodide catalyzed, ultrasound-promoted, one-pot four-component synthesis of novel 1,4,5,6-tetrahydropyridine-3-carboxylate derivatives. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2017,</strong> <em>192 </em>
                                    (3)
                                     , 292-299. <a href="https://doi.org/10.1080/10426507.2016.1237948" title="DOI URL">https://doi.org/10.1080/10426507.2016.1237948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2016.1237948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2016.1237948%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DSilica%252Biodide%252Bcatalyzed%25252C%252Bultrasound-promoted%25252C%252Bone-pot%252Bfour-component%252Bsynthesis%252Bof%252Bnovel%252B1%25252C4%25252C5%25252C6-tetrahydropyridine-3-carboxylate%252Bderivatives%26aulast%3DGovindaraju%26aufirst%3DSanthosh%26date%3D2017%26date%3D2016%26volume%3D192%26issue%3D3%26spage%3D292%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaobin  Jin</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the medicinal chemistry of group II and group III mGlu receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 501-515. <a href="https://doi.org/10.1039/C6MD00612D" title="DOI URL">https://doi.org/10.1039/C6MD00612D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00612D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00612D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bgroup%252BII%252Band%252Bgroup%252BIII%252BmGlu%252Breceptors%26aulast%3DJin%26aufirst%3DChaobin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D501%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caitlin E.  McOmish</span>, <span class="hlFld-ContribAuthor ">Elena Y.  Demireva</span>, <span class="hlFld-ContribAuthor ">Jay A.  Gingrich</span>. </span><span class="cited-content_cbyCitation_article-title">Developmental expression of mGlu2 and mGlu3 in the mouse brain. </span><span class="cited-content_cbyCitation_journal-name">Gene Expression Patterns</span><span> <strong>2016,</strong> <em>22 </em>
                                    (2)
                                     , 46-53. <a href="https://doi.org/10.1016/j.gep.2016.10.001" title="DOI URL">https://doi.org/10.1016/j.gep.2016.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gep.2016.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gep.2016.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%2520Expression%2520Patterns%26atitle%3DDevelopmental%252Bexpression%252Bof%252BmGlu2%252Band%252BmGlu3%252Bin%252Bthe%252Bmouse%252Bbrain%26aulast%3DMcOmish%26aufirst%3DCaitlin%2BE.%26date%3D2016%26volume%3D22%26issue%3D2%26spage%3D46%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qifei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoding  Jiang</span>, <span class="hlFld-ContribAuthor ">Weixing  Zhu</span>, <span class="hlFld-ContribAuthor ">Chuo  Chen</span>, <span class="hlFld-ContribAuthor ">Gaoyun  Hu</span>, <span class="hlFld-ContribAuthor ">Qianbin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, preliminary biological evaluation and 3D-QSAR study of novel 1,5-disubstituted-2(1H)-pyridone derivatives as potential anti-lung cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2016,</strong> <em>9 </em>
                                    (5)
                                     , 721-735. <a href="https://doi.org/10.1016/j.arabjc.2015.08.001" title="DOI URL">https://doi.org/10.1016/j.arabjc.2015.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2015.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Bpreliminary%252Bbiological%252Bevaluation%252Band%252B3D-QSAR%252Bstudy%252Bof%252Bnovel%252B1%25252C5-disubstituted-2%2525281H%252529-pyridone%252Bderivatives%252Bas%252Bpotential%252Banti-lung%252Bcancer%252Bagents%26aulast%3DXu%26aufirst%3DQifei%26date%3D2016%26volume%3D9%26issue%3D5%26spage%3D721%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">N-bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 719-731. <a href="https://doi.org/10.1016/j.ejmech.2014.12.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-bridged%252B5%25252C6-bicyclic%252Bpyridines%25253A%252BRecent%252Bapplications%252Bin%252Bcentral%252Bnervous%252Bsystem%252Bdisorders%26aulast%3DDelgado%26aufirst%3DOscar%26date%3D2015%26volume%3D97%26spage%3D719%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A  Farinha</span>, <span class="hlFld-ContribAuthor ">H  Lavreysen</span>, <span class="hlFld-ContribAuthor ">L  Peeters</span>, <span class="hlFld-ContribAuthor ">B  Russo</span>, <span class="hlFld-ContribAuthor ">S  Masure</span>, <span class="hlFld-ContribAuthor ">A A  Trabanco</span>, <span class="hlFld-ContribAuthor ">J  Cid</span>, <span class="hlFld-ContribAuthor ">G  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2015,</strong> <em>172 </em>
                                    (9)
                                     , 2383-2396. <a href="https://doi.org/10.1111/bph.13065" title="DOI URL">https://doi.org/10.1111/bph.13065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13065%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DMolecular%252Bdeterminants%252Bof%252Bpositive%252Ballosteric%252Bmodulation%252Bof%252Bthe%252Bhuman%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%26aulast%3DFarinha%26aufirst%3DA%26date%3D2015%26date%3D2015%26volume%3D172%26issue%3D9%26spage%3D2383%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 290-333. <a href="https://doi.org/10.1002/9781118943670.refs" title="DOI URL">https://doi.org/10.1002/9781118943670.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118943670.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118943670.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2014%26date%3D2014%26spage%3D290%26epage%3D333%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%252Bfor%252Bthe%252BTreatment%252Bof%252BAddiction%26aulast%3DFulton%26aufirst%3DBrian%2BS.%26date%3D2014%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">José-Maria  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2014,</strong> <em>53 </em>, 82-91. <a href="https://doi.org/10.1016/j.jmgm.2014.07.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2014.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2014.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2014.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DQSAR%252Bdesign%252Bof%252Btriazolopyridine%252BmGlu2%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2014%26volume%3D53%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptor 2 Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-142. <a href="https://doi.org/10.1007/7355_2014_48" title="DOI URL">https://doi.org/10.1007/7355_2014_48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_48%26sid%3Dliteratum%253Aachs%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252B2%252BActivators%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2014%26date%3D2014%26spage%3D101%26epage%3D142%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Wentao  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">First Synthesis of Ferrocenyl-Substituted 1,2-Dihydro-2-oxopyridine-3-carbonitriles. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2013,</strong> <em>96 </em>
                                    (11)
                                     , 2134-2140. <a href="https://doi.org/10.1002/hlca.201300015" title="DOI URL">https://doi.org/10.1002/hlca.201300015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201300015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201300015%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DFirst%252BSynthesis%252Bof%252BFerrocenyl-Substituted%252B1%25252C2-Dihydro-2-oxopyridine-3-carbonitriles%26aulast%3DZhang%26aufirst%3DHong%26date%3D2013%26date%3D2013%26volume%3D96%26issue%3D11%26spage%3D2134%26epage%3D2140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 positive allosteric modulators: a patent review (2009 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 629-647. <a href="https://doi.org/10.1517/13543776.2013.777043" title="DOI URL">https://doi.org/10.1517/13543776.2013.777043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.777043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.777043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGluR2%252Bpositive%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D629%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Célanire</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Sonia  Poli</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 71-88. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DmGluR2%252BActivators%252Band%252BmGluR5%252BBlockers%252BAdvancing%252Bin%252Bthe%252BClinic%252Bfor%252BMajor%252BCNS%252BDisorders%26aulast%3DC%25C3%25A9lanire%26aufirst%3DSylvain%26date%3D2012%26spage%3D71%26epage%3D88%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported mGlu2 receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Origin of the 1,4-disubstituted 2-pyridone mGlu2 receptor PAM series. Shown are HTS hit <b>13</b> and overlay comparison of <b>13</b> (blue) with other known mGlu2 receptor PAMs: <b>2</b> (yellow), <b>3</b> (magenta), <b>5</b> (green), and <b>6</b> (black). Dotted spheres show similar overlapping features. F1 is a scaffold acceptor. F2 is a hydrophobic group. V1 is a volume containing a small substituent such as Br, Me, or Cl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Final Compounds <b>13</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O/1,4-dioxane, 150 °C, 10 min, microwave.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Bromopyridone Building Blocks <b>51a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, MeCN, 100 °C, 18 h; (b) NaOH, H<sub>2</sub>O, reflux, 18 h; (c) POBr<sub>3</sub>, DMF, 110 °C, 3 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tetrahydropyranyl Substituted Boronates <b>53a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) polymer supported PPh<sub>3</sub>, DBAD, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (b) PdCl<sub>2</sub>dppf, AcOK, DMF/1,4-dioxane, 150 °C, 10 min, microwave; (c) NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, rt, 16 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 3-Pyridyloxy Substituted Boronates <b>53c</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 170 °C, 30 min, microwave; (b) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 130 °C, 16–24 h; (c) H<sub>2</sub> (1 atm), Pd/C, EtOAc, rt, 16 h; (d) SnCl<sub>2</sub>, EtOH, 90 °C, 1 h; (e) NaNO<sub>2</sub>, HBr, H<sub>2</sub>O, rt, 2 h; (f) CuBr, rt, 2 h, then 140 °C, 2 h; (g) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, DMSO, 120 °C, 5 h; (h) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, 1,4-dioxane, DMF, 150 °C, 10 min, microwave.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 4-Pyridyloxy Substituted Boronates <b>53h</b>–<b>n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH or K<sub>2</sub>CO<sub>3</sub>, DMF, 170 °C, 30 min, microwave; (b) bis(pinacolato)diboron, PdCl<sub>2</sub>dppf, AcOK, DMSO, 120 °C, 5 h; (c) NaH or K<sub>2</sub>CO<sub>3</sub>, solvent, 150–180 °C, 3 h to 2 days.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glutamate CRC in presence of varying concentration of compound <b>48</b>, demonstrating an approximate 11-fold decrease in glutamate EC<sub>50</sub> at 3 μM <b>48</b> (experiment performed with CHO cells expressing cloned human mGlu2 receptor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/medium/jm-2011-016864_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of subcutaneous administration of <b>48</b> (10 mg/kg) or vehicle (20% CD + 2H2T) on sleep–wake organization in rats during 20 consecutive hours. Mean percentage of occurrence per 30 min period is indicated for each sleep–wake state. Black bar under the graphs indicates dark period. Small bar charts indicate amounts of vigilance states in min (plus SEM) during the first 2 h postadministration. For REM sleep, the REM sleep onset latency (ROL) is indicated additionally in the small bottom right panel. <i>N</i> = 8 for each group. ∗ indicates <i>p</i> < 0.05: Wilcoxon–Mann–Whitney rank sum tests compared to vehicle values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm2016864/production/images/large/jm-2011-016864_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2016864&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Watkins, J. C.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Glutamate as a central neurotransmitter: looking back</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1042%2F0300-5127%3A0280297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=10961913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=297-310&author=J.+C.+Watkins&title=l-Glutamate+as+a+central+neurotransmitter%3A+looking+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">L-Glutamate as a central neurotransmitter: looking back</span></div><div class="casAuthors">Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-310</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 114 refs.  The high concn. in brain of unbound L-glutamic acid (in its anionic form, L-glutamate) fueled considerable speculation as to its role in central nervous function more than 50 yr ago.  Claims in the 1940s that it could improve cognitive acuity in patients with mental impairment were particularly intriguing, though later refuted.  In the early 1950s Hayashi found that L-glutamate could cause convulsions and proposed that it might be a central synaptic transmitter.  Soon thereafter, Curtis and colleagues showed that L-glutamate depolarized and excited central neurons, as expected for an excitatory transmitter; however, various aspects of the action of L-glutamate seemed to argue strongly against a transmitter function.  This neg. view prevailed for some 20 yr, before compelling evidence for such a role was adduced.  Over the last two decades, extensive research has revealed a host of glutamate receptor subtypes, subserving several different functions in excitatory synaptic transmission.  This paper gives a very brief and personal over-view of the development of the field over the last 50 yr from a mainly pharmacol. stand-point.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ2Xbf1GO6rVg90H21EOLACvtfcHk0lhJFSHcrFZ_wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D&md5=feb7517645ed59e3eaa0179c4ac6bd60</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1042%2F0300-5127%3A0280297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0300-5127%253A0280297%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DJ.%2BC.%26atitle%3Dl-Glutamate%2520as%2520a%2520central%2520neurotransmitter%253A%2520looking%2520back%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2000%26volume%3D28%26spage%3D297%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J. P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.+P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0lhJFSHcrFZ_wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psyhopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+C.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0lhJFSHcrFZ_wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsyhopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2FS0163-7258%2803%2900038-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=12782243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2003&pages=325-354&author=J.+P.+Pinauthor=T.+Galvezauthor=L.+Prezeau&title=Evolution%2C+structure%2C+and+activation+mechanism+of+family+3%2FC+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span></div><div class="casAuthors">Pin, Jean-Philippe; Galvez, Thierry; Prezeau, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-354</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) represent one of the largest gene families in the animal genome.  These receptors can be classified into several groups based on the sequence similarity of their common heptahelical domain.  The family 3 (or C) GPCRs are receptors for the main neurotransmitters glutamate and γ-aminobutyric acid, for Ca2+, for sweet and amino acid taste compds., and for some pheromone mols., as well as for odorants in fish.  Although none of these family 3 receptors have been found in plants, members have been identified in ancient organisms, such as slime molds (Dictyostelium) and sponges.  Like any other GPCRs, family 3 receptors possess a transmembrane heptahelical domain responsible for G-protein activation.  However, most of these identified receptors also possess a large extracellular domain that is responsible for ligand recognition, is structurally similar to bacterial periplasmic proteins involved in the transport of small mols., and is called a Venus Flytrap module.  The recent resoln. of the structure of this binding domain in one of these receptors, the metabotropic glutamate 1 receptor, together with the recent demonstration that these receptors are dimers, revealed a unique mechanism of activation for these GPCRs.  Such data open new possibilities in the development of drugs aimed at modulating these receptors, and raise a no. of interesting questions on the activation mechanism of the other GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNRDDmZSLFrVg90H21EOLACvtfcHk0lh2P7t1gOaeJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D&md5=33ed658debc421c5dbd63a8b6dbf56b1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900038-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900038-X%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DGalvez%26aufirst%3DT.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DEvolution%252C%2520structure%252C%2520and%2520activation%2520mechanism%2520of%2520family%25203%252FC%2520G-protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D98%26spage%3D325%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F138945007779315614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=17266540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=169-184&author=H.+Brauner-Osborneauthor=P.+Wellendorphauthor=A.+A.+Jensen&title=Structure%2C+pharmacology+and+therapeutic+prospects+of+family+C+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span></div><div class="casAuthors">Brauner-Osborne Hans; Wellendorph Petrine; Jensen Anders A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five orphan receptors.  Aside from the orphan receptors, the family C GPCRs are characterised by a large amino-terminal domain, which bind the endogenous orthosteric agonists.  Recently, a number of allosteric modulators binding to the seven transmembrane domains of the receptors have also been reported.  Family C GPCRs regulate a number of important physiological functions and are thus intensively pursued as drug targets.  So far, two drugs acting at family C receptors (the GABA(B) agonist baclofen and the positive allosteric CaR modulator cinacalcet) have been marketed.  Cinacalcet is the first allosteric GPCR modulator to enter the market, which demonstrates that the therapeutic principle of allosteric modulation can also be extended to this important drug target class.  In this review we outline the structure and function of family C GPCRs with particular focus on the ligand binding sites, and we present the most important pharmacological agents and the therapeutic prospects of the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMO1HRaArq6WxpATR2EQURfW6udTcc2eYCiNdc9mgmerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D&md5=242ec346ee4fd59c033b5574983fd164</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138945007779315614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945007779315614%26sid%3Dliteratum%253Aachs%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DStructure%252C%2520pharmacology%2520and%2520therapeutic%2520prospects%2520of%2520family%2520C%2520G-protein%2520coupled%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">7503</span><span class="NLM_x">–</span> <span class="NLM_lpage">7522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=9295396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADyaK2sXmtl2lt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=7503-7522&author=R.+Shigemotoauthor=A.+Kinoshitaauthor=E.+Wadaauthor=S.+Nomuraauthor=H.+Ohishiauthor=M.+Takadaauthor=P.+J.+Florauthor=A.+Nekiauthor=T.+Abeauthor=S.+Nakanishiauthor=N.+Mizuno&title=Differential+presynaptic+localization+of+metabotropic+glutamate+receptor+subtypes+in+the+rat+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus</span></div><div class="casAuthors">Shigemoto, Ryuichi; Kinoshita, Ayae; Wada, Eiki; Nomura, Sakashi; Ohishi, Hitoshi; Takada, Masahiko; Flor, Peter J.; Neki, Akio; Abe, Takaaki; Nakanishi, Shigetada; Mizuno, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7503-7522</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurotransmission in the hippocampus is modulated variously through presynaptic metabotropic glutamate receptors (mGluRs).  To establish the precise localization of presynaptic mGluRs in the rat hippocampus, the authors used subtype-specific antibodies for eight mGluRs (mGluR1-mGluR8) for immunohistochem. combined with lesioning of the three major hippocampal pathways: the perforant path, mossy fiber, and Schaffer collateral.  Immunoreactivity for group II (mGluR2) and group III (mGluR4a, mGluR7a, mGluR7b, and mGluR8) mGluRs was predominantly localized to presynaptic elements, whereas that for group I mGluRs (mGluR1 and mGluR5) was localized to postsynaptic elements.  The medial perforant path was strongly immunoreactive for mGluR2 and mGluR7a throughout the hippocampus, and the lateral perforant path was prominently immunoreactive for mGluR8 in the dentate gyrus and CA3 area.  The mossy fiber was labeled for mGluR2, mGluR7a, and mGluR7b, whereas the Schaffer collateral was labeled only for mGluR7a.  Electron microscopy further revealed the spatial segregation of group II and group III mGluRs within presynaptic elements.  Immunolabeling for the group III receptors was predominantly obsd. in presynaptic active zones of asym. and sym. synapses, whereas that for the group II receptor (mGluR2) was found in preterminal rather than terminal portions of axons.  Target cell-specific segregation of receptors, first reported for mGluR7a, was also apparent for the other group III mGluRs, suggesting that transmitter release is differentially regulated by 2-amino-4-phosphonobutyrate-sensitive mGluRs in individual synapses on single axons according to the identity of postsynaptic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXc5O2pAWWw7Vg90H21EOLACvtfcHk0lh2P7t1gOaeJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtl2lt7s%253D&md5=80decb8f071ae684aeb5378de4df9281</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DKinoshita%26aufirst%3DA.%26aulast%3DWada%26aufirst%3DE.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DTakada%26aufirst%3DM.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DNeki%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDifferential%2520presynaptic%2520localization%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtypes%2520in%2520the%2520rat%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D7503%26epage%3D7522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lh2P7t1gOaeJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of the messenger RNA for metabotropic glutamate receptor, mGlu2, in the central nervous system of the rat</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=1009-1018&author=H.+Ohishiauthor=R.+Shigemotoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Distribution+of+the+messenger+RNA+for+metabotropic+glutamate+receptor%2C+mGlu2%2C+in+the+central+nervous+system+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520the%2520messenger%2520RNA%2520for%2520metabotropic%2520glutamate%2520receptor%252C%2520mGlu2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D53%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPγS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+J.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTP%CE%B3S+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0ljA8LihJBR7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTP%25CE%25B3S%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span> </span><span class="NLM_article-title">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1197</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.brainres.2007.12.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=18242587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1197&publication_year=2008&pages=47-62&author=G.+Guauthor=D.+S.+Lorrainauthor=H.+Weiauthor=R.+L.+Coleauthor=X.+Zhangauthor=L.+P.+Daggettauthor=H.+J.+Schaffhauserauthor=L.+J.+Bristowauthor=S.+M.+Lechner&title=Distribution+of+metabotropic+glutamate+2+and+3+receptors+in+the+rat+forebrain%3A+implication+in+emotional+responses+and+central+disinhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition</span></div><div class="casAuthors">Gu, Guibao; Lorrain, Daniel S.; Wei, Hongbing; Cole, Rebecca L.; Zhang, Xin; Daggett, Lorrie P.; Schaffhauser, Herve J.; Bristow, Linda J.; Lechner, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-62</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The receptor localization of metabotropic glutamate receptors (mGlu) 2 and 3 was examd. by using in situ hybridization and a well-characterized mGlu2-selective antibody in the rat forebrain.  The mGlu2 was highly and discretely expressed in cell bodies in almost all of the key regions of the limbic system in the forebrain, including the midline and intralaminar structures of the thalamus, the assocn. cortices, the dentate gyrus of the hippocampus, the medial mammillary nucleus, and the lateral and basolateral nuclei of the amygdala.  Moreover, presynaptic mGlu2 terminals were found in most of the forebrain structures, esp. in the lateral part of the central nucleus of the amygdala, and the CA1 region of the hippocampus.  Although some overlaps exist, such as in the hippocampus and the amygdala, the expression of mGlu3 mRNA, however, appeared to be more disperse, compared with that of mGlu2 mRNA.  These distribution results support previous behavioral studies that the mGlu2 and 3 receptors may play important roles in emotional responses.  In addn. to its expression in glia, mGlu3 was distinctively expressed in cells in the GABAergic reticular nucleus of the thalamus.  Local infusion of a non-selective mGlu2/3 agonist, LY 379268, in the reticular nucleus of the thalamus, significantly reduced GABA release, suggesting that mGlu3 may also play a role in central disinhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fnpYDrcWc7Vg90H21EOLACvtfcHk0ljA8LihJBR7Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D&md5=48befca37fcd63a7a5b86562a5672826</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DG.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DR.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26atitle%3DDistribution%2520of%2520metabotropic%2520glutamate%25202%2520and%25203%2520receptors%2520in%2520the%2520rat%2520forebrain%253A%2520implication%2520in%2520emotional%2520responses%2520and%2520central%2520disinhibition%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1197%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ghose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Amezcua, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1176%2Fappi.ajp.2009.08091445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19487395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=812-820&author=S.+Ghoseauthor=K.+A.+Gleasonauthor=B.+W.+Pottsauthor=K.+Lewis-Amezcuaauthor=C.+A.+Tamminga&title=Differential+expression+of+metabotropic+glutamate+receptors+2+and+3+in+schizophrenia%3A+a+mechanism+for+antipsychotic+drug+action%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span></div><div class="casAuthors">Ghose Subroto; Gleason Kelly A; Potts Bryan W; Lewis-Amezcua Kelly; Tamminga Carol A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Preclinical and clinical data implicate the group II metabotropic glutamate receptors mGluR2 and mGluR3 in the pathophysiology of schizophrenia.  Moreover, a recent phase II clinical trial demonstrated the antipsychotic efficacy of a mGluR2/mGluR3 agonist.  The purpose of the present study was to distinguish the expression of mGluR2 and mGluR3 receptor proteins in schizophrenia and to quantify glutamate carboxypeptidase II (GCP II) in order to explore a role for the metabotropic receptors in schizophrenia therapeutics.  GCP II is an enzyme that metabolizes N-acetyl-aspartyl-glutamate (NAAG), which is the only known specific endogenous agonist of mGluR3 in the mammalian brain.  METHOD:  The normal expression levels of mGluR2, mGluR3, and GCP II were determined for 10 regions of the postmortem human brain using specific antibodies.  Differences in expression levels of each protein were examined in the dorsolateral prefrontal cortex, temporal cortex, and motor cortex in 15 postmortem schizophrenia subjects and 15 postmortem matched normal comparison subjects.  Chronic antipsychotic treatment in rodents was conducted to examine the potential effect of antipsychotic drugs on expression of the three proteins.  RESULTS:  Findings revealed a significant increase in GCP II protein and a reduction in mGluR3 protein in the dorsolateral prefrontal cortex in schizophrenia subjects, with mGluR2 protein levels unchanged.  Chronic antipsychotic treatment in rodents did not influence GCP II or mGluR3 levels.  CONCLUSIONS:  Increased GCP II expression and low mGluR3 expression in the dorsolateral prefrontal cortex suggest that NAAG-mediated signaling is impaired in this brain region in schizophrenia.  Further, these data implicate the mGluR3 receptor in the antipsychotic action of mGluR2/mGluR3 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH7FPLGZ5fKrHHuJhbyicZfW6udTcc2eZVSr8JzLWxm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D&md5=b2f45d5fc6ff54baa76c335b0fa08c4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.08091445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.08091445%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DS.%26aulast%3DGleason%26aufirst%3DK.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BW.%26aulast%3DLewis-Amezcua%26aufirst%3DK.%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DDifferential%2520expression%2520of%2520metabotropic%2520glutamate%2520receptors%25202%2520and%25203%2520in%2520schizophrenia%253A%2520a%2520mechanism%2520for%2520antipsychotic%2520drug%2520action%253F%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D812%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Swanson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Glutamate receptors as novel targets for anxiety and stress disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=131-144&author=C.+J.+Swansonauthor=M.+Buresauthor=M.+P.+Johnsonauthor=A.+M.+Lindenauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Glutamate+receptors+as+novel+targets+for+anxiety+and+stress+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DC.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DGlutamate%2520receptors%2520as%2520novel%2520targets%2520for%2520anxiety%2520and%2520stress%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D131%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacology of mGluR2/3 receptor agonists: novel agents for schizophrenia?</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F1568007024606177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=215-225&author=D.+D.+Schoeppauthor=G.+J.+Marek&title=Preclinical+pharmacology+of+mGluR2%2F3+receptor+agonists%3A+novel+agents+for+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?</span></div><div class="casAuthors">Schoepp, Darryle D.; Marek, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Agonists for mGlu2/3 receptors decrease the evoked release of glutamate at certain (ie. forebrain / limbic) glutamatergic synapses, indicating that the functional role of mGlu2 and/or mGlu3 receptors is to suppress glutamate excitations.  This offers a mechanism for dampening glutamate excitation under pathol. states resulting from excessive glutamate release.  Based, in part, on the psychotomimetic actions of phencyclidine (PCP)-like drugs, excessive or pathol. glutamate release has been implicated in a no. of clin. conditions including psychosis.  With this in mind, the pharmacol. of multiple mGlu2/3 receptor agonists have been investigated in PCP treated rats.  Agonists for mGlu2/3 receptors such as LY354740 and LY379268 have been shown to block certain behavioral responses to PCP in rats.  The effects of mGlu2/3 agonists on PCP-induced behaviors are blocked by a low doses of a selective mGlu2/3 receptor antagonist, indicating that these actions are mediated via mGlu2/3 receptors.  In addn., mGlu2/3 agonists potently suppress glutamate release in rat prefrontal cortex, as reflected by excitatory post-synaptic potentials (EPSPs) induced by serotonin (5-HT) acting on 5HT2A receptors.  These actions of LY354740 and LY379268 are also blocked by a selective mGlu2/3 antagonist.  Atypical antipsychotic drugs such as clozapine also suppress 5-HT-induced EPSPs in this brain region, thus suggesting a common pathway for the actions of atypical antipsychotic drugs and mGlu2/3 receptor agonists.  As glutamatergic dysfunction has been implicated in psychotic states and possibly in the etiol. of schizophrenia, clin. studies with mGlu2/3 agonists may be warranted to further explore the validity of the glutamatergic hypothesis of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPEl6C2-lj4rVg90H21EOLACvtfcHk0lgDxJDW-scosw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2nu7o%253D&md5=7b0d86049ef459f8bc419e63cfd6b653</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1568007024606177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007024606177%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DPreclinical%2520pharmacology%2520of%2520mGluR2%252F3%2520receptor%2520agonists%253A%2520novel%2520agents%2520for%2520schizophrenia%253F%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2002%26volume%3D1%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.tips.2008.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19058862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=25-30&author=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+K.+Jones&title=Activation+of+metabotropic+glutamate+receptors+as+a+novel+approach+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia</span></div><div class="casAuthors">Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In recent years, the metabotropic glutamate (mGlu) receptors have emerged as potential new drug targets for treatment of a range of CNS disorders.  Some of the most compelling advances have been made in targeting specific mGlu receptor subtypes as a fundamentally new approach to the treatment of schizophrenia.  Recent animal and clin. studies provide strong evidence that agonists of group II mGlu receptors (mGluR2 and mGluR3) are effective in the treatment of the pos. symptoms of schizophrenia, and animal studies suggest that mGluR5 agonists could provide a novel approach for the treatment of all major symptom domains (pos., neg., and cognitive) of this disorder.  Although the discovery of selective agonists of these receptors is a challenge, there have been recent advances in the discovery of highly selective pos. allosteric modulators (PAMs) of mGluR2 and mGluR5.  These mGlu receptor-selective PAMs have properties needed for optimization as clin. candidates and have robust effects in animal models that predict efficacy in treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_CxX6LmkZObVg90H21EOLACvtfcHk0ljhL6PUdu71kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktlygsg%253D%253D&md5=06ee21863b9528fb70211f87827b98ce</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DC.%2BK.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptors%2520as%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Shigeyuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohiko, H.</span><span> </span><span class="NLM_article-title">Targeting of metabotropic glutamate receptors for the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F138161211795049570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=21355835" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=94-102&author=C.+Shigeyukiauthor=H.+Hirohiko&title=Targeting+of+metabotropic+glutamate+receptors+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F138161211795049570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049570%26sid%3Dliteratum%253Aachs%26aulast%3DShigeyuki%26aufirst%3DC.%26aulast%3DHirohiko%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520metabotropic%2520glutamate%2520receptors%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0ljhL6PUdu71kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Levine, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feighner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by a CO<sub>2</sub> challenge in patients diagnosed with panic disorder</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=294&author=L.+Levineauthor=B.+Gaydosauthor=D.+Sheehanauthor=A.+Goddardauthor=J.+Feighnerauthor=W.+Potterauthor=D.+D.+Schoepp&title=The+mGlu2%2F3+receptor+agonist%2C+LY354740%2C+reduces+panic+anxiety+induced+by+a+CO2+challenge+in+patients+diagnosed+with+panic+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DL.%26aulast%3DGaydos%26aufirst%3DB.%26aulast%3DSheehan%26aufirst%3DD.%26aulast%3DGoddard%26aufirst%3DA.%26aulast%3DFeighner%26aufirst%3DJ.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mGlu2%252F3%2520receptor%2520agonist%252C%2520LY354740%252C%2520reduces%2520panic%2520anxiety%2520induced%2520by%2520a%2520CO2%2520challenge%2520in%2520patients%2520diagnosed%2520with%2520panic%2520disorder%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26spage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. N.</span><span> </span><span class="NLM_article-title">Recent developments in metabotropic glutamate receptors as novel drug targets</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1358%2Fdof.2010.035.04.1487693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=307-324&author=M.+J.+O%E2%80%99Neillauthor=M.+J.+Fellauthor=K.+A.+Svenssonauthor=J.+M.+Witkinauthor=S.+N.+Mitchell&title=Recent+developments+in+metabotropic+glutamate+receptors+as+novel+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in metabotropic glutamate receptors as novel drug targets</span></div><div class="casAuthors">O'Neill, M. J.; Fell, M. J.; Svensson, K. A.; Witkin, J. M.; Mitchell, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-324</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system, activating ionotropic (iGlu) and metabotropic (mGlu) glutamate receptors.  Targeting iGlu receptors has proven difficult, as these receptors play such a crit. role in fast synaptic transmission.  In recent years, there has been a switch in the focus of the pharmaceutical industry to target mGlu receptors, as these receptors have a more modulatory role in the brain.  Eight subtypes of the C protein-coupled mGlu receptors have been cloned and classified into three groups according to their second messenger assocn., sequence homol. and agonist selectivity.  Group I (mGlu1 and mGlu5) receptors are pos. coupled to phosphatidylinositol (PI) hydrolysis, while group II (mGlu2 and mGlu3) and group III (mGlu4, mGlu6, mGlu7 and mGlu8) receptors are neg. coupled to adenylate cyclase and thought to act as presynaptic autoreceptors, regulating glutamate transmission.  There has been rapid progress in understanding the biol. of mGlu receptors and their function in the central nervous system (CNS), and the field now has highly potent and selective ligands for many of the mGlu receptor subtypes.  Pharmacol. tools include both orthosteric and allosteric agonists and antagonists.  These mols. have been explored across a range of CNS conditions, the findings of which will be discussed briefly in this review.  Recently, some of the most promising mols. have progressed into clin. trials (mGlu2/3 receptor agonists for the treatment of anxiety and schizophrenia and mGlu5 receptor antagonists for acute migraine and L-DOPA-induced dyskinesia) and achieved proof of concept.  These encouraging results suggest mGlu receptors as novel drug targets with application in a range of psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9EtQj2lZSbVg90H21EOLACvtfcHk0lgx7msKrBJWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslajtb4%253D&md5=1b51466a1778a814d0988eab288c623e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.04.1487693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.04.1487693%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DMitchell%26aufirst%3DS.%2BN.%26atitle%3DRecent%2520developments%2520in%2520metabotropic%2520glutamate%2520receptors%2520as%2520novel%2520drug%2520targets%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D307%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=342-353&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wooley, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pemberton, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. M.</span><span> </span><span class="NLM_article-title">The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=431-440&author=M.+L.+Wooleyauthor=D.+J.+Pembertonauthor=S.+Bateauthor=C.+Cortiauthor=D.+M.+Jones&title=The+mGlu2+but+not+the+mGlu3+receptor+mediates+the+actions+of+the+mGluR2%2F3+agonist%2C+LY379268%2C+in+mouse+models+predictive+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWooley%26aufirst%3DM.%2BL.%26aulast%3DPemberton%26aufirst%3DD.%2BJ.%26aulast%3DBate%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mGlu2%2520but%2520not%2520the%2520mGlu3%2520receptor%2520mediates%2520the%2520actions%2520of%2520the%2520mGluR2%252F3%2520agonist%252C%2520LY379268%252C%2520in%2520mouse%2520models%2520predictive%2520of%2520antipsychotic%2520activity%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0lgx7msKrBJWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.+P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0ljTr13oJhD7Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span> </span><span class="NLM_article-title">Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1622</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1038%2Fsj.npp.1300238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=12825094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFeisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1622-1632&author=D.+S.+Lorrainauthor=H.+Schaffhauserauthor=U.+C.+Campbellauthor=C.+S.+Bacceiauthor=L.+D.+Correaauthor=B.+Roweauthor=D.+E.+Rodriguezauthor=J.+J.+Andersonauthor=M.+A.+Varneyauthor=A.+B.+Pinkertonauthor=J.-M.+Vernierauthor=L.+J.+Bristow&title=Group+II+mGlu+receptor+activation+suppresses+norepinephrine+release+in+the+ventral+hippocampus+and+locomotor+responses+to+acute+ketamine+challenge"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge</span></div><div class="casAuthors">Lorrain, Daniel S.; Schaffhauser, Herve; Campbell, Una C.; Baccei, Christopher S.; Correa, Lucia D.; Rowe, Blake; Rodriguez, Dana E.; Anderson, Jeffery J.; Varney, Mark A.; Pinkerton, Anthony B.; Vernier, Jean-Michel; Bristow, Linda J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1622-1632</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Group II mGlu receptor agonists (eg LY379268 and LY354740) have been shown to reverse many of the behavioral responses to PCP as well as glutamate release elicited by PCP and ketamine.  In the present set of expts., the authors used in vivo microdialysis to show that, in addn. to reversing PCP- and ketamine-evoked glutamate release, group II mGlu receptor stimulation also prevents ketamine-evoked norepinephrine (NE) release.  Pretreating animals with the mixed 2/3 metabotropic glutamate (mGlu2/3) receptor agonist LY379268 (0.3-10 mg/kg) dose-dependently inhibited ketamine (25 mg/kg)-evoked NE release in the ventral hippocampus (VHipp).  Ketamine hyperactivity was also reduced in a similar dose range.  Following the authors' initial observation on NE release, they conducted a series of microinjection expts. to reveal that the inhibitory effects of LY379268 on VHipp NE release may be linked to glutamate transmission within the medial prefrontal cortex.  Finally, the authors were able to mimic the inhibitory effects of LY379268 on ketamine-evoked NE release by using a novel mGlu2 receptor selective pos. modulator.  (+/-) 2,2,2-Trifluoroethyl [3-(1-methyl-butoxy)-phenyl]-pyridin-3-ylmethyl-sulfonamide (2,2,2-TEMPS, characterized through in vitro GTPγS binding) at a dose of 100 mg/kg significantly reduced the NE response.  Together, these results demonstrate a novel means to suppress noradrenergic neurotransmission (i.e. by activating mGlu2 receptors) and may, therefore, have important implications for neuropsychiatric disorders in which aberrant activation of the noradrenergic system is thought to be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1EmzIVF7NI7Vg90H21EOLACvtfcHk0ljTr13oJhD7Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFeisLY%253D&md5=b17d585f28f71d8ef7d52cdcac2697f5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300238%26sid%3Dliteratum%253Aachs%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DRowe%26aufirst%3DB.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DAnderson%26aufirst%3DJ.%2BJ.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26atitle%3DGroup%2520II%2520mGlu%2520receptor%2520activation%2520suppresses%2520norepinephrine%2520release%2520in%2520the%2520ventral%2520hippocampus%2520and%2520locomotor%2520responses%2520to%2520acute%2520ketamine%2520challenge%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1622%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callagaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of <i>N</i>-(4-(2-methoxyphenoxy)phenyl)-<i>N</i>-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3192</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034015u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3189-3192&author=M.+P.+Johnsonauthor=M.+Baezauthor=G.+E.+Jagdmannauthor=T.+C.+Brittonauthor=T.+H.+Largeauthor=D.+O.+Callagaroauthor=J.+P.+Tizzanoauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Discovery+of+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor%3A+synthesis+and+subtype+selectivity+of+N-%284-%282-methoxyphenoxy%29phenyl%29-N-%282%2C2%2C2-trifluoroethylsulfonyl%29pyrid-3-ylmethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm034015u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034015u%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DLarge%26aufirst%3DT.%2BH.%26aulast%3DCallagaro%26aufirst%3DD.%2BO.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%253A%2520synthesis%2520and%2520subtype%2520selectivity%2520of%2520N-%25284-%25282-methoxyphenoxy%2529phenyl%2529-N-%25282%252C2%252C2-trifluoroethylsulfonyl%2529pyrid-3-ylmethylamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3189%26epage%3D3192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Barda, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, <i>N</i>-(4-phenoxyphenyl)-<i>N</i>-(3-pyridylmethyl)ethanesulfonamide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3099-3102&author=D.+A.+Bardaauthor=Z.-Q.+Wangauthor=T.+C.+Brittonauthor=S.+S.+Henryauthor=G.+E.+Jagdmannauthor=D.+S.+Colemanauthor=M.+P.+Johnsonauthor=S.+L.+Andisauthor=D.+D.+Schoepp&title=SAR+study+of+a+subtype+selective+allosteric+potentiator+of+metabotropic+glutamate+2+receptor%2C+N-%284-phenoxyphenyl%29-N-%283-pyridylmethyl%29ethanesulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarda%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DZ.-Q.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DHenry%26aufirst%3DS.%2BS.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DColeman%26aufirst%3DD.%2BS.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DSAR%2520study%2520of%2520a%2520subtype%2520selective%2520allosteric%2520potentiator%2520of%2520metabotropic%2520glutamate%25202%2520receptor%252C%2520N-%25284-phenoxyphenyl%2529-N-%25283-pyridylmethyl%2529ethanesulfonamide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3099%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span> </span><span class="NLM_article-title">Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiators for the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4595</span><span class="NLM_x">–</span> <span class="NLM_lpage">4599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040088h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4595-4599&author=A.+B.+Pinkertonauthor=J.-M.+Vernierauthor=H.+Schaffhauserauthor=B.+A.+Roweauthor=U.+C.+Campbellauthor=D.+E.+Rodriguezauthor=D.+S.+Lorrainauthor=C.+S.+Bacceiauthor=L.+P.+Daggettauthor=L.+J.+Bristow&title=Phenyl-tetrazolyl+acetophenones%3A+discovery+of+positive+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm040088h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040088h%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26atitle%3DPhenyl-tetrazolyl%2520acetophenones%253A%2520discovery%2520of%2520positive%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4595%26epage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: identification and synthesis of phenyl-tetrazolyl acetophenones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5329</span><span class="NLM_x">–</span> <span class="NLM_lpage">5332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5329-5332&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=X.+Zhaoauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+1%3A+identification+and+synthesis+of+phenyl-tetrazolyl+acetophenones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25201%253A%2520identification%2520and%2520synthesis%2520of%2520phenyl-tetrazolyl%2520acetophenones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5329%26epage%3D5332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5867</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5867-5872&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=J.+K.+Jamesauthor=M.+F.+Gardnerauthor=H.+Schaffhauserauthor=B.+A.+Roweauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+2%3A+4-thiopyridyl+acetophenones+as+non-tetrazole+containing+mGlu2+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25202%253A%25204-thiopyridyl%2520acetophenones%2520as%2520non-tetrazole%2520containing%2520mGlu2%2520receptor%2520potentiators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5867%26epage%3D5872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span> </span><span class="NLM_article-title">3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)-phenoxy]butoxy}phenylpropanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2389</span><span class="NLM_x">–</span> <span class="NLM_lpage">2393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2389-2393&author=R.+V.+Cubeauthor=J.-M.+Vernierauthor=J.+H.+Hutchinsonauthor=M.+F.+Gardnerauthor=J.+K.+Jamesauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=L.+Daggettauthor=A.+B.+Pinkerton&title=3-%282-Ethoxy-4-%7B4-%5B3-hydroxy-2-methyl-4-%283-methylbutanoyl%29-phenoxy%5Dbutoxy%7Dphenylpropanoic+acid%3A+a+brain+penetrant+allosteric+potentiator+at+the+metabotropic+glutamate+receptor+2+%28mGluR2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DDaggett%26aufirst%3DL.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3D3-%25282-Ethoxy-4-%257B4-%255B3-hydroxy-2-methyl-4-%25283-methylbutanoyl%2529-phenoxy%255Dbutoxy%257Dphenylpropanoic%2520acid%253A%2520a%2520brain%2520penetrant%2520allosteric%2520potentiator%2520at%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2389%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T. M.</span><span> </span><span class="NLM_article-title">Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4354-4358&author=C.+Bonnefousauthor=J.-M.+Vernierauthor=J.+H.+Hutchinsonauthor=M.+F.+Gardnerauthor=M.+Cramerauthor=J.+K.+Jamesauthor=B.+A.+Roweauthor=L.+P.+Daggettauthor=H.+Schaffhauserauthor=T.+M.+Kamenecka&title=Biphenyl-indanones%3A+allosteric+potentiators+of+the+metabotropic+glutamate+subtype+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DVernier%26aufirst%3DJ.-M.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DCramer%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DBiphenyl-indanones%253A%2520allosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520subtype%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cube, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: identification and biological activity of indanone containing mGlu2 receptor potentiators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">–</span> <span class="NLM_lpage">1571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1565-1571&author=A.+B.+Pinkertonauthor=R.+V.+Cubeauthor=J.+H.+Hutchinsonauthor=J.+K.+Jamesauthor=M.+F.+Gardnerauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=D.+E.+Rodriguezauthor=L.+P.+Campbellauthor=L.+P.+Daggettauthor=J.-M.+Vernier&title=Allosteric+potentiators+of+the+metabotropic+glutamate+receptor+2+%28mGlu2%29.+Part+3%3A+identification+and+biological+activity+of+indanone+containing+mGlu2+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCube%26aufirst%3DR.%2BV.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DRodriguez%26aufirst%3DD.%2BE.%26aulast%3DCampbell%26aufirst%3DL.%2BP.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DAllosteric%2520potentiators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGlu2%2529.%2520Part%25203%253A%2520identification%2520and%2520biological%2520activity%2520of%2520indanone%2520containing%2520mGlu2%2520receptor%2520potentiators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1565%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Govek, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuiston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pracitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, U. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, J.-M.</span><span> </span><span class="NLM_article-title">Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4068</span><span class="NLM_x">–</span> <span class="NLM_lpage">4072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4068-4072&author=S.+P.+Govekauthor=C.+Bonnefousauthor=J.+H.+Hutchinsonauthor=T.+Kameneckaauthor=J.+McQuistonauthor=R.+Pracittoauthor=L.+X.+Zhaoauthor=M.+F.+Gardnerauthor=J.+K.+Jamesauthor=L.+P.+Daggettauthor=B.+A.+Roweauthor=H.+Schaffhauserauthor=L.+J.+Bristowauthor=U.+C.+Campbellauthor=D.+E.+Rodriguesauthor=J.-M.+Vernier&title=Benzazoles+as+allosteric+potentiators+of+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+efficacy+in+an+animal+model+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGovek%26aufirst%3DS.%2BP.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DMcQuiston%26aufirst%3DJ.%26aulast%3DPracitto%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DGardner%26aufirst%3DM.%2BF.%26aulast%3DJames%26aufirst%3DJ.%2BK.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DRowe%26aufirst%3DB.%2BA.%26aulast%3DSchaffhauser%26aufirst%3DH.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DCampbell%26aufirst%3DU.%2BC.%26aulast%3DRodrigues%26aufirst%3DD.%2BE.%26aulast%3DVernier%26aufirst%3DJ.-M.%26atitle%3DBenzazoles%2520as%2520allosteric%2520potentiators%2520of%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520efficacy%2520in%2520an%2520animal%2520model%2520for%2520schizophrenia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4068%26epage%3D4072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Clayton, J.; Ma, F.; Van Wagenen, B.; Ukkiramapandian, R.; Egle, I.; Empfield, J.; Isaac, M.; Slassi, A.; Steelman, G.; Urbanek, R.; Walsh, S.</span> Patent WO2006/020879 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clayton%2C+J.%3B+Ma%2C+F.%3B+Van+Wagenen%2C+B.%3B+Ukkiramapandian%2C+R.%3B+Egle%2C+I.%3B+Empfield%2C+J.%3B+Isaac%2C+M.%3B+Slassi%2C+A.%3B+Steelman%2C+G.%3B+Urbanek%2C+R.%3B+Walsh%2C+S.+Patent+WO2006%2F020879+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DJ.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Balestra, M.; Bunting, H.; Chen, D.; Egle, I.; Forst, J.; Frey, J.; Isaac, M.; Ma, F.; Nugiel, D.; Slassi, A.; Steelman, G.; Sun, G.; Sundar, B.; Ukkiramapandian, R.; Urbanek, R.; Walsh, S.</span> Patent WO2006/071730 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Balestra%2C+M.%3B+Bunting%2C+H.%3B+Chen%2C+D.%3B+Egle%2C+I.%3B+Forst%2C+J.%3B+Frey%2C+J.%3B+Isaac%2C+M.%3B+Ma%2C+F.%3B+Nugiel%2C+D.%3B+Slassi%2C+A.%3B+Steelman%2C+G.%3B+Sun%2C+G.%3B+Sundar%2C+B.%3B+Ukkiramapandian%2C+R.%3B+Urbanek%2C+R.%3B+Walsh%2C+S.+Patent+WO2006%2F071730+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBalestra%26aufirst%3DM.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Dhanya, R. -P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Highfield Nickols, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=342-353&author=R.+-P.+Dhanyaauthor=S.+Sidiqueauthor=D.+S.+Shefflerauthor=H.+Highfield+Nickolsauthor=A.+Herathauthor=L.+Yangauthor=R.+Dahlauthor=R.+Ardeckyauthor=S.+Semenovaauthor=A.+Markouauthor=P.+J.+Connauthor=N.+D.+P.+Cosford&title=Design+and+synthesis+of+an+orally+active+metabotropic+glutamate+receptor+subtype-2+%28mGluR2%29+positive+allosteric+modulator+%28PAM%29+that+decreases+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span></div><div class="casAuthors">Dhanya, Raveendra-Panickar; Sidique, Shyama; Sheffler, Douglas J.; Nickols, Hilary Highfield; Herath, Ananda; Yang, Li; Dahl, Russell; Ardecky, Robert; Semenova, Svetlana; Markou, Athina; Conn, P. Jeffrey; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modification of 3'-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid (BINA, I) by incorporating heteroatoms into the structure and replacing the cyclopentyl moiety led to the development of new mGluR2 pos. allosteric modulators (PAMs) with optimized potency and superior druglike properties.  These analogs are more potent than I in vitro and are highly selective for mGluR2 vs other mGluR subtypes.  They have significantly improved pharmacokinetic (PK) properties, with excellent oral bioavailability and brain penetration.  The benzisothiazol-3-one deriv. II decreased cocaine self-administration in rats, providing proof-of-concept for the use of mGluR2 PAMs for the treatment of cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmO8DAzKVg7Vg90H21EOLACvtfcHk0lgv2zeNXvCElQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO&md5=402c4f95aa11618fe07c8d146ffc2a8e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1012165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012165%26sid%3Dliteratum%253Aachs%26aulast%3DDhanya%26aufirst%3DR.%2B-P.%26aulast%3DSidique%26aufirst%3DS.%26aulast%3DSheffler%26aufirst%3DD.%2BS.%26aulast%3DHighfield%2BNickols%26aufirst%3DH.%26aulast%3DHerath%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520active%2520metabotropic%2520glutamate%2520receptor%2520subtype-2%2520%2528mGluR2%2529%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520that%2520decreases%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span> </span><span class="NLM_article-title">3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5493-5496&author=L.+Zhangauthor=B.+N.+Rogersauthor=A.+J.+Duplantierauthor=S.+F.+McHardyauthor=I.+Efremovauthor=H.+Berkeauthor=W.+Qianauthor=A.+Q.+Zhangauthor=N.+Makladauthor=J.+Candlerauthor=A.+C.+Doranauthor=J.+T.+Lazarroauthor=A.+H.+Ganong&title=3-%28Imidazolyl+methyl%29-3-aza-bicyclo%5B3.1.0%5Dhexan-6-yl%29methyl+ethers%3A+a+novel+series+of+mGluR2+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DBerke%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DLazarro%26aufirst%3DJ.%2BT.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26atitle%3D3-%2528Imidazolyl%2520methyl%2529-3-aza-bicyclo%255B3.1.0%255Dhexan-6-yl%2529methyl%2520ethers%253A%2520a%2520novel%2520series%2520of%2520mGluR2%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5493%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">D’Alessandro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppe, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Fuente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=759-762&author=P.+L.+D%E2%80%99Alessandroauthor=C.+Cortiauthor=A.+Rothauthor=A.+Ugoliniauthor=A.+Savaauthor=D.+Montanariauthor=F.+Bianchiauthor=S.+L.+Garlandauthor=B.+Powneyauthor=E.+L.+Koppeauthor=M.+Rochevilleauthor=G.+Osborneauthor=P.+Perezauthor=J.+de+la+Fuenteauthor=M.+De+Los+Frailesauthor=P.+W.+Smithauthor=C.+Branchauthor=D.+Nashauthor=S.+P.+Watson&title=The+identification+of+structurally+novel%2C+selective%2C+orally+bioavailable+positive+modulators+of+mGluR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Alessandro%26aufirst%3DP.%2BL.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DF.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DKoppe%26aufirst%3DE.%2BL.%26aulast%3DRocheville%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3Dde%2Bla%2BFuente%26aufirst%3DJ.%26aulast%3DDe%2BLos%2BFrailes%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DBranch%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520structurally%2520novel%252C%2520selective%252C%2520orally%2520bioavailable%2520positive%2520modulators%2520of%2520mGluR2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span> </span><span class="NLM_article-title">1-[(1-Methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101414h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1724-1739&author=L.+Zhangauthor=M.+A.+Brodneyauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+J.+Duplantierauthor=I.+V.+Efremovauthor=E.+Evrardauthor=K.+Krausauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Jenzaauthor=J.+T.+Lazzaroauthor=N.+Makladauthor=S.+A.+McCarthyauthor=W.+Qianauthor=B.+N.+Rogersauthor=M.+D.+Rottasauthor=C.+J.+Schmidtauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=A.+Q.+Zhang&title=1-%5B%281-Methyl-1H-imidazol-2-yl%29methyl%5D-4-phenylpiperidines+as+mGluR2+positive+allosteric+modulators+for+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm101414h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101414h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DJenza%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DRottas%26aufirst%3DM.%2BD.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26atitle%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1724%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.-</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: hit to lead and lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2524-2529&author=A.+J.+Duplantierauthor=I.+Efremovauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+H.-+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Krausauthor=J.+T.+Lazzaroauthor=J.+Luauthor=N.+Makladauthor=S.+A.+McCarthyauthor=T.+J.+O%E2%80%99Sullivanauthor=B.+N.+Rogersauthor=J.+A.+Siuciakauthor=D.+K.+Spracklinauthor=L.+Zhang&title=3-Benzyl-1%2C3-oxazolidin-2-ones+as+mGluR2+positive+allosteric+modulators%3A+hit+to+lead+and+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DGanong%26aufirst%3DA.%2BH.-%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D3-Benzyl-1%252C3-oxazolidin-2-ones%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%253A%2520hit%2520to%2520lead%2520and%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: hit-to-lead efforts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3129-3133&author=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=M.+E.+Laytonauthor=J.+M.+Sandersauthor=C.+Culbersonauthor=M.+A.+Jacobsonauthor=B.+C.+Magliaroauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=S.+L.+Huszarauthor=J.+M.+Uslanerauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=S.+M.+Surauthor=G.+D.+Hartman&title=3-Aryl-5-phenoxymethyl-1%2C3-oxazolidin-2-ones+as+positive+allosteric+modulators+of+mGluR2+for+the+treatment+of+schizophrenia%3A+hit-to-lead+efforts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3D3-Aryl-5-phenoxymethyl-1%252C3-oxazolidin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520hit-to-lead%2520efforts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3129%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as positive allosteric modulators for the mGluR2 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+positive+allosteric+modulators+for+the+mGluR2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520positive%2520allosteric%2520modulators%2520for%2520the%2520mGluR2%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-8-chloro-6-substituted isoquinolones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=971-976&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=H.+Lavreysenauthor=S.+Poliauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-8-chloro-6-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-8-chloro-6-substituted%2520isoquinolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D971%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-5-substituted isoquinolones</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1039%2Fc0md00200c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=132-139&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=S.+Poliauthor=H.+Lavreysenauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-5-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones</span></div><div class="casAuthors">Trabanco, Andres A.; Duvey, Guillaume; Cid, Jose Maria; Macdonald, Gregor J.; Cluzeau, Philippe; Nhem, Vanthea; Furnari, Rocco; Behaj, Nadia; Poulain, Geraldine; Finn, Terry; Poli, Sonia; Lavreysen, Hilde; Raux, Alexandre; Thollon, Yves; Poirier, Nicolas; D'Addona, David; Andres, Jose Ignacio; Lutjens, Robert; Le Poul, Emmanuel; Imogai, Hassan; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of N-propyl-5-substituted isoquinolones was identified as pos. allosteric modulators (PAM) of metabotropic glutamate receptor 2 (mGluR2) via high-throughput screening (HTS).  The subsequent synthesis and preliminary SAR exploration that led to the identification of compd. 20 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w5fK6sXL07Vg90H21EOLACvtfcHk0lhy0GH86DDOxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D&md5=f729cbf8bcdeb592859e3e921c089be1</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0md00200c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00200c%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-5-substituted%2520isoquinolones%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garc%C3%ADaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-disubstituted pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C.+Boleaauthor=T.+Finnauthor=S.+Poliauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Metesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=J.+Oyarzabalauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andresauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C5-disubstituted+pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0lgd0XXKNWnrtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMetesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C5-disubstituted%2520pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Imogai, H. I.; Cid-Nuñez, J. M.; Andrés-Gil, J. I.; Trabanco-Suárez, A. A.; Oyarzábal-Santamarina, J.; Dautzenberg, F. M.; Macdonald, G. J.; Pullan, S. E.; Lutjens, R. J.; Duvey, G. A. J.; Nhem, V.; Finn, T. P.; Melikyan, G.</span> Patent WO2007/104783 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Imogai%2C+H.+I.%3B+Cid-Nu%C3%B1ez%2C+J.+M.%3B+Andr%C3%A9s-Gil%2C+J.+I.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Oyarz%C3%A1bal-Santamarina%2C+J.%3B+Dautzenberg%2C+F.+M.%3B+Macdonald%2C+G.+J.%3B+Pullan%2C+S.+E.%3B+Lutjens%2C+R.+J.%3B+Duvey%2C+G.+A.+J.%3B+Nhem%2C+V.%3B+Finn%2C+T.+P.%3B+Melikyan%2C+G.+Patent+WO2007%2F104783+A2%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BI.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.</span> Patent WO2008/107480 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid-Nu%C3%B1ez%2C+J.+M.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Macdonald%2C+G.+J.%3B+Duvey%2C+G.+A.+J.+Patent+WO2008%2F107480+A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.</span> Patent WO2008/107481 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cid-Nu%C3%B1ez%2C+J.+M.%3B+Trabanco-Su%C3%A1rez%2C+A.+A.%3B+Macdonald%2C+G.+J.%3B+Duvey%2C+G.+A.+J.+Patent+WO2008%2F107481+A1%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="note"><p class="first last">The in vitro [<sup>35</sup>S]GTPγS assay provides two measures of compound activity: pEC<sub>50</sub>, which is defined as the negative logarithm of the concentration at which half-maximal potentiation of glutamate is reached; % <i>E</i><sub>MAX</sub>, which is the maximal increase in observed glutamate response.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibelin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H. I. M.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">603</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm2016864&amp;key=10.1016%2Fj.ejphar.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm2016864&amp;key=19046965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2016864&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=603&publication_year=2009&pages=62-72&author=A.+Ahnaouauthor=F.+M.+Dautzenbergauthor=H.+Geysauthor=H.+Imogaiauthor=A.+Gibelinauthor=D.+Moecharsauthor=T.+Stecklerauthor=W.+H.+I.+M.+Drinkenburg&title=Modulation+of+group+II+metabotropic+glutamate+receptor+%28mGlu2%29+elicits+common+changes+in+rat+and+mice+sleep-wake+architecture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span></div><div class="casAuthors">Ahnaou, Abdellah; Dautzenberg, Frank M.; Geys, Helena; Imogai, Hassan; Gibelin, Antoine; Moechars, Dieder; Steckler, Thomas; Drinkenburg, Wilhelmus H. I. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">603</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">62-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compiling pharmacol. evidence implicates metabotropic glutamate mGlu2 receptors in the regulation of emotional states and suggests pos. modulators as a novel therapeutic approach of Anxiety/Depression and Schizophrenia.  Here, we investigated s.c. effects of the metabotropic glutamate mGlu2/3 agonist (LY354740) on sleep-wake architecture in rat.  To confirm the specific effects on rapid eye movement (REM) sleep were mediated via metabotropic glutamate mGlu2 receptors, we characterized the sleep-wake cycles in metabotropic glutamate mGlu2 receptor deficient mice (mGlu2R-/-) and their arousal response to LY354740.  We furthermore examd. effects on sleep behavior in rats of the pos. allosteric modulator, biphenyl-indanone A (BINA) alone and in combination with LY354740 at sub-EDs.  LY354740 (1, 3 and 10 mg/kg) dose-dependently suppressed REM sleep and prolonged its onset latency.  Metabotropic glutamate mGlu2R-/- and their wild type (WT) littermates exhibited similar spontaneous sleep-wake phenotype, while LY354740 (10 mg/kg) significantly affected REM sleep variables in WT but not in the mutant.  In rats, BINA (1, 3, 10, 20, 40 mg/kg) dose-dependently suppressed REM sleep, lengthened its onset latency and slightly enhanced passive waking.  Addnl., combined treatment elicited a synergistic action on REM sleep variables.  Our findings show common changes of REM sleep variables following modulation of metabotropic glutamate mGlu2 receptor and support an active role of this receptor in the regulation of REM sleep.  The synergistic action of BINA on LY354740's effects on sleep pattern implies that pos. modulators would tune the endogenous glutamate tone suggesting potential benefit in the treatment of psychiatric disorders, in which REM sleep overdrive is manifested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUXqoXCoqp7Vg90H21EOLACvtfcHk0lgd0XXKNWnrtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D&md5=eb1e676deebb6b39aad64cf14a281bf2</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DGeys%26aufirst%3DH.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DGibelin%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%2BI.%2BM.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520%2528mGlu2%2529%2520elicits%2520common%2520changes%2520in%2520rat%2520and%2520mice%2520sleep-wake%2520architecture%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D603%26spage%3D62%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Crespi, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penman, B. W.</span><span> </span><span class="NLM_article-title">Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1997&pages=188-190&author=C.+L.+Crespiauthor=V.+P.+Millerauthor=B.+W.+Penman&title=Microtiter+plate+assays+for+inhibition+of+human%2C+drug-metabolizing+cytochromes+P450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26aulast%3DMiller%26aufirst%3DV.%2BP.%26aulast%3DPenman%26aufirst%3DB.%2BW.%26atitle%3DMicrotiter%2520plate%2520assays%2520for%2520inhibition%2520of%2520human%252C%2520drug-metabolizing%2520cytochromes%2520P450%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D248%26spage%3D188%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Miller, V. P.; Ackermann, J.; Stresser, D. M.; Crespi, C. L.</span><span> </span><span class="NLM_article-title">Novel High Throughput Fluorescent P450 Assays</span>. <span class="NLM_publisher-name">GENTEST Corp.</span>: <span class="NLM_publisher-loc">Woburn, MA</span>; <a href="http://www.bdj.co.jp/gentest/articles/hkdqj2000001c7w6-att/Poster2-6_Novel_HTS_CYP_I.pdf" class="extLink">http://www.bdj.co.jp/gentest/articles/hkdqj2000001c7w6-att/Poster2-6_Novel_HTS_CYP_I.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Miller%2C+V.+P.%3B+Ackermann%2C+J.%3B+Stresser%2C+D.+M.%3B+Crespi%2C+C.+L.+Novel+High+Throughput+Fluorescent+P450+Assays.+GENTEST+Corp.%3A+Woburn%2C+MA%3B+http%3A%2F%2Fwww.bdj.co.jp%2Fgentest%2Farticles%2Fhkdqj2000001c7w6-att%2FPoster2-6_Novel_HTS_CYP_I.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DV.%2BP.%26atitle%3DNovel%2520High%2520Throughput%2520Fluorescent%2520P450%2520Assays%26pub%3DGENTEST%2520Corp" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, Beta<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i106"><a href="/doi/suppl/10.1021/jm2016864">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62863"></div></div></div></div></div><hr /></hr><p class="last">Details of LC–MS methods. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2016864/suppl_file/jm2016864_si_001.pdf">jm2016864_si_001.pdf (135.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2016864&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm2016864%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2016864" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799200a2a1c22a8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
